assay,std_type,SMILES,std_value,std_units,standard_relation,molecule_chembl_id,activity_type,structure_curated,substance_type_name,pIC50
Inhibition of A-beta-42 production by inhibiting Gamma-secretase proteolytic pathway in HEK293 cell stably transfected with a double mutant form of human APP(K595N/M596L),IC50,CC12CCC(C1)C(C)(C)C2NS(=O)(=O)c1ccc(F)cc1,5000.0,nM,=,CHEMBL311039,active,CC12CCC(C1)C(C)(C)C2NS(=O)(=O)c1ccc(F)cc1,organic,5.301029995663981
Inhibition of A-beta-42 production by inhibiting Gamma-secretase proteolytic pathway in HEK293 cell stably transfected with a double mutant form of human APP(K595N/M596L),IC50,CC12CC[C@@H](C1)C(C)(C)[C@@H]2NS(=O)(=O)c1cccs1,2700.0,nM,=,CHEMBL450926,active,CC12CC[C@@H](C1)C(C)(C)[C@@H]2NS(=O)(=O)c1cccs1,organic,5.568636235841013
Inhibition of A-beta-42 production by inhibiting Gamma-secretase proteolytic pathway in HEK293 cell stably transfected with a double mutant form of human APP(K595N/M596L),IC50,CC12CC[C@@H](C1)C(C)(C)[C@@H]2NS(=O)(=O)c1ccc(F)cc1,1800.0,nM,=,CHEMBL310242,active,CC12CC[C@@H](C1)C(C)(C)[C@@H]2NS(=O)(=O)c1ccc(F)cc1,organic,5.7447274948966935
Inhibition of A-beta-42 production by inhibiting Gamma-secretase proteolytic pathway in HEK293 cell stably transfected with a double mutant form of human APP(K595N/M596L),IC50,CC12CC[C@@H](C1)C(C)(C)[C@@H]2NS(=O)(=O)c1ccc(Cl)cc1,11000.0,nM,=,CHEMBL74874,inactive,CC12CC[C@@H](C1)C(C)(C)[C@@H]2NS(=O)(=O)c1ccc(Cl)cc1,organic,4.958607314841775
Inhibition of A-beta-42 production by inhibiting Gamma-secretase proteolytic pathway in HEK293 cell stably transfected with a double mutant form of human APP(K595N/M596L),IC50,CC12CC[C@@H](C1)C(C)(C)[C@@H]2NS(=O)(=O)c1ccc(Br)cc1,10000.0,nM,=,CHEMBL75183,active,CC12CC[C@@H](C1)C(C)(C)[C@@H]2NS(=O)(=O)c1ccc(Br)cc1,organic,5.0
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1,305000.0,nM,=,CHEMBL563,inactive,CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1,organic,3.515700160653214
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC(C(=O)O)c1ccc(-c2ccc(Cl)c(Cl)c2)c(F)c1,75000.0,nM,=,CHEMBL196279,inactive,CC(C(=O)O)c1ccc(-c2ccc(Cl)c(Cl)c2)c(F)c1,organic,4.1249387366083
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC(C(=O)O)c1ccc(-c2cc(Cl)cc(Cl)c2)c(F)c1,77000.0,nM,=,CHEMBL195970,inactive,CC(C(=O)O)c1ccc(-c2cc(Cl)cc(Cl)c2)c(F)c1,organic,4.113509274827518
Concentration required to inhibit A beta 40 peptide,IC50,CC(C(=O)O)c1ccc(-c2cc(Cl)cc(Cl)c2)c(F)c1,94000.0,nM,=,CHEMBL195970,inactive,CC(C(=O)O)c1ccc(-c2cc(Cl)cc(Cl)c2)c(F)c1,organic,4.026872146400302
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC(C(=O)O)c1ccc(-c2ccc(C3CCCCC3)cc2)c(F)c1,21000.0,nM,=,CHEMBL264006,inactive,CC(C(=O)O)c1ccc(-c2ccc(C3CCCCC3)cc2)c(F)c1,organic,4.6777807052660805
Concentration required to inhibit A beta 40 peptide,IC50,CC(C(=O)O)c1ccc(-c2ccc(C3CCCCC3)cc2)c(F)c1,46000.0,nM,=,CHEMBL264006,inactive,CC(C(=O)O)c1ccc(-c2ccc(C3CCCCC3)cc2)c(F)c1,organic,4.337242168318426
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC(C(=O)O)c1ccc(-c2ccc(C(F)(F)F)cc2)c(F)c1,129000.0,nM,=,CHEMBL193971,inactive,CC(C(=O)O)c1ccc(-c2ccc(C(F)(F)F)cc2)c(F)c1,organic,3.8894102897007508
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC(C(=O)O)c1ccc(-c2csc3ccccc23)c(F)c1,83000.0,nM,=,CHEMBL194274,inactive,CC(C(=O)O)c1ccc(-c2csc3ccccc23)c(F)c1,organic,4.080921907623926
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,COc1ccc(-c2ccc(C(C)C(=O)O)cc2F)cc1,67000.0,nM,=,CHEMBL196321,inactive,COc1ccc(-c2ccc(C(C)C(=O)O)cc2F)cc1,organic,4.173925197299174
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC(C(=O)O)c1ccc(-c2ccc3c(c2)OCO3)c(F)c1,210000.0,nM,=,CHEMBL196322,inactive,CC(C(=O)O)c1ccc(-c2ccc3c(c2)OCO3)c(F)c1,organic,3.677780705266081
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC(C(=O)O)c1ccc(-c2ccc(OC3CCCCC3)cc2)c(F)c1,41000.0,nM,=,CHEMBL380778,inactive,CC(C(=O)O)c1ccc(-c2ccc(OC3CCCCC3)cc2)c(F)c1,organic,4.3872161432802645
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC(C(=O)O)c1ccc(-c2ccc(-c3ccc(O)cc3)cc2)c(F)c1,35000.0,nM,=,CHEMBL197202,inactive,CC(C(=O)O)c1ccc(-c2ccc(-c3ccc(O)cc3)cc2)c(F)c1,organic,4.455931955649724
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,O=C(O)C1(c2ccc(-c3ccc(C(F)(F)F)cc3)c(F)c2)CC1,111000.0,nM,=,CHEMBL196246,inactive,O=C(O)C1(c2ccc(-c3ccc(C(F)(F)F)cc3)c(F)c2)CC1,organic,3.9546770212133424
Concentration required to inhibit A beta 40 peptide 100 um,IC50,O=C(O)C1(c2ccc(-c3ccc(C(F)(F)F)cc3)c(F)c2)CC1,22000.0,nM,=,CHEMBL196246,inactive,O=C(O)C1(c2ccc(-c3ccc(C(F)(F)F)cc3)c(F)c2)CC1,organic,4.657577319177793
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,O=C(O)C1(c2ccc(-c3ccc(Cl)c(Cl)c3)c(F)c2)CC1,41000.0,nM,=,CHEMBL196945,inactive,O=C(O)C1(c2ccc(-c3ccc(Cl)c(Cl)c3)c(F)c2)CC1,organic,4.3872161432802645
Concentration required to inhibit A beta 40 peptide 100 uM,IC50,O=C(O)C1(c2ccc(-c3ccc(Cl)c(Cl)c3)c(F)c2)CC1,14000.0,nM,=,CHEMBL196945,inactive,O=C(O)C1(c2ccc(-c3ccc(Cl)c(Cl)c3)c(F)c2)CC1,organic,4.853871964321762
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,O=C(O)C1(c2ccc(-c3csc4ccccc34)c(F)c2)CC1,96300.0,nM,=,CHEMBL196946,inactive,O=C(O)C1(c2ccc(-c3csc4ccccc34)c(F)c2)CC1,organic,4.016373712875465
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC1(C)CCC(c2ccc(-c3ccc(C4(C(=O)O)CC4)cc3F)cc2)CC1,46000.0,nM,=,CHEMBL372751,inactive,CC1(C)CCC(c2ccc(-c3ccc(C4(C(=O)O)CC4)cc3F)cc2)CC1,organic,4.337242168318426
Concentration required to inhibit A beta 40 peptide 100 uM,IC50,CC1(C)CCC(c2ccc(-c3ccc(C4(C(=O)O)CC4)cc3F)cc2)CC1,101000.0,nM,=,CHEMBL372751,inactive,CC1(C)CCC(c2ccc(-c3ccc(C4(C(=O)O)CC4)cc3F)cc2)CC1,organic,3.9956786262173574
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC(C)(C(=O)O)c1ccc(-c2ccc(C(F)(F)F)cc2)c(F)c1,70600.0,nM,=,CHEMBL194692,inactive,CC(C)(C(=O)O)c1ccc(-c2ccc(C(F)(F)F)cc2)c(F)c1,organic,4.151195298948196
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,O=C(O)C1(c2ccc(-c3ccc(-c4ccc(O)cc4)cc3)c(F)c2)CC1,31600.0,nM,=,CHEMBL196947,inactive,O=C(O)C1(c2ccc(-c3ccc(-c4ccc(O)cc4)cc3)c(F)c2)CC1,organic,4.5003129173815966
Concentration required to inhibit A beta 40 peptide 100 uM,IC50,O=C(O)C1(c2ccc(-c3ccc(-c4ccc(O)cc4)cc3)c(F)c2)CC1,409000.0,nM,=,CHEMBL196947,inactive,O=C(O)C1(c2ccc(-c3ccc(-c4ccc(O)cc4)cc3)c(F)c2)CC1,organic,3.388276691992658
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,O=C(O)C1(c2ccc(-c3ccc(-c4ccc(O)cc4)c(F)c3)c(F)c2)CC1,33600.0,nM,=,CHEMBL372846,inactive,O=C(O)C1(c2ccc(-c3ccc(-c4ccc(O)cc4)c(F)c3)c(F)c2)CC1,organic,4.473660722610156
Concentration required to inhibit A beta 40 peptide,IC50,O=C(O)C1(c2ccc(-c3ccc(-c4ccc(O)cc4)c(F)c3)c(F)c2)CC1,111000.0,nM,=,CHEMBL372846,inactive,O=C(O)C1(c2ccc(-c3ccc(-c4ccc(O)cc4)c(F)c3)c(F)c2)CC1,organic,3.9546770212133424
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,O=C(O)C1(c2ccc(-c3ccc(-c4ccc(F)cc4)c(F)c3)c(F)c2)CC1,57900.0,nM,=,CHEMBL427548,inactive,O=C(O)C1(c2ccc(-c3ccc(-c4ccc(F)cc4)c(F)c3)c(F)c2)CC1,organic,4.2373214362725635
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC1(C)CC(Oc2ccc(-c3ccc(C4(C(=O)O)CC4)cc3F)cc2)CC(C)(C)C1,11000.0,nM,=,CHEMBL197140,inactive,CC1(C)CC(Oc2ccc(-c3ccc(C4(C(=O)O)CC4)cc3F)cc2)CC(C)(C)C1,organic,4.958607314841775
Concentration required to inhibit A beta 40 peptide,IC50,O=C(O)C1(c2ccc(-c3ccc(OC4CCOCC4)cc3)c(F)c2)CC1,81000.0,nM,=,CHEMBL382721,inactive,O=C(O)C1(c2ccc(-c3ccc(OC4CCOCC4)cc3)c(F)c2)CC1,organic,4.0915149811213505
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,O=C(O)C1(c2ccc(-c3ccc(OC4CCC(C(F)(F)F)CC4)cc3)c(F)c2)CC1,17700.0,nM,=,CHEMBL436483,inactive,O=C(O)C1(c2ccc(-c3ccc(OC4CCC(C(F)(F)F)CC4)cc3)c(F)c2)CC1,organic,4.752026733638194
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC(c1ccc(-c2ccc(C(F)(F)F)cc2)c(F)c1)c1nnn[nH]1,114000.0,nM,=,CHEMBL196070,inactive,CC(c1ccc(-c2ccc(C(F)(F)F)cc2)c(F)c1)c1nnn[nH]1,organic,3.9430951486635273
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,CC(C(N)=O)c1ccc(-c2cc(Cl)cc(Cl)c2)c(F)c1,64000.0,nM,=,CHEMBL193900,inactive,CC(C(N)=O)c1ccc(-c2cc(Cl)cc(Cl)c2)c(F)c1,organic,4.1938200260161125
Concentration required to inhibit A beta 40 peptide 100 uM,IC50,CC(C(N)=O)c1ccc(-c2cc(Cl)cc(Cl)c2)c(F)c1,12000.0,nM,=,CHEMBL193900,inactive,CC(C(N)=O)c1ccc(-c2cc(Cl)cc(Cl)c2)c(F)c1,organic,4.920818753952375
Concentration required to inhibit A beta 40 peptide 100 uM,IC50,CC(C(=O)OC(C)(C)C)c1ccc(-c2cc(Cl)cc(Cl)c2)c(F)c1,20000.0,nM,=,CHEMBL194020,inactive,CC(C(=O)OC(C)(C)C)c1ccc(-c2cc(Cl)cc(Cl)c2)c(F)c1,organic,4.698970004336019
Inhibitory concentration against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL),IC50,C[C@@H](C(=O)O)c1ccc(-c2ccccc2)c(F)c1,280000.0,nM,=,CHEMBL190083,inactive,C[C@@H](C(=O)O)c1ccc(-c2ccccc2)c(F)c1,organic,3.5528419686577806
Inhibition of soluble APPbeta N-terminal fragment secretion in cultured HEK293T cells,IC50,CCCN(CCC)C(=O)c1cccc(C(=O)N[C@@H](Cc2ccccc2)[C@@H](N)C[C@@H](C)C(=O)N[C@H](C(=O)NCc2ccccc2)C(C)C)c1,5.2,nM,=,CHEMBL199946,active,CCCN(CCC)C(=O)c1cccc(C(=O)N[C@@H](Cc2ccccc2)[C@@H](N)C[C@@H](C)C(=O)N[C@H](C(=O)NCc2ccccc2)C(C)C)c1,organic,8.2839966563652
Inhibition of soluble APPbeta N-terminal fragment secretion in cultured HEK293T cells,IC50,CCCN(CCC)C(=O)c1cccc(C(=O)N[C@@H](CC(C)C)[C@@H](N)C[C@@H](C)C(=O)Nc2ccc(F)cc2)c1,6000.0,nM,=,CHEMBL202877,active,CCCN(CCC)C(=O)c1cccc(C(=O)N[C@@H](CC(C)C)[C@@H](N)C[C@@H](C)C(=O)Nc2ccc(F)cc2)c1,organic,5.221848749616356
Inhibition of soluble APPbeta N-terminal fragment secretion in cultured HEK293T cells,IC50,CCCN(CCC)C(=O)c1cccc(C(=O)N[C@@H](CC(C)C)[C@H](N)C[C@@H](C)C(=O)N[C@H](C(=O)NCc2ccccc2)C(C)C)c1,9900.0,nM,=,CHEMBL200014,active,CCCN(CCC)C(=O)c1cccc(C(=O)N[C@@H](CC(C)C)[C@H](N)C[C@@H](C)C(=O)N[C@H](C(=O)NCc2ccccc2)C(C)C)c1,organic,5.00436480540245
Inhibition of soluble APPbeta N-terminal fragment secretion in cultured HEK293T cells,IC50,CCCN(CCC)C(=O)c1cccc(C(=O)N[C@@H](CC(C)C)[C@@H](N)C[C@@H](C)C(=O)N[C@H](C(=O)NCc2ccccc2)C(C)C)c1,740.0,nM,=,CHEMBL202507,active,CCCN(CCC)C(=O)c1cccc(C(=O)N[C@@H](CC(C)C)[C@@H](N)C[C@@H](C)C(=O)N[C@H](C(=O)NCc2ccccc2)C(C)C)c1,organic,6.130768280269024
Inhibition of soluble APPbeta N-terminal fragment secretion in cultured HEK293T cells,IC50,CCCN(CCC)C(=O)c1cccc(C(=O)N[C@@H](Cc2ccccc2)[C@@H](N)C[C@@H](C)C(=O)Nc2ccc(F)cc2)c1,180.0,nM,=,CHEMBL200077,active,CCCN(CCC)C(=O)c1cccc(C(=O)N[C@@H](Cc2ccccc2)[C@@H](N)C[C@@H](C)C(=O)Nc2ccc(F)cc2)c1,organic,6.7447274948966935
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(=O)NO)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Oc3ccccc3)c2)C1=O,200.0,nM,=,CHEMBL204357,active,CCC[C@H](C(=O)NO)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Oc3ccccc3)c2)C1=O,organic,6.698970004336019
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(=O)NO)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2ccccc2)C1=O,6800.0,nM,=,CHEMBL206766,active,CCC[C@H](C(=O)NO)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2ccccc2)C1=O,organic,5.167491087293763
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(=O)NC/C=C/Cc1ccccc1)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Oc3ccccc3)c2)C1=O,3000.0,nM,=,CHEMBL204443,active,CCC[C@H](C(=O)NC/C=C/Cc1ccccc1)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Oc3ccccc3)c2)C1=O,organic,5.522878745280337
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(=O)NC1CCCC1)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Oc3ccccc3)c2)C1=O,6000.0,nM,=,CHEMBL381336,active,CCC[C@H](C(=O)NC1CCCC1)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Oc3ccccc3)c2)C1=O,organic,5.221848749616356
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(=O)NCc1ccco1)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Oc3ccccc3)c2)C1=O,3000.0,nM,=,CHEMBL205400,active,CCC[C@H](C(=O)NCc1ccco1)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Oc3ccccc3)c2)C1=O,organic,5.522878745280337
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCCCNC(=O)[C@@H](CCC)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Oc3ccccc3)c2)C1=O,5000.0,nM,=,CHEMBL205714,active,CCCCNC(=O)[C@@H](CCC)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Oc3ccccc3)c2)C1=O,organic,5.301029995663981
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(NN3CCCCC3)c2)C1=O,74.0,nM,=,CHEMBL208230,active,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(NN3CCCCC3)c2)C1=O,organic,7.130768280269024
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3ccc(C(F)(F)F)cc3)c2)C1=O,30.0,nM,=,CHEMBL424684,active,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3ccc(C(F)(F)F)cc3)c2)C1=O,organic,7.522878745280337
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3ccc(OC)cc3)c2)C1=O,160.0,nM,=,CHEMBL274414,active,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3ccc(OC)cc3)c2)C1=O,organic,6.795880017344075
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3ccc(F)c(Cl)c3)c2)C1=O,17.0,nM,=,CHEMBL208504,active,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3ccc(F)c(Cl)c3)c2)C1=O,organic,7.769551078621726
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3ccc4c(c3)OCO4)c2)C1=O,152.0,nM,=,CHEMBL205970,active,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3ccc4c(c3)OCO4)c2)C1=O,organic,6.818156412055227
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3cccc(OC)c3)c2)C1=O,54.0,nM,=,CHEMBL410532,active,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3cccc(OC)c3)c2)C1=O,organic,7.267606240177032
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3cccc(C)c3)c2)C1=O,17.0,nM,=,CHEMBL208350,active,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3cccc(C)c3)c2)C1=O,organic,7.769551078621726
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3ccccc3Cl)c2)C1=O,29.0,nM,=,CHEMBL382880,active,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3ccccc3Cl)c2)C1=O,organic,7.5376020021010435
Inhibition of beta-amyloid peptide production in CHO N9 cell line,IC50,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3ccccc3)c2)C1=O,15.0,nM,=,CHEMBL205907,active,CCC[C@H](C(N)=O)[C@@H](CC(C)C)C(=O)N[C@H]1CCCCN(Cc2cccc(Nc3ccccc3)c2)C1=O,organic,7.823908740944319
Inhibition of gamma-secretase,IC50,CN1CCCC1CCNC(=O)OCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1,530.0,nM,=,CHEMBL231446,active,CN1CCCC1CCNC(=O)OCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1,organic,6.275724130399211
Inhibition of gamma-secretase,IC50,O=C(OC[C@H]1CCC[C@@H](c2ccccc2)N1S(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCCCC2)CC1,16.0,nM,=,CHEMBL396543,active,O=C(OC[C@H]1CCC[C@@H](c2ccccc2)N1S(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCCCC2)CC1,organic,7.795880017344075
Inhibition of gamma-secretase,IC50,O=C(OC[C@H]1CC[C@@H](c2ccccc2)N1S(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCCCC2)CC1,180.0,nM,=,CHEMBL231548,active,O=C(OC[C@H]1CC[C@@H](c2ccccc2)N1S(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCCCC2)CC1,organic,6.7447274948966935
Inhibition of gamma-secretase,IC50,O=C(NC1CCN(Cc2ccccc2)CC1)OC[C@H]1CC[C@@H](c2ccccc2)N1S(=O)(=O)c1ccc(Cl)cc1,140.0,nM,=,CHEMBL231547,active,O=C(NC1CCN(Cc2ccccc2)CC1)OC[C@H]1CC[C@@H](c2ccccc2)N1S(=O)(=O)c1ccc(Cl)cc1,organic,6.853871964321762
Inhibition of gamma-secretase,IC50,O=C(OC[C@H]1CC[C@@H](c2ccccc2)N1S(=O)(=O)c1ccc(Cl)cc1)N1CCN(C2CCCCC2)CC1,120.0,nM,=,CHEMBL231449,active,O=C(OC[C@H]1CC[C@@H](c2ccccc2)N1S(=O)(=O)c1ccc(Cl)cc1)N1CCN(C2CCCCC2)CC1,organic,6.920818753952375
Inhibition of gamma-secretase,IC50,O=C(OC[C@H]1CC[C@@H](c2ccccc2)N1S(=O)(=O)c1ccc(Cl)cc1)N1CCN(CCO)CC1,540.0,nM,=,CHEMBL231448,active,O=C(OC[C@H]1CC[C@@H](c2ccccc2)N1S(=O)(=O)c1ccc(Cl)cc1)N1CCN(CCO)CC1,organic,6.267606240177032
Inhibition of gamma-secretase,IC50,CN1CCN(C(=O)OC[C@H]2CC[C@@H](c3ccccc3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1,450.0,nM,=,CHEMBL396542,active,CN1CCN(C(=O)OC[C@H]2CC[C@@H](c3ccccc3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1,organic,6.346787486224656
Inhibition of gamma-secretase,IC50,O=C(NCCCn1ccnc1)OC[C@H]1CC[C@@H](c2ccccc2)N1S(=O)(=O)c1ccc(Cl)cc1,650.0,nM,=,CHEMBL231351,active,O=C(NCCCn1ccnc1)OC[C@H]1CC[C@@H](c2ccccc2)N1S(=O)(=O)c1ccc(Cl)cc1,organic,6.187086643357144
Inhibition of gamma-secretase,IC50,CN1CCCC1CCNC(=O)OC[C@H]1CC[C@@H](c2ccccc2)N1S(=O)(=O)c1ccc(Cl)cc1,600.0,nM,=,CHEMBL395313,active,CN1CCCC1CCNC(=O)OC[C@H]1CC[C@@H](c2ccccc2)N1S(=O)(=O)c1ccc(Cl)cc1,organic,6.221848749616356
Inhibition of gamma-secretase,IC50,O=C(OCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCCCC2)CC1,73.0,nM,=,CHEMBL231250,active,O=C(OCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCCCC2)CC1,organic,7.136677139879544
Inhibition of gamma-secretase,IC50,O=C(OCCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCCCC2)CC1,60.0,nM,=,CHEMBL231248,active,O=C(OCCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCCCC2)CC1,organic,7.221848749616356
Inhibition of gamma-secretase,IC50,O=C(OCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCCCC2)CC1,360.0,nM,=,CHEMBL395312,active,O=C(OCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCCCC2)CC1,organic,6.443697499232712
Inhibition of gamma-secretase,IC50,O=C(NC1CCN(Cc2ccccc2)CC1)OCCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1,190.0,nM,=,CHEMBL390889,active,O=C(NC1CCN(Cc2ccccc2)CC1)OCCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1,organic,6.721246399047171
Inhibition of gamma-secretase,IC50,O=C(NC1CCN(Cc2ccccc2)CC1)OCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1,900.0,nM,=,CHEMBL231647,active,O=C(NC1CCN(Cc2ccccc2)CC1)OCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1,organic,6.045757490560675
Inhibition of gamma-secretase,IC50,O=C(OCCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCN(C2CCCCC2)CC1,180.0,nM,=,CHEMBL231545,active,O=C(OCCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCN(C2CCCCC2)CC1,organic,6.7447274948966935
Inhibition of gamma-secretase,IC50,O=C(OCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCN(C2CCCCC2)CC1,1000.0,nM,=,CHEMBL231035,active,O=C(OCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCN(C2CCCCC2)CC1,organic,6.0
Inhibition of gamma-secretase,IC50,O=C(OCCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCN(CCO)CC1,680.0,nM,=,CHEMBL230931,active,O=C(OCCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCN(CCO)CC1,organic,6.167491087293763
Inhibition of gamma-secretase,IC50,O=C(OCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCN(CCO)CC1,880.0,nM,=,CHEMBL425304,active,O=C(OCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1)N1CCN(CCO)CC1,organic,6.055517327849832
Inhibition of gamma-secretase,IC50,CN1CCN(C(=O)OCCCC2CCc3ccccc3N2S(=O)(=O)c2ccc(Cl)cc2)CC1,780.0,nM,=,CHEMBL231125,active,CN1CCN(C(=O)OCCCC2CCc3ccccc3N2S(=O)(=O)c2ccc(Cl)cc2)CC1,organic,6.107905397309519
Inhibition of gamma-secretase,IC50,CN1CCN(C(=O)OCCC2CCc3ccccc3N2S(=O)(=O)c2ccc(Cl)cc2)CC1,1900.0,nM,=,CHEMBL390478,active,CN1CCN(C(=O)OCCC2CCc3ccccc3N2S(=O)(=O)c2ccc(Cl)cc2)CC1,organic,5.721246399047171
Inhibition of gamma-secretase,IC50,O=C(NCCCn1ccnc1)OCCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1,86.0,nM,=,CHEMBL231544,active,O=C(NCCCn1ccnc1)OCCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1,organic,7.0655015487564325
Inhibition of gamma-secretase,IC50,O=C(NCCCn1ccnc1)OCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1,280.0,nM,=,CHEMBL389549,active,O=C(NCCCn1ccnc1)OCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1,organic,6.552841968657781
Inhibition of gamma-secretase,IC50,CN1CCCC1CCNC(=O)OCCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1,220.0,nM,=,CHEMBL231447,active,CN1CCCC1CCNC(=O)OCCCC1CCc2ccccc2N1S(=O)(=O)c1ccc(Cl)cc1,organic,6.657577319177793
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,O=C(OC1([C@H]2CCC[C@@H](c3cc(F)cc(F)c3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCC(N2CCCCC2)CC1,0.3,nM,=,CHEMBL240055,active,O=C(OC1([C@H]2CCC[C@@H](c3cc(F)cc(F)c3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCC(N2CCCCC2)CC1,organic,9.522878745280337
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CC[C@@H](O)C3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,56.0,nM,=,CHEMBL240286,active,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CC[C@@H](O)C3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,organic,7.251811972993799
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CCC[C@@H]1CCC[C@H](C2(OC(=O)N3CC[C@@H](O)C3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,47.0,nM,=,CHEMBL240285,active,CCC[C@@H]1CCC[C@H](C2(OC(=O)N3CC[C@@H](O)C3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,organic,7.327902142064283
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,O=C(OC1([C@H]2CCC[C@@H](C3CC3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CC[C@@H](O)C1,46.0,nM,=,CHEMBL398395,active,O=C(OC1([C@H]2CCC[C@@H](C3CC3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CC[C@@H](O)C1,organic,7.337242168318426
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,O=C(OC1([C@H]2CCC[C@@H](c3cc(F)cc(F)c3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CC[C@@H](O)C1,17.0,nM,=,CHEMBL240284,active,O=C(OC1([C@H]2CCC[C@@H](c3cc(F)cc(F)c3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CC[C@@H](O)C1,organic,7.769551078621726
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,O=C(OC1([C@H]2CCC[C@@H](CC(F)(F)F)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCN(CCO)CC1,14.0,nM,=,CHEMBL240071,active,O=C(OC1([C@H]2CCC[C@@H](CC(F)(F)F)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCN(CCO)CC1,organic,7.853871964321762
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(CCO)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,12.0,nM,=,CHEMBL240070,active,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(CCO)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,organic,7.920818753952375
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,O=C(OC1([C@H]2CCC[C@@H](C3CC3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCN(CCO)CC1,27.0,nM,=,CHEMBL240069,active,O=C(OC1([C@H]2CCC[C@@H](C3CC3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCN(CCO)CC1,organic,7.568636235841013
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,O=C(OC1([C@H]2CCC[C@@H](CC(F)(F)F)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCC(N2CCCCC2)CC1,3.5,nM,=,CHEMBL442801,active,O=C(OC1([C@H]2CCC[C@@H](CC(F)(F)F)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCC(N2CCCCC2)CC1,organic,8.455931955649724
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,3.5,nM,=,CHEMBL239859,active,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,organic,8.455931955649724
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CCC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,2.5,nM,=,CHEMBL239858,active,CCC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,organic,8.602059991327963
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,O=C(OC1([C@H]2CCC[C@@H](C3CC3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCC(N2CCCCC2)CC1,2.8,nM,=,CHEMBL400420,active,O=C(OC1([C@H]2CCC[C@@H](C3CC3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCC(N2CCCCC2)CC1,organic,8.55284196865778
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,O=C(OC1([C@H]2CCC[C@@H](c3cc(F)cc(F)c3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCN(CCO)CC1,2.4,nM,=,CHEMBL239629,active,O=C(OC1([C@H]2CCC[C@@H](c3cc(F)cc(F)c3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCN(CCO)CC1,organic,8.619788758288394
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC(C)(CO)N1CCN(C(=O)OC2([C@H]3CCC[C@@H](C4CC4)N3S(=O)(=O)c3ccc(Cl)cc3)CC2)CC1,12.0,nM,=,CHEMBL393941,active,CC(C)(CO)N1CCN(C(=O)OC2([C@H]3CCC[C@@H](C4CC4)N3S(=O)(=O)c3ccc(Cl)cc3)CC2)CC1,organic,7.920818753952375
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,O=C(OC1([C@H]2CCC[C@@H](C3CC3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCN(CCCO)CC1,16.0,nM,=,CHEMBL236192,active,O=C(OC1([C@H]2CCC[C@@H](C3CC3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCN(CCCO)CC1,organic,7.795880017344075
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1cc(F)cc(F)c1,29.0,nM,=,CHEMBL429448,active,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1cc(F)cc(F)c1,organic,7.5376020021010435
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(C(C)(C)CO)CC3)CC2)N1S(=O)(=O)c1cc(F)cc(F)c1,81.0,nM,=,CHEMBL236191,active,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(C(C)(C)CO)CC3)CC2)N1S(=O)(=O)c1cc(F)cc(F)c1,organic,7.0915149811213505
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1ccc(F)c(F)c1,6.9,nM,=,CHEMBL236190,active,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1ccc(F)c(F)c1,organic,8.161150909262744
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CC4CCC(C3)N4CCO)CC2)N1S(=O)(=O)c1ccc(F)c(F)c1,27.0,nM,=,CHEMBL236189,active,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CC4CCC(C3)N4CCO)CC2)N1S(=O)(=O)c1ccc(F)c(F)c1,organic,7.568636235841013
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(C(C)(C)CO)CC3)CC2)N1S(=O)(=O)c1ccc(F)c(F)c1,9.6,nM,=,CHEMBL236188,active,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(C(C)(C)CO)CC3)CC2)N1S(=O)(=O)c1ccc(F)c(F)c1,organic,8.017728766960431
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1ccc(F)cc1,16.0,nM,=,CHEMBL236187,active,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1ccc(F)cc1,organic,7.795880017344075
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CC4CCC(C3)N4CCO)CC2)N1S(=O)(=O)c1ccc(F)cc1,25.0,nM,=,CHEMBL236186,active,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CC4CCC(C3)N4CCO)CC2)N1S(=O)(=O)c1ccc(F)cc1,organic,7.6020599913279625
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(C(C)(C)CO)CC3)CC2)N1S(=O)(=O)c1ccc(F)cc1,10.0,nM,=,CHEMBL236185,active,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(C(C)(C)CO)CC3)CC2)N1S(=O)(=O)c1ccc(F)cc1,organic,8.0
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CC4CCC(C3)N4CCO)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,3.5,nM,=,CHEMBL392060,active,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CC4CCC(C3)N4CCO)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,organic,8.455931955649724
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(C(C)(C)CO)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,6.9,nM,=,CHEMBL236184,active,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(C(C)(C)CO)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,organic,8.161150909262744
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(CCCO)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,17.0,nM,=,CHEMBL236183,active,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(CCCO)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,organic,7.769551078621726
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(CCO)C[C@@H]3C)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,12.0,nM,=,CHEMBL392059,active,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(CCO)C[C@@H]3C)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,organic,7.920818753952375
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(CCO)[C@@H](C)C3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,13.0,nM,=,CHEMBL236182,active,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(CCO)[C@@H](C)C3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,organic,7.886056647693163
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(CCO)(OC)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,9.0,nM,=,CHEMBL394132,active,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(CCO)(OC)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,organic,8.045757490560675
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CCCC1(O)CCN(C(=O)OC2([C@H]3CCC[C@@H](CC)N3S(=O)(=O)c3ccc(Cl)cc3)CC2)C1,28.0,nM,=,CHEMBL238271,active,CCCC1(O)CCN(C(=O)OC2([C@H]3CCC[C@@H](CC)N3S(=O)(=O)c3ccc(Cl)cc3)CC2)C1,organic,7.552841968657781
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(O)(CC)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,3.2,nM,=,CHEMBL392144,active,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(O)(CC)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,organic,8.494850021680094
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CCC1(O)CCN(C(=O)O[C@H]2CCC3CCCC2N3S(=O)(=O)c2ccc(Cl)cc2)CC1,104.0,nM,=,CHEMBL236196,active,CCC1(O)CCN(C(=O)O[C@H]2CCC3CCCC2N3S(=O)(=O)c2ccc(Cl)cc2)CC1,organic,6.982966660701219
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,CC(C)(CO)N1CCN(C(=O)O[C@H]2CCC3CCCC2N3S(=O)(=O)c2ccc(Cl)cc2)CC1,57.0,nM,=,CHEMBL429449,active,CC(C)(CO)N1CCN(C(=O)O[C@H]2CCC3CCCC2N3S(=O)(=O)c2ccc(Cl)cc2)CC1,organic,7.2441251443275085
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,O=C(O[C@@H]1CCC2CCCC1N2S(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCCCC2)CC1,2425.0,nM,=,CHEMBL236195,active,O=C(O[C@@H]1CCC2CCCC1N2S(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCCCC2)CC1,organic,5.615288257061717
Inhibition of gamma-secretase assessed as reduction of membrane A-beta-40 level,IC50,O=C(O[C@H]1CCC2CCCC1N2S(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCCCC2)CC1,15.0,nM,=,CHEMBL236193,active,O=C(O[C@H]1CCC2CCCC1N2S(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCCCC2)CC1,organic,7.823908740944319
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(O)(CC)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,4.3,nM,=,CHEMBL392144,active,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(O)(CC)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,organic,8.366531544420413
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CC(C)(CO)N1CCN(C(=O)OC2([C@H]3CCC[C@@H](C4CC4)N3S(=O)(=O)c3ccc(Cl)cc3)CC2)CC1,39.0,nM,=,CHEMBL393941,active,CC(C)(CO)N1CCN(C(=O)OC2([C@H]3CCC[C@@H](C4CC4)N3S(=O)(=O)c3ccc(Cl)cc3)CC2)CC1,organic,7.4089353929735005
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,O=C(OC1([C@H]2CCC[C@@H](C3CC3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCN(CCCO)CC1,32.0,nM,=,CHEMBL236192,active,O=C(OC1([C@H]2CCC[C@@H](C3CC3)N2S(=O)(=O)c2ccc(Cl)cc2)CC1)N1CCN(CCCO)CC1,organic,7.494850021680094
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1cc(F)cc(F)c1,144.0,nM,=,CHEMBL429448,active,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1cc(F)cc(F)c1,organic,6.841637507904751
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1ccc(F)c(F)c1,45.0,nM,=,CHEMBL236190,active,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1ccc(F)c(F)c1,organic,7.346787486224656
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(C(C)(C)CO)CC3)CC2)N1S(=O)(=O)c1ccc(F)c(F)c1,20.0,nM,=,CHEMBL236188,active,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(C(C)(C)CO)CC3)CC2)N1S(=O)(=O)c1ccc(F)c(F)c1,organic,7.698970004336019
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1ccc(F)cc1,115.0,nM,=,CHEMBL236187,active,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(N4CCCCC4)CC3)CC2)N1S(=O)(=O)c1ccc(F)cc1,organic,6.939302159646388
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(C(C)(C)CO)CC3)CC2)N1S(=O)(=O)c1ccc(F)cc1,25.0,nM,=,CHEMBL236185,active,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(C(C)(C)CO)CC3)CC2)N1S(=O)(=O)c1ccc(F)cc1,organic,7.6020599913279625
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CC4CCC(C3)N4CCO)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,7.7,nM,=,CHEMBL392060,active,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CC4CCC(C3)N4CCO)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,organic,8.113509274827518
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(C(C)(C)CO)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,8.3,nM,=,CHEMBL236184,active,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(C(C)(C)CO)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,organic,8.080921907623926
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(CCCO)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,15.0,nM,=,CHEMBL236183,active,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(CCCO)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,organic,7.823908740944319
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(CCO)C[C@@H]3C)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,14.0,nM,=,CHEMBL392059,active,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(CCO)C[C@@H]3C)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,organic,7.853871964321762
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(CCO)[C@@H](C)C3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,10.0,nM,=,CHEMBL236182,active,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCN(CCO)[C@@H](C)C3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,organic,8.0
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(CCO)(OC)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,20.0,nM,=,CHEMBL394132,active,CC[C@@H]1CCC[C@H](C2(OC(=O)N3CCC(CCO)(OC)CC3)CC2)N1S(=O)(=O)c1ccc(Cl)cc1,organic,7.698970004336019
Inhibition of gamma-secretase assessed as reduction of cell A-beta-40 level,IC50,CCCC1(O)CCN(C(=O)OC2([C@H]3CCC[C@@H](CC)N3S(=O)(=O)c3ccc(Cl)cc3)CC2)C1,190.0,nM,=,CHEMBL238271,active,CCCC1(O)CCN(C(=O)OC2([C@H]3CCC[C@@H](CC)N3S(=O)(=O)c3ccc(Cl)cc3)CC2)C1,organic,6.721246399047171
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1ccc(/C=C/c2cccc(/C=C/c3ccc(OC)c(N)c3)n2)cc1N,600.0,nM,=,CHEMBL392878,active,COc1ccc(/C=C/c2cccc(/C=C/c3ccc(OC)c(N)c3)n2)cc1N,organic,6.221848749616356
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,O=C(O)c1cc(/C=C/c2ccc(/C=C/c3ccc(O)c(C(=O)O)c3)c(I)c2)ccc1O,8000.0,nM,=,CHEMBL418455,active,O=C(O)c1cc(/C=C/c2ccc(/C=C/c3ccc(O)c(C(=O)O)c3)c(I)c2)ccc1O,organic,5.096910013008056
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,CN(C)c1ccc2cc3ccc(N(C)C)cc3nc2c1,600.0,nM,=,CHEMBL81880,active,CN(C)c1ccc2cc3ccc(N(C)C)cc3nc2c1,organic,6.221848749616356
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,800.0,nM,=,CHEMBL116438,active,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,organic,6.096910013008056
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2cc(Br)cc(/C=C/c3ccc(O)c(OC)c3)c2)ccc1O,100.0,nM,=,CHEMBL245688,active,COc1cc(/C=C/c2cc(Br)cc(/C=C/c3ccc(O)c(OC)c3)c2)ccc1O,organic,7.0
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1ccc(/C=C/c2cc(Br)cc(/C=C/c3ccc(OC)c(OC)c3)c2)cc1OC,20000.0,nM,=,CHEMBL245476,inactive,COc1ccc(/C=C/c2cc(Br)cc(/C=C/c3ccc(OC)c(OC)c3)c2)cc1OC,organic,4.698970004336019
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2cc(Br)cc(/C=C/c3ccc(N)c(OC)c3)c2)ccc1N,1800.0,nM,=,CHEMBL396917,active,COc1cc(/C=C/c2cc(Br)cc(/C=C/c3ccc(N)c(OC)c3)c2)ccc1N,organic,5.7447274948966935
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,CN(C)c1cc(/C=C/c2cccc(/C=C/c3ccc(O)c(N(C)C)c3)c2)ccc1O,2700.0,nM,=,CHEMBL248338,active,CN(C)c1cc(/C=C/c2cccc(/C=C/c3ccc(O)c(N(C)C)c3)c2)ccc1O,organic,5.568636235841013
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1ccc(/C=C/c2cccc(/C=C/c3ccc(OC)c(N(C)C)c3)c2)cc1N(C)C,1100.0,nM,=,CHEMBL248337,active,COc1ccc(/C=C/c2cccc(/C=C/c3ccc(OC)c(N(C)C)c3)c2)cc1N(C)C,organic,5.958607314841775
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,CNc1cc(/C=C/c2cccc(/C=C/c3ccc(OC)c(NC)c3)c2)ccc1OC,1300.0,nM,=,CHEMBL248133,active,CNc1cc(/C=C/c2cccc(/C=C/c3ccc(OC)c(NC)c3)c2)ccc1OC,organic,5.886056647693163
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1ccc(/C=C/c2cccc(/C=C/c3ccc(OC)c(N)c3)c2)cc1N,300.0,nM,=,CHEMBL248132,active,COc1ccc(/C=C/c2cccc(/C=C/c3ccc(OC)c(N)c3)c2)cc1N,organic,6.522878745280337
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,CN(C)c1ccc(/C=C/c2cccc(/C=C/c3ccc(N(C)C)c(O)c3)c2)cc1O,700.0,nM,=,CHEMBL248131,active,CN(C)c1ccc(/C=C/c2cccc(/C=C/c3ccc(N(C)C)c(O)c3)c2)cc1O,organic,6.154901959985743
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2cccc(/C=C/c3ccc(N(C)C)c(OC)c3)c2)ccc1N(C)C,1000.0,nM,=,CHEMBL247932,active,COc1cc(/C=C/c2cccc(/C=C/c3ccc(N(C)C)c(OC)c3)c2)ccc1N(C)C,organic,6.0
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,CNc1ccc(/C=C/c2cccc(/C=C/c3ccc(NC)c(OC)c3)c2)cc1OC,600.0,nM,=,CHEMBL247931,active,CNc1ccc(/C=C/c2cccc(/C=C/c3ccc(NC)c(OC)c3)c2)cc1OC,organic,6.221848749616356
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2cccc(/C=C/c3ccc(N)c(OC)c3)c2)ccc1N,600.0,nM,=,CHEMBL247930,active,COc1cc(/C=C/c2cccc(/C=C/c3ccc(N)c(OC)c3)c2)ccc1N,organic,6.221848749616356
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2cc(N(C)C)cc(/C=C/c3ccc(O)c(OC)c3)n2)ccc1O,1900.0,nM,=,CHEMBL247728,active,COc1cc(/C=C/c2cc(N(C)C)cc(/C=C/c3ccc(O)c(OC)c3)n2)ccc1O,organic,5.721246399047171
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2cc(C)cc(/C=C/c3ccc(O)c(OC)c3)n2)ccc1O,1400.0,nM,=,CHEMBL247727,active,COc1cc(/C=C/c2cc(C)cc(/C=C/c3ccc(O)c(OC)c3)n2)ccc1O,organic,5.853871964321762
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2ccc(O)c(OC)c2)nc(/C=C/c2ccc(O)c(OC)c2)c1,1700.0,nM,=,CHEMBL247726,active,COc1cc(/C=C/c2ccc(O)c(OC)c2)nc(/C=C/c2ccc(O)c(OC)c2)c1,organic,5.769551078621726
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2cc(Cl)cc(/C=C/c3ccc(O)c(OC)c3)n2)ccc1O,1100.0,nM,=,CHEMBL247530,active,COc1cc(/C=C/c2cc(Cl)cc(/C=C/c3ccc(O)c(OC)c3)n2)ccc1O,organic,5.958607314841775
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2cc(Br)cc(/C=C/c3ccc(O)c(OC)c3)n2)ccc1O,1100.0,nM,=,CHEMBL427878,active,COc1cc(/C=C/c2cc(Br)cc(/C=C/c3ccc(O)c(OC)c3)n2)ccc1O,organic,5.958607314841775
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2cccc(/C=C/c3ccc(O)c(OC)c3)n2)ccc1O,800.0,nM,=,CHEMBL247328,active,COc1cc(/C=C/c2cccc(/C=C/c3ccc(O)c(OC)c3)n2)ccc1O,organic,6.096910013008056
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2cc(Br)cc(/C=C/c3ccc(N)c(OC)c3)n2)ccc1N,1100.0,nM,=,CHEMBL247929,active,COc1cc(/C=C/c2cc(Br)cc(/C=C/c3ccc(N)c(OC)c3)n2)ccc1N,organic,5.958607314841775
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,CN(C)c1ccc(/C=C/c2cccc(/C=C/c3ccc(N(C)C)c(O)c3)n2)cc1O,900.0,nM,=,CHEMBL247927,active,CN(C)c1ccc(/C=C/c2cccc(/C=C/c3ccc(N(C)C)c(O)c3)n2)cc1O,organic,6.045757490560675
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2cccc(/C=C/c3ccc(N(C)C)c(OC)c3)n2)ccc1N(C)C,800.0,nM,=,CHEMBL391205,active,COc1cc(/C=C/c2cccc(/C=C/c3ccc(N(C)C)c(OC)c3)n2)ccc1N(C)C,organic,6.096910013008056
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,CNc1ccc(/C=C/c2cccc(/C=C/c3ccc(NC)c(O)c3)n2)cc1O,900.0,nM,=,CHEMBL247725,active,CNc1ccc(/C=C/c2cccc(/C=C/c3ccc(NC)c(O)c3)n2)cc1O,organic,6.045757490560675
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,CNc1ccc(/C=C/c2cccc(/C=C/c3ccc(NC)c(OC)c3)n2)cc1OC,500.0,nM,=,CHEMBL247674,active,CNc1ccc(/C=C/c2cccc(/C=C/c3ccc(NC)c(OC)c3)n2)cc1OC,organic,6.301029995663981
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1cc(/C=C/c2cccc(/C=C/c3ccc(N)c(OC)c3)n2)ccc1N,700.0,nM,=,CHEMBL247524,active,COc1cc(/C=C/c2cccc(/C=C/c3ccc(N)c(OC)c3)n2)ccc1N,organic,6.154901959985743
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,CN(C)c1cc(/C=C/c2cccc(/C=C/c3ccc(O)c(N(C)C)c3)n2)ccc1O,2300.0,nM,=,CHEMBL427877,active,CN(C)c1cc(/C=C/c2cccc(/C=C/c3ccc(O)c(N(C)C)c3)n2)ccc1O,organic,5.638272163982407
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,COc1ccc(/C=C/c2cccc(/C=C/c3ccc(OC)c(N(C)C)c3)n2)cc1N(C)C,900.0,nM,=,CHEMBL394713,active,COc1ccc(/C=C/c2cccc(/C=C/c3ccc(OC)c(N(C)C)c3)n2)cc1N(C)C,organic,6.045757490560675
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,CNc1cc(/C=C/c2cccc(/C=C/c3ccc(O)c(NC)c3)n2)ccc1O,500.0,nM,=,CHEMBL248327,active,CNc1cc(/C=C/c2cccc(/C=C/c3ccc(O)c(NC)c3)n2)ccc1O,organic,6.301029995663981
Inhibition of amyloid beta 42 fibril formation by thioflavin T assay,IC50,CNc1cc(/C=C/c2cccc(/C=C/c3ccc(OC)c(NC)c3)n2)ccc1OC,1100.0,nM,=,CHEMBL248122,active,CNc1cc(/C=C/c2cccc(/C=C/c3ccc(OC)c(NC)c3)n2)ccc1OC,organic,5.958607314841775
Inhibition of self-induced amyloid beta (1-40) aggregation by thioflavin T formation assay,IC50,CCN(CCCCCCN1C(=O)c2ccc3c4c(ccc(c24)C1=O)C(=O)N(CCCCCCN(CC)Cc1ccccc1OC)C3=O)Cc1ccccc1OC,9690.0,nM,=,CHEMBL450553,active,CCN(CCCCCCN1C(=O)c2ccc3c4c(ccc(c24)C1=O)C(=O)N(CCCCCCN(CC)Cc1ccccc1OC)C3=O)Cc1ccccc1OC,organic,5.013676222949234
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CN(C)c1ccc(/C=C/c2cc3ccccc3o2)cc1,2300.0,nM,=,CHEMBL492216,active,CN(C)c1ccc(/C=C/c2cc3ccccc3o2)cc1,organic,5.638272163982407
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,COc1ccc2oc(/C=C/c3ccc(N(C)C)cc3)cc2c1,810.0,nM,=,CHEMBL492217,active,COc1ccc2oc(/C=C/c3ccc(N(C)C)cc3)cc2c1,organic,6.0915149811213505
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CN(C)c1ccc(/C=C/c2cc3cc(O)ccc3o2)cc1,160.0,nM,=,CHEMBL491203,active,CN(C)c1ccc(/C=C/c2cc3cc(O)ccc3o2)cc1,organic,6.795880017344075
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,Cc1ccc2oc(/C=C/c3ccc(N(C)C)cc3)cc2c1,130.0,nM,=,CHEMBL509088,active,Cc1ccc2oc(/C=C/c3ccc(N(C)C)cc3)cc2c1,organic,6.886056647693163
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CN(C)c1ccc(/C=C/c2cc3cc(F)ccc3o2)cc1,1980.0,nM,=,CHEMBL489978,active,CN(C)c1ccc(/C=C/c2cc3cc(F)ccc3o2)cc1,organic,5.703334809738469
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CN(C)c1ccc(/C=C/c2cc3cc(Cl)ccc3o2)cc1,200.0,nM,=,CHEMBL446870,active,CN(C)c1ccc(/C=C/c2cc3cc(Cl)ccc3o2)cc1,organic,6.698970004336019
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CN(C)c1ccc(/C=C/c2cc3cc(Br)ccc3o2)cc1,470.0,nM,=,CHEMBL489979,active,CN(C)c1ccc(/C=C/c2cc3cc(Br)ccc3o2)cc1,organic,6.327902142064283
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CN(C)c1ccc(/C=C/c2cc3cc(I)ccc3o2)cc1,170.0,nM,=,CHEMBL524114,active,CN(C)c1ccc(/C=C/c2cc3cc(I)ccc3o2)cc1,organic,6.769551078621726
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,COc1ccc2cc(/C=C/c3ccc(N(C)C)cc3)oc2c1,70.0,nM,=,CHEMBL524141,active,COc1ccc2cc(/C=C/c3ccc(N(C)C)cc3)oc2c1,organic,7.154901959985743
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CN(C)c1ccc(/C=C/c2cc3ccc(O)cc3o2)cc1,3620.0,nM,=,CHEMBL443097,active,CN(C)c1ccc(/C=C/c2cc3ccc(O)cc3o2)cc1,organic,5.441291429466834
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,Cc1ccc2cc(/C=C/c3ccc(N(C)C)cc3)oc2c1,3440.0,nM,=,CHEMBL491406,active,Cc1ccc2cc(/C=C/c3ccc(N(C)C)cc3)oc2c1,organic,5.46344155742847
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CN(C)c1ccc(/C=C/c2cc3ccc(F)cc3o2)cc1,2190.0,nM,=,CHEMBL491407,active,CN(C)c1ccc(/C=C/c2cc3ccc(F)cc3o2)cc1,organic,5.6595558851598815
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CN(C)c1ccc(/C=C/c2cc3ccc(Cl)cc3o2)cc1,3210.0,nM,=,CHEMBL490798,active,CN(C)c1ccc(/C=C/c2cc3ccc(Cl)cc3o2)cc1,organic,5.493494967595128
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CN(C)c1ccc(/C=C/c2cc3ccc(Br)cc3o2)cc1,1340.0,nM,=,CHEMBL490799,active,CN(C)c1ccc(/C=C/c2cc3ccc(Br)cc3o2)cc1,organic,5.872895201635193
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CN(C)c1ccc(/C=C/c2cc3ccc(I)cc3o2)cc1,2800.0,nM,=,CHEMBL492023,active,CN(C)c1ccc(/C=C/c2cc3ccc(I)cc3o2)cc1,organic,5.552841968657781
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,COc1ccc2oc(/C=C/c3ccc(N)cc3)cc2c1,820.0,nM,=,CHEMBL492024,active,COc1ccc2oc(/C=C/c3ccc(N)cc3)cc2c1,organic,6.086186147616283
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CNc1ccc(/C=C/c2cc3cc(OC)ccc3o2)cc1,80.0,nM,=,CHEMBL523824,active,CNc1ccc(/C=C/c2cc3cc(OC)ccc3o2)cc1,organic,7.096910013008056
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,COc1ccc2cc(/C=C/c3ccc(N)cc3)oc2c1,5440.0,nM,=,CHEMBL490806,active,COc1ccc2cc(/C=C/c3ccc(N)cc3)oc2c1,organic,5.26440110030182
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,CNc1ccc(/C=C/c2cc3ccc(OC)cc3o2)cc1,800.0,nM,=,CHEMBL489994,active,CNc1ccc(/C=C/c2cc3ccc(OC)cc3o2)cc1,organic,6.096910013008056
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,COc1ccc2oc(/C=C/c3ccc(N(C)C)c(OC)c3)cc2c1,160.0,nM,=,CHEMBL489792,active,COc1ccc2oc(/C=C/c3ccc(N(C)C)c(OC)c3)cc2c1,organic,6.795880017344075
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,COc1ccc2cc(/C=C/c3ccc(N(C)C)c(OC)c3)oc2c1,530.0,nM,=,CHEMBL521929,active,COc1ccc2cc(/C=C/c3ccc(N(C)C)c(OC)c3)oc2c1,organic,6.275724130399211
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,800.0,nM,=,CHEMBL116438,active,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,organic,6.096910013008056
Inhibition of amyloid beta42 fibril formation by thioflavin T formation,IC50,O=C(O)c1cc(/C=C/c2ccc(/C=C/c3ccc(O)c(C(=O)O)c3)c(I)c2)ccc1O,8000.0,nM,=,CHEMBL418455,active,O=C(O)c1cc(/C=C/c2ccc(/C=C/c3ccc(O)c(C(=O)O)c3)c(I)c2)ccc1O,organic,5.096910013008056
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,[3H]N(c1ccc(-c2nc3ccc(O)cc3s2)cc1)C([3H])([3H])[3H],27.0,nM,=,CHEMBL1788111,active,[3H]N(c1ccc(-c2nc3ccc(O)cc3s2)cc1)C([3H])([3H])[3H],organic,7.568636235841013
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,[3H]N(c1ccc(-c2nc3ccc(O)cc3s2)cn1)C([3H])([3H])[3H],58.0,nM,=,CHEMBL1788121,active,[3H]N(c1ccc(-c2nc3ccc(O)cc3s2)cn1)C([3H])([3H])[3H],organic,7.236572006437063
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,[3H]N(c1ccc(-c2nc3ccc(OC)cc3s2)cn1)C([3H])([3H])[3H],58.0,nM,=,CHEMBL1744459,active,[3H]N(c1ccc(-c2nc3ccc(OC)cc3s2)cn1)C([3H])([3H])[3H],organic,7.236572006437063
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,[3H]C([3H])([3H])N(c1ccc(-c2nc3ccc(O)cc3s2)cn1)C([3H])([3H])[3H],19.0,nM,=,CHEMBL1744460,active,[3H]C([3H])([3H])N(c1ccc(-c2nc3ccc(O)cc3s2)cn1)C([3H])([3H])[3H],organic,7.721246399047171
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,COc1ccc2nc(-c3ccc(N(C)C)nc3)sc2c1,81.0,nM,=,CHEMBL1082545,active,COc1ccc2nc(-c3ccc(N(C)C)nc3)sc2c1,organic,7.0915149811213505
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,CNc1ccc(-c2nc3cc(O)ccc3s2)cn1,74.0,nM,=,CHEMBL1082546,active,CNc1ccc(-c2nc3cc(O)ccc3s2)cn1,organic,7.130768280269024
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,CN(C)c1ncc(-c2nc3ccc(O)cc3s2)cn1,41.0,nM,=,CHEMBL1088617,active,CN(C)c1ncc(-c2nc3ccc(O)cc3s2)cn1,organic,7.3872161432802645
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,CNc1ncc(-c2nc3ccc(O)cc3s2)cn1,267.0,nM,=,CHEMBL1077196,active,CNc1ncc(-c2nc3ccc(O)cc3s2)cn1,organic,6.573488738635425
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,CNc1ccc(-c2nc3ccc(C(N)=O)cc3s2)cn1,85.0,nM,=,CHEMBL1087548,active,CNc1ccc(-c2nc3ccc(C(N)=O)cc3s2)cn1,organic,7.070581074285707
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,CNc1ccc2nc(-c3ccc(C(N)=O)nc3)sc2c1,35.0,nM,=,CHEMBL1077208,active,CNc1ccc2nc(-c3ccc(C(N)=O)nc3)sc2c1,organic,7.455931955649724
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,[3H]N(c1ccc(-c2nc3ccc(O)cc3o2)cn1)C([3H])([3H])[3H],182.0,nM,=,CHEMBL1744461,active,[3H]N(c1ccc(-c2nc3ccc(O)cc3o2)cn1)C([3H])([3H])[3H],organic,6.739928612014925
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,[3H]C([3H])([3H])N(c1ccc(-c2nc3ccc(OC)cc3o2)cn1)C([3H])([3H])[3H],204.0,nM,=,CHEMBL1744462,active,[3H]C([3H])([3H])N(c1ccc(-c2nc3ccc(OC)cc3o2)cn1)C([3H])([3H])[3H],organic,6.690369832574102
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,CNc1ccc(-c2nc3ccc(OC)cc3o2)cn1,185.0,nM,=,CHEMBL1082889,active,CNc1ccc(-c2nc3ccc(OC)cc3o2)cn1,organic,6.732828271596986
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,[3H]C([3H])([3H])N(c1ccc(-c2nc3ccc(O)cc3o2)cn1)C([3H])([3H])[3H],85.0,nM,=,CHEMBL1744463,active,[3H]C([3H])([3H])N(c1ccc(-c2nc3ccc(O)cc3o2)cn1)C([3H])([3H])[3H],organic,7.070581074285707
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,CN(C)c1ccc(-c2nc3cc(O)ccc3o2)cn1,137.0,nM,=,CHEMBL1083207,active,CN(C)c1ccc(-c2nc3cc(O)ccc3o2)cn1,organic,6.863279432843593
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,[3H]C([3H])([3H])N(c1ncc(-c2nc3ccc(O)cc3o2)cn1)C([3H])([3H])[3H],75.0,nM,=,CHEMBL1744464,active,[3H]C([3H])([3H])N(c1ncc(-c2nc3ccc(O)cc3o2)cn1)C([3H])([3H])[3H],organic,7.1249387366083
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,CNc1ccc(-c2cc3ccc(O)cc3o2)cn1,45.0,nM,=,CHEMBL1084943,active,CNc1ccc(-c2cc3ccc(O)cc3o2)cn1,organic,7.346787486224656
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,CNc1ccc(-c2cc3ccc(OC)cc3o2)cn1,66.0,nM,=,CHEMBL1084944,active,CNc1ccc(-c2cc3ccc(OC)cc3o2)cn1,organic,7.180456064458132
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,COc1ccc2cc(-c3ccc(C(N)=O)nc3)oc2c1,60.0,nM,=,CHEMBL1084945,active,COc1ccc2cc(-c3ccc(C(N)=O)nc3)oc2c1,organic,7.221848749616356
Displacement of [3H]PIB from human amyloid beta (1 to 40) after 30 mins by liquid scintillation counting,IC50,COc1ccc2cc(-c3ccc(C(N)=O)cn3)oc2c1,33.0,nM,=,CHEMBL1084946,active,COc1ccc2cc(-c3ccc(C(N)=O)cn3)oc2c1,organic,7.481486060122112
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,CNc1ccc(-c2nc3ccc(O)cc3s2)cc1,19.0,nM,=,CHEMBL93124,active,CNc1ccc(-c2nc3ccc(O)cc3s2)cc1,organic,7.721246399047171
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,CNc1ccc(-c2nc3ccc(O)cc3s2)cn1,22.0,nM,=,CHEMBL570378,active,CNc1ccc(-c2nc3ccc(O)cc3s2)cn1,organic,7.657577319177793
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,Oc1ccc2nc(-c3ccc(NCCF)nc3)oc2c1,158.0,nM,=,CHEMBL2048299,active,Oc1ccc2nc(-c3ccc(NCCF)nc3)oc2c1,organic,6.801342913045577
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,COc1ccc2nc(-c3ccc(NCCF)nc3)oc2c1,35.0,nM,=,CHEMBL2048300,active,COc1ccc2nc(-c3ccc(NCCF)nc3)oc2c1,organic,7.455931955649724
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,Oc1ccc2nc(-c3ccc(NCCCF)nc3)oc2c1,395.0,nM,=,CHEMBL2048301,active,Oc1ccc2nc(-c3ccc(NCCCF)nc3)oc2c1,organic,6.403402904373539
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,Oc1ccc2nc(-c3ccc(NCCF)nc3)sc2c1,33.0,nM,=,CHEMBL2048302,active,Oc1ccc2nc(-c3ccc(NCCF)nc3)sc2c1,organic,7.481486060122112
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,Oc1ccc2nc(-c3ccc(NCCCF)nc3)sc2c1,66.0,nM,=,CHEMBL2048303,active,Oc1ccc2nc(-c3ccc(NCCCF)nc3)sc2c1,organic,7.180456064458132
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,CNc1ccc(-c2nc3ccc(O)cc3s2)cc1F,24.0,nM,=,CHEMBL579205,active,CNc1ccc(-c2nc3ccc(O)cc3s2)cc1F,organic,7.619788758288394
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,CNc1ccc(-c2nc3ccc(O)cc3s2)nc1F,44.0,nM,=,CHEMBL2048304,active,CNc1ccc(-c2nc3ccc(O)cc3s2)nc1F,organic,7.356547323513812
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,CNc1ccc(-c2nc3ccc(OC)cc3s2)c(F)n1,14.0,nM,=,CHEMBL2048305,active,CNc1ccc(-c2nc3ccc(OC)cc3s2)c(F)n1,organic,7.853871964321762
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,CNc1ccc(-c2nc3ccc(O)cc3s2)c(F)n1,124.0,nM,=,CHEMBL2048306,active,CNc1ccc(-c2nc3ccc(O)cc3s2)c(F)n1,organic,6.906578314837765
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,CNc1ncc(-c2nc3ccc(O)cc3s2)cc1F,98.0,nM,=,CHEMBL2048307,active,CNc1ncc(-c2nc3ccc(O)cc3s2)cc1F,organic,7.008773924307505
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,CNc1ccc(-c2cc3cc(O)ccc3o2)c(F)n1,24.0,nM,=,CHEMBL2048308,active,CNc1ccc(-c2cc3cc(O)ccc3o2)c(F)n1,organic,7.619788758288394
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,CNc1ccc(-c2cc3cc(C(N)=O)ccc3o2)c(F)n1,19.0,nM,=,CHEMBL2048309,active,CNc1ccc(-c2cc3cc(C(N)=O)ccc3o2)c(F)n1,organic,7.721246399047171
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,CNc1ncc(-c2cc3cc(O)ccc3o2)cc1F,30.0,nM,=,CHEMBL2048310,active,CNc1ncc(-c2cc3cc(O)ccc3o2)cc1F,organic,7.522878745280337
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,COc1ccc2oc(-c3ccc(C(N)=O)nc3F)cc2c1,32.0,nM,=,CHEMBL2048311,active,COc1ccc2oc(-c3ccc(C(N)=O)nc3F)cc2c1,organic,7.494850021680094
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,NC(=O)c1ccc(-c2cc3cc(O)ccc3o2)c(F)n1,44.0,nM,=,CHEMBL2048312,active,NC(=O)c1ccc(-c2cc3cc(O)ccc3o2)c(F)n1,organic,7.356547323513812
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,CNc1ccc(-c2cc3cc(O)ccc3o2)nc1F,35.0,nM,=,CHEMBL2048313,active,CNc1ccc(-c2cc3cc(O)ccc3o2)nc1F,organic,7.455931955649724
Displacement of [3H]AZD2184 from human amyloid beta(1 to 40),IC50,CNc1ccc(-c2cc3cc(C(N)=O)ccc3o2)nc1F,32.0,nM,=,CHEMBL2048314,active,CNc1ccc(-c2cc3cc(C(N)=O)ccc3o2)nc1F,organic,7.494850021680094
Inhibition of amyloid beta (1 to 42) fibril formation after 1 hr by ThT spectrofluorometric analysis,IC50,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)ncn2)ccc1O,3200.0,nM,=,CHEMBL2059203,active,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)ncn2)ccc1O,organic,5.494850021680094
Inhibition of amyloid beta (1 to 42) fibril formation after 1 hr by ThT spectrofluorometric analysis,IC50,COc1ccc(/C=C/c2cc(/C=C/c3ccc(OC)c(O)c3)ncn2)cc1O,2100.0,nM,=,CHEMBL2059204,active,COc1ccc(/C=C/c2cc(/C=C/c3ccc(OC)c(O)c3)ncn2)cc1O,organic,5.6777807052660805
Inhibition of amyloid beta (1 to 42) fibril formation after 1 hr by ThT spectrofluorometric analysis,IC50,CN(C)c1cc(/C=C/c2cc(/C=C/c3ccc(O)c(N(C)C)c3)ncn2)ccc1O,3700.0,nM,=,CHEMBL2059205,active,CN(C)c1cc(/C=C/c2cc(/C=C/c3ccc(O)c(N(C)C)c3)ncn2)ccc1O,organic,5.431798275933005
Inhibition of amyloid beta (1 to 42) fibril formation after 1 hr by ThT spectrofluorometric analysis,IC50,CN(C)c1ccc(/C=C/c2cc(/C=C/c3ccc(N(C)C)c(O)c3)ncn2)cc1O,3400.0,nM,=,CHEMBL2059206,active,CN(C)c1ccc(/C=C/c2cc(/C=C/c3ccc(N(C)C)c(O)c3)ncn2)cc1O,organic,5.468521082957745
Inhibition of amyloid beta (1 to 42) fibril formation after 1 hr by ThT spectrofluorometric analysis,IC50,COc1nc(/C=C/c2ccc(N(C)C)c(O)c2)cc(/C=C/c2ccc(N(C)C)c(O)c2)n1,800.0,nM,=,CHEMBL2059212,active,COc1nc(/C=C/c2ccc(N(C)C)c(O)c2)cc(/C=C/c2ccc(N(C)C)c(O)c2)n1,organic,6.096910013008056
Inhibition of amyloid beta (1 to 42) fibril formation after 1 hr by ThT spectrofluorometric analysis,IC50,CSc1nc(/C=C/c2ccc(N(C)C)c(O)c2)cc(/C=C/c2ccc(N(C)C)c(O)c2)n1,1100.0,nM,=,CHEMBL2059218,active,CSc1nc(/C=C/c2ccc(N(C)C)c(O)c2)cc(/C=C/c2ccc(N(C)C)c(O)c2)n1,organic,5.958607314841775
Inhibition of amyloid beta (1 to 42) fibril formation after 1 hr by ThT spectrofluorometric analysis,IC50,Oc1ccc(/C=C/c2cc(O)cc(/C=C/c3ccc(O)cc3)c2)cc1,1600.0,nM,=,CHEMBL2059388,active,Oc1ccc(/C=C/c2cc(O)cc(/C=C/c3ccc(O)cc3)c2)cc1,organic,5.795880017344075
Inhibition of amyloid beta (1 to 42) fibril formation after 1 hr by ThT spectrofluorometric analysis,IC50,COc1ccc(/C=C/c2cc(O)cc(/C=C/c3ccc(OC)c(O)c3)c2)cc1O,1600.0,nM,=,CHEMBL2059391,active,COc1ccc(/C=C/c2cc(O)cc(/C=C/c3ccc(OC)c(O)c3)c2)cc1O,organic,5.795880017344075
Inhibition of amyloid beta (1 to 42) fibril formation after 1 hr by ThT spectrofluorometric analysis,IC50,CN(C)c1ccc(/C=C/c2cc(O)cc(/C=C/c3ccc(N(C)C)c(O)c3)c2)cc1O,3300.0,nM,=,CHEMBL2059393,active,CN(C)c1ccc(/C=C/c2cc(O)cc(/C=C/c3ccc(N(C)C)c(O)c3)c2)cc1O,organic,5.481486060122113
Inhibition of amyloid beta42 aggregation assessed as reduction in fluorescence after 4 days by thioflavin T-based fluorometry,IC50,Cc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)c(/N=C/c2cc(Cl)cc(Cl)c2O)c1,13000.0,nM,=,CHEMBL2063873,inactive,Cc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)c(/N=C/c2cc(Cl)cc(Cl)c2O)c1,organic,4.886056647693163
Inhibition of amyloid beta42 aggregation assessed as reduction in fluorescence measured immediately post-compound addition by thioflavin T-based fluorometry,IC50,Cc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)c(/N=C/c2cc(Cl)cc(Cl)c2O)c1,62000.0,nM,=,CHEMBL2063873,inactive,Cc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)c(/N=C/c2cc(Cl)cc(Cl)c2O)c1,organic,4.207608310501746
Inhibition of amyloid beta42 aggregation assessed as reduction in fluorescence measured immediately post-compound addition by thioflavin T-based fluorometry,IC50,Cc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)c(N)c1,30000.0,nM,=,CHEMBL2063874,inactive,Cc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)c(N)c1,organic,4.522878745280337
Inhibition of amyloid beta42 aggregation assessed as reduction in fluorescence after 4 days by thioflavin T-based fluorometry,IC50,Cc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)c(N)c1,23000.0,nM,=,CHEMBL2063874,inactive,Cc1ccc(NS(=O)(=O)c2ccc(Cl)cc2)c(N)c1,organic,4.638272163982407
Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,O=C(O)/C=C/c1ccc(O)c(O)c1,32800.0,nM,=,CHEMBL145,inactive,O=C(O)/C=C/c1ccc(O)c(O)c1,organic,4.484126156288321
Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](O)[C@H]1O,92900.0,nM,=,CHEMBL284616,inactive,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](O)[C@H]1O,organic,4.031984286006359
Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H]1O,16400.0,nM,=,CHEMBL249447,inactive,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H]1O,organic,4.785156151952302
Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1[C@H](O)C[C@@](O)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,4700.0,nM,=,CHEMBL249448,active,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1[C@H](O)C[C@@](O)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,organic,5.327902142064283
Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H]1[C@H](O)C[C@](O)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,100.0,nM,=,CHEMBL177126,active,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H]1[C@H](O)C[C@](O)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,organic,7.0
Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H]1[C@H](O)C[C@](OC(=O)/C=C/c2ccc(O)c(O)c2)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,2200.0,nM,=,CHEMBL2146607,active,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H]1[C@H](O)C[C@](OC(=O)/C=C/c2ccc(O)c(O)c2)(C(=O)O)C[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,organic,5.657577319177793
Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,300.0,nM,=,CHEMBL499997,active,O=C(/C=C/c1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H]1OC(=O)/C=C/c1ccc(O)c(O)c1,organic,6.522878745280337
Inhibition of human amyloid beta (1 to 42) aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,COC(=O)[C@]1(O)C[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H](OC(=O)/C=C/c2ccc(O)c(O)c2)C1,3000.0,nM,=,CHEMBL2146608,active,COC(=O)[C@]1(O)C[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H](OC(=O)/C=C/c2ccc(O)c(O)c2)C1,organic,5.522878745280337
Inhibition of aggregation of human DHFR-fused amyloid beta (1 to 42) expressed in yeast harboring erg6delta assessed as increase in yeast viability measured up to 20 hrs in presence of MTX,IC50,Nc1c(S(=O)(=O)c2ccc(Cl)cc2)cnc2cc(-c3ccccc3)nn12,2300.0,nM,=,CHEMBL2179241,active,Nc1c(S(=O)(=O)c2ccc(Cl)cc2)cnc2cc(-c3ccccc3)nn12,organic,5.638272163982407
Inhibition of aggregation of human DHFR-fused amyloid beta (1 to 42) expressed in yeast harboring erg6delta assessed as increase in yeast viability measured up to 20 hrs in presence of MTX,IC50,O=C(Nc1ccccc1)Nc1ccc(Cl)cc1[N+](=O)[O-],900.0,nM,=,CHEMBL2179242,active,O=C(Nc1ccccc1)Nc1ccc(Cl)cc1[N+](=O)[O-],organic,6.045757490560675
Inhibition of aggregation of human DHFR-fused amyloid beta (1 to 42) expressed in yeast harboring erg6delta assessed as increase in yeast viability measured up to 20 hrs in presence of MTX,IC50,O=S(=O)(Nc1ccc(N2CCCCC2)cc1)c1cc(Cl)sc1Cl,700.0,nM,=,CHEMBL2179243,active,O=S(=O)(Nc1ccc(N2CCCCC2)cc1)c1cc(Cl)sc1Cl,organic,6.154901959985743
Inhibition of aggregation of human DHFR-fused amyloid beta (1 to 42) expressed in yeast harboring erg6delta assessed as increase in yeast viability measured up to 20 hrs in presence of MTX,IC50,Cc1nc2sc3c(c2c(=O)o1)CCCC3,1200.0,nM,=,CHEMBL1458517,active,Cc1nc2sc3c(c2c(=O)o1)CCCC3,organic,5.920818753952375
Binding affinity to human amyloid beta plaque,IC50,Cn1ncc2cc(-c3nc4ccc(F)nc4o3)ccc21,48.7,nM,=,CHEMBL2203390,active,Cn1ncc2cc(-c3nc4ccc(F)nc4o3)ccc21,organic,7.3124710387853655
Binding affinity to human amyloid beta plaque,IC50,Fc1ccc2nc(-c3ccc4cc[nH]c4c3)oc2n1,45.3,nM,=,CHEMBL2203389,active,Fc1ccc2nc(-c3ccc4cc[nH]c4c3)oc2n1,organic,7.343901797987168
Binding affinity to human amyloid beta plaque,IC50,Fc1ccc2nc(-c3ccc4ncsc4c3)oc2n1,35.8,nM,=,CHEMBL2203388,active,Fc1ccc2nc(-c3ccc4ncsc4c3)oc2n1,organic,7.446116973356125
Binding affinity to human amyloid beta plaque,IC50,Cn1ncc2cc(-c3nc4ccc(F)nc4o3)cnc21,30.2,nM,=,CHEMBL2203387,active,Cn1ncc2cc(-c3nc4ccc(F)nc4o3)cnc21,organic,7.519993057042849
Binding affinity to human amyloid beta plaque,IC50,CN1CCc2cc(-c3nc4ccc(F)nc4o3)cnc21,47.0,nM,=,CHEMBL2203386,active,CN1CCc2cc(-c3nc4ccc(F)nc4o3)cnc21,organic,7.327902142064283
Binding affinity to human amyloid beta plaque,IC50,Cn1ccc2cc(-c3nc4ccc(F)nc4o3)cnc21,10.5,nM,=,CHEMBL2203385,active,Cn1ccc2cc(-c3nc4ccc(F)nc4o3)cnc21,organic,7.978810700930062
Binding affinity to human amyloid beta plaque,IC50,Fc1ccc2nc(-c3cnc4[nH]ccc4c3)oc2n1,25.7,nM,=,CHEMBL2203384,active,Fc1ccc2nc(-c3cnc4[nH]ccc4c3)oc2n1,organic,7.590066876668706
Binding affinity to human amyloid beta plaque,IC50,Cn1ccc2cc(-c3nc4ccc(F)nc4o3)ccc21,8.0,nM,=,CHEMBL2203383,active,Cn1ccc2cc(-c3nc4ccc(F)nc4o3)ccc21,organic,8.096910013008056
Binding affinity to human amyloid beta plaque,IC50,Fc1ccc2nc(-c3ccc4[nH]ccc4c3)oc2n1,13.8,nM,=,CHEMBL2203382,active,Fc1ccc2nc(-c3ccc4[nH]ccc4c3)oc2n1,organic,7.860120913598763
Binding affinity to human amyloid beta plaque,IC50,CN(C)c1ccc(-c2nc3ccc(F)nc3o2)cn1,41.8,nM,=,CHEMBL2203381,active,CN(C)c1ccc(-c2nc3ccc(F)nc3o2)cn1,organic,7.3788237182249645
Binding affinity to human amyloid beta plaque,IC50,CNc1ccc(-c2nc3ccc(F)nc3o2)cn1,102.0,nM,=,CHEMBL2203380,active,CNc1ccc(-c2nc3ccc(F)nc3o2)cn1,organic,6.991399828238082
Binding affinity to human amyloid beta plaque,IC50,CN(C)c1ccc(-c2nc3ccc(F)nc3o2)cc1,4.0,nM,=,CHEMBL2203379,active,CN(C)c1ccc(-c2nc3ccc(F)nc3o2)cc1,organic,8.397940008672037
Binding affinity to human amyloid beta plaque,IC50,CNc1ccc(-c2nc3ccc(F)nc3o2)cc1,23.1,nM,=,CHEMBL2203378,active,CNc1ccc(-c2nc3ccc(F)nc3o2)cc1,organic,7.636388020107856
Binding affinity to human amyloid beta plaque,IC50,COc1ccc(-c2nc3ccc(F)nc3o2)cc1,32.5,nM,=,CHEMBL2203288,active,COc1ccc(-c2nc3ccc(F)nc3o2)cc1,organic,7.488116639021126
Inhibition of amyloid-beta40 (unknown origin) aggregation by congo red spectral-shift assay,IC50,Oc1ccc(-c2ccc(O)c(O)c2)cc1O,1000.0,nM,=,CHEMBL2337291,active,Oc1ccc(-c2ccc(O)c(O)c2)cc1O,organic,6.0
Inhibition of amyloid-beta40 (unknown origin) aggregation by congo red spectral-shift assay,IC50,Oc1ccc(-c2ccccc2-c2ccc(O)c(O)c2)cc1O,2700.0,nM,=,CHEMBL2337290,active,Oc1ccc(-c2ccccc2-c2ccc(O)c(O)c2)cc1O,organic,5.568636235841013
Inhibition of amyloid-beta40 (unknown origin) aggregation by congo red spectral-shift assay,IC50,Oc1ccc(-c2cccc(-c3ccc(O)c(O)c3)c2)cc1O,3700.0,nM,=,CHEMBL2337293,active,Oc1ccc(-c2cccc(-c3ccc(O)c(O)c3)c2)cc1O,organic,5.431798275933005
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomer dissociation after 16 to 18 hrs by ELISA,IC50,COc1ccc2cc(C(=O)CN3CCN(c4ccccc4)CC3)c(=O)oc2c1,6500.0,nM,=,CHEMBL2381403,active,COc1ccc2cc(C(=O)CN3CCN(c4ccccc4)CC3)c(=O)oc2c1,organic,5.187086643357144
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomer dissociation after 16 to 18 hrs by ELISA,IC50,COc1ccc2cc(C(=O)CN3CCN(c4ncccn4)CC3)c(=O)oc2c1,4000.0,nM,=,CHEMBL2381384,active,COc1ccc2cc(C(=O)CN3CCN(c4ncccn4)CC3)c(=O)oc2c1,organic,5.3979400086720375
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomer dissociation after 16 to 18 hrs by ELISA,IC50,COc1ccc2cc(C(=O)CN3CCOCC3)c(=O)oc2c1,5000.0,nM,=,CHEMBL2381385,active,COc1ccc2cc(C(=O)CN3CCOCC3)c(=O)oc2c1,organic,5.301029995663981
Inhibition of amyloid beta ((1 to 42) (unknown origin) oligomer assembly after 30 mins by biotinyl-streptavidin assay,IC50,COc1ccc2cc(C(=O)CN3CCC(c4ccccc4)CC3)c(=O)oc2c1,14000.0,nM,=,CHEMBL2381402,inactive,COc1ccc2cc(C(=O)CN3CCC(c4ccccc4)CC3)c(=O)oc2c1,organic,4.853871964321762
Inhibition of amyloid beta ((1 to 42) (unknown origin) oligomer assembly after 30 mins by biotinyl-streptavidin assay,IC50,COc1ccc2cc(C(=O)CN3CCN(c4ccccc4)CC3)c(=O)oc2c1,21000.0,nM,=,CHEMBL2381403,inactive,COc1ccc2cc(C(=O)CN3CCN(c4ccccc4)CC3)c(=O)oc2c1,organic,4.6777807052660805
Inhibition of amyloid beta (1 to 42) (unknown origin) oligomer dissociation after 16 to 18 hrs by ELISA,IC50,COc1ccc2cc(C(=O)CN3CCC(c4ccccc4)CC3)c(=O)oc2c1,29000.0,nM,=,CHEMBL2381402,inactive,COc1ccc2cc(C(=O)CN3CCC(c4ccccc4)CC3)c(=O)oc2c1,organic,4.5376020021010435
Inhibition of amyloid beta ((1 to 42) (unknown origin) oligomer assembly after 30 mins by biotinyl-streptavidin assay,IC50,COc1ccc2cc(C(=O)CN3CCN(c4ncccn4)CC3)c(=O)oc2c1,1000.0,nM,=,CHEMBL2381384,active,COc1ccc2cc(C(=O)CN3CCN(c4ncccn4)CC3)c(=O)oc2c1,organic,6.0
Inhibition of amyloid beta ((1 to 42) (unknown origin) oligomer assembly after 30 mins by biotinyl-streptavidin assay,IC50,COc1ccc2cc(C(=O)CN3CCOCC3)c(=O)oc2c1,29000.0,nM,=,CHEMBL2381385,inactive,COc1ccc2cc(C(=O)CN3CCOCC3)c(=O)oc2c1,organic,4.5376020021010435
Inhibition of amyloid beta ((1 to 42) (unknown origin) oligomer assembly after 30 mins by biotinyl-streptavidin assay,IC50,COc1ccc2cc(C(=O)CN3CCC(Cc4ccccc4)CC3)c(=O)oc2c1,36000.0,nM,=,CHEMBL2381386,inactive,COc1ccc2cc(C(=O)CN3CCC(Cc4ccccc4)CC3)c(=O)oc2c1,organic,4.443697499232712
Inhibition of amyloid beta ((1 to 42) (unknown origin) oligomer assembly after 30 mins by biotinyl-streptavidin assay,IC50,COc1ccc2cc(C(=O)CN3CCN(Cc4ccccc4)CC3)c(=O)oc2c1,36000.0,nM,=,CHEMBL2381401,inactive,COc1ccc2cc(C(=O)CN3CCN(Cc4ccccc4)CC3)c(=O)oc2c1,organic,4.443697499232712
Inhibition of amyloid beta fibril aggregation (unknown origin) by thioflavin T fluorescence method,IC50,COc1cc(/C=C/c2cccc(/C=C/c3ccc(N(C)C)c(OC)c3)c2)ccc1N(C)C,1000.0,nM,=,CHEMBL247932,active,COc1cc(/C=C/c2cccc(/C=C/c3ccc(N(C)C)c(OC)c3)c2)ccc1N(C)C,organic,6.0
Inhibition of amyloid beta (1 to 40) (unknown origin) fibril formation after 18 hrs by DELFIA,IC50,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,30000.0,nM,=,CHEMBL723,inactive,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12,organic,4.522878745280337
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 4:1 compound to protein concentration after 48 hrs by thioflavin T fluorescence assay,IC50,CN(C)c1cccc(Oc2cnc(Nc3cccc(O)c3)nc2)c1,100000.0,nM,=,CHEMBL2386874,inactive,CN(C)c1cccc(Oc2cnc(Nc3cccc(O)c3)nc2)c1,organic,4.0
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 4:1 compound to protein concentration after 48 hrs by thioflavin T fluorescence assay,IC50,CCCCCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@@H]3[C@@H]4C[C@@H]5O[C@]6(CC[C@@H](C)CO6)[C@@H](C)[C@@H]5[C@@]4(C)CC[C@@H]32)C1,100000.0,nM,=,CHEMBL2386881,inactive,CCCCCC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@@H]3[C@@H]4C[C@@H]5O[C@]6(CC[C@@H](C)CO6)[C@@H](C)[C@@H]5[C@@]4(C)CC[C@@H]32)C1,organic,4.0
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 4:1 compound to protein concentration after 48 hrs by thioflavin T fluorescence assay,IC50,Oc1c(I)cc(Cl)c2cccnc12,100000.0,nM,=,CHEMBL497,inactive,Oc1c(I)cc(Cl)c2cccnc12,organic,4.0
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 4:1 compound to protein concentration after 48 hrs by thioflavin T fluorescence assay,IC50,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,100000.0,nM,=,CHEMBL297453,inactive,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,organic,4.0
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 4:1 compound to protein concentration after 48 hrs by thioflavin T fluorescence assay,IC50,O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O,100000.0,nM,=,CHEMBL468154,inactive,O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O,organic,4.0
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) at 4:1 compound to protein concentration after 48 hrs by thioflavin T fluorescence assay,IC50,NCCCS(=O)(=O)O,100000.0,nM,=,CHEMBL149082,inactive,NCCCS(=O)(=O)O,organic,4.0
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,15110.0,nM,=,CHEMBL165,inactive,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,organic,4.820735535660974
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,12350.0,nM,=,CHEMBL116438,inactive,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,organic,4.9083330424043154
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/c2ccc(NCc3cc(NC(C)C)ccc3O)cc2)cc(OC)c1,18350.0,nM,=,CHEMBL2402063,inactive,COc1cc(/C=C/c2ccc(NCc3cc(NC(C)C)ccc3O)cc2)cc(OC)c1,organic,4.7363639314118915
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/c2ccc(NCc3cc(NCC(C)C)ccc3O)cc2)cc(OC)c1,10320.0,nM,=,CHEMBL2402075,inactive,COc1cc(/C=C/c2ccc(NCc3cc(NCC(C)C)ccc3O)cc2)cc(OC)c1,organic,4.986320302708807
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,CCCNc1ccc(O)c(CNc2ccc(/C=C/c3cc(OC)cc(OC)c3)cc2)c1,13070.0,nM,=,CHEMBL2402074,inactive,CCCNc1ccc(O)c(CNc2ccc(/C=C/c3cc(OC)cc(OC)c3)cc2)c1,organic,4.883724412419456
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/c2ccc(NCc3cc(N(C)C)ccc3O)cc2)cc(OC)c1,7560.0,nM,=,CHEMBL2402067,active,COc1cc(/C=C/c2ccc(NCc3cc(N(C)C)ccc3O)cc2)cc(OC)c1,organic,5.121478204498794
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,CN(C)c1ccccc1CNc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,14160.0,nM,=,CHEMBL2402161,inactive,CN(C)c1ccccc1CNc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,organic,4.84893674664625
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,CN(C)c1ccc(O)c(CNc2ccc(/C=C/c3cc(O)cc(O)c3)cc2)c1,6510.0,nM,=,CHEMBL2402160,active,CN(C)c1ccc(O)c(CNc2ccc(/C=C/c3cc(O)cc(O)c3)cc2)c1,organic,5.186419011431808
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,O=[N+]([O-])c1ccc(O)c(CNc2ccc(/C=C/c3cc(O)cc(O)c3)cc2)c1,7060.0,nM,=,CHEMBL2402159,active,O=[N+]([O-])c1ccc(O)c(CNc2ccc(/C=C/c3cc(O)cc(O)c3)cc2)c1,organic,5.151195298948196
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,Oc1cc(O)cc(/C=C/c2ccc(NCc3cccc(O)c3O)cc2)c1,7870.0,nM,=,CHEMBL2402158,active,Oc1cc(O)cc(/C=C/c2ccc(NCc3cccc(O)c3O)cc2)c1,organic,5.104025267640935
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,Oc1cc(O)cc(/C=C/c2ccc(NCc3ccccc3O)cc2)c1,10220.0,nM,=,CHEMBL2402157,inactive,Oc1cc(O)cc(/C=C/c2ccc(NCc3ccccc3O)cc2)c1,organic,4.990549104201306
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,CN(C)c1ccc(/C=C/c2ccc(NCc3cc(N(C)C)ccc3O)cc2)cc1,10660.0,nM,=,CHEMBL2402163,inactive,CN(C)c1ccc(/C=C/c2ccc(NCc3cc(N(C)C)ccc3O)cc2)cc1,organic,4.972242795309446
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 48 hrs by thioflavin T fluorescence assay,IC50,COc1ccc(/C=C/c2ccc(NCc3cc(N(C)C)ccc3O)cc2)cc1,12200.0,nM,=,CHEMBL2402162,inactive,COc1ccc(/C=C/c2ccc(NCc3cc(N(C)C)ccc3O)cc2)cc1,organic,4.913640169325252
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,O=C(/C=C/c1ccc(O)cc1)c1ccc(O)cc1O,19700.0,nM,=,CHEMBL129795,inactive,O=C(/C=C/c1ccc(O)cc1)c1ccc(O)cc1O,organic,4.705533773838407
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,15900.0,nM,=,CHEMBL165,inactive,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,organic,4.798602875679548
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(C(=O)O)cc2)c(O)c1,18500.0,nM,=,CHEMBL2408097,inactive,COc1ccc(C(=O)/C=C/c2ccc(C(=O)O)cc2)c(O)c1,organic,4.732828271596986
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COC(=O)c1ccc(/C=C/C(=O)c2ccc(OC)cc2O)cc1,23800.0,nM,=,CHEMBL2408096,inactive,COC(=O)c1ccc(/C=C/C(=O)c2ccc(OC)cc2O)cc1,organic,4.623423042943488
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2cc(Br)c(OCc3ccccc3)c(OC)c2)c(O)c1,12500.0,nM,=,CHEMBL2408095,inactive,COc1ccc(C(=O)/C=C/c2cc(Br)c(OCc3ccccc3)c(OC)c2)c(O)c1,organic,4.903089986991944
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2cc(OC)c(OC)c(OC)c2)c(O)c1,9700.0,nM,=,CHEMBL260867,active,COc1ccc(C(=O)/C=C/c2cc(OC)c(OC)c(OC)c2)c(O)c1,organic,5.013228265733755
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2cc(OC)c(OC)cc2OC)c(O)c1,10200.0,nM,=,CHEMBL258752,inactive,COc1ccc(C(=O)/C=C/c2cc(OC)c(OC)cc2OC)c(O)c1,organic,4.991399828238082
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,CCOCCOc1ccc(/C=C/C(=O)c2ccc(OC)cc2O)cc1,19100.0,nM,=,CHEMBL2408094,inactive,CCOCCOc1ccc(/C=C/C(=O)c2ccc(OC)cc2O)cc1,organic,4.718966632752273
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(/C=C/C(=O)c2ccc(OC)cc2O)cc1,8400.0,nM,=,CHEMBL229907,active,COc1ccc(/C=C/C(=O)c2ccc(OC)cc2O)cc1,organic,5.075720713938118
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(OCc3ccccc3)cc2)c(O)c1,7800.0,nM,=,CHEMBL2408093,active,COc1ccc(C(=O)/C=C/c2ccc(OCc3ccccc3)cc2)c(O)c1,organic,5.107905397309519
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,CCOCCOc1cccc(/C=C/C(=O)c2ccc(OC)cc2O)c1,10500.0,nM,=,CHEMBL2408092,inactive,CCOCCOc1cccc(/C=C/C(=O)c2ccc(OC)cc2O)c1,organic,4.978810700930062
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(OCCCOc3ccccc3)c(OC)c2)c(O)c1,10900.0,nM,=,CHEMBL2408091,inactive,COc1ccc(C(=O)/C=C/c2ccc(OCCCOc3ccccc3)c(OC)c2)c(O)c1,organic,4.962573502059376
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,CCOCCCOc1ccc(/C=C/C(=O)c2ccc(OC)cc2O)cc1OC,5800.0,nM,=,CHEMBL2407101,active,CCOCCCOc1ccc(/C=C/C(=O)c2ccc(OC)cc2O)cc1OC,organic,5.236572006437063
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(C(=O)Nc3cc([N+](=O)[O-])ccc3O)cc2)c(O)c1,13300.0,nM,=,CHEMBL2408265,inactive,COc1ccc(C(=O)/C=C/c2ccc(C(=O)Nc3cc([N+](=O)[O-])ccc3O)cc2)c(O)c1,organic,4.876148359032914
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(C(=O)Nc3ccccc3O)cc2)c(O)c1,10100.0,nM,=,CHEMBL2408264,inactive,COc1ccc(C(=O)/C=C/c2ccc(C(=O)Nc3ccccc3O)cc2)c(O)c1,organic,4.995678626217358
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(C(=O)Nc3ccccc3OC)cc2)c(O)c1,7300.0,nM,=,CHEMBL2408263,active,COc1ccc(C(=O)/C=C/c2ccc(C(=O)Nc3ccccc3OC)cc2)c(O)c1,organic,5.136677139879544
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(C(=O)Nc3ccc(C)cc3C)cc2)c(O)c1,8300.0,nM,=,CHEMBL2408262,active,COc1ccc(C(=O)/C=C/c2ccc(C(=O)Nc3ccc(C)cc3C)cc2)c(O)c1,organic,5.080921907623926
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(C(=O)N(C)c3ccccc3)cc2)c(O)c1,20100.0,nM,=,CHEMBL2408261,inactive,COc1ccc(C(=O)/C=C/c2ccc(C(=O)N(C)c3ccccc3)cc2)c(O)c1,organic,4.696803942579511
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(C(=O)NCc3ccccc3)cc2)c(O)c1,18900.0,nM,=,CHEMBL2408106,inactive,COc1ccc(C(=O)/C=C/c2ccc(C(=O)NCc3ccccc3)cc2)c(O)c1,organic,4.723538195826756
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(C(=O)NCCc3ccccc3)cc2)c(O)c1,19100.0,nM,=,CHEMBL2408105,inactive,COc1ccc(C(=O)/C=C/c2ccc(C(=O)NCCc3ccccc3)cc2)c(O)c1,organic,4.718966632752273
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,CCCCCCCCCCCCNC(=O)c1ccc(/C=C/C(=O)c2ccc(OC)cc2O)cc1,15900.0,nM,=,CHEMBL2408104,inactive,CCCCCCCCCCCCNC(=O)c1ccc(/C=C/C(=O)c2ccc(OC)cc2O)cc1,organic,4.798602875679548
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,CCCNC(=O)c1ccc(/C=C/C(=O)c2ccc(OC)cc2O)cc1,19900.0,nM,=,CHEMBL2408103,inactive,CCCNC(=O)c1ccc(/C=C/C(=O)c2ccc(OC)cc2O)cc1,organic,4.701146923590294
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(C(=O)NC(C)C)cc2)c(O)c1,17800.0,nM,=,CHEMBL2408102,inactive,COc1ccc(C(=O)/C=C/c2ccc(C(=O)NC(C)C)cc2)c(O)c1,organic,4.749579997691106
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(C(=O)N3CCOCC3)cc2)c(O)c1,3200.0,nM,=,CHEMBL2408101,active,COc1ccc(C(=O)/C=C/c2ccc(C(=O)N3CCOCC3)cc2)c(O)c1,organic,5.494850021680094
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(C(=O)N3CCCCC3)cc2)c(O)c1,5900.0,nM,=,CHEMBL2408100,active,COc1ccc(C(=O)/C=C/c2ccc(C(=O)N3CCCCC3)cc2)c(O)c1,organic,5.229147988357856
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(C(=O)N3CCN(C)CC3)cc2)c(O)c1,2200.0,nM,=,CHEMBL2408099,active,COc1ccc(C(=O)/C=C/c2ccc(C(=O)N3CCN(C)CC3)cc2)c(O)c1,organic,5.657577319177793
Inhibition of amyloid beta (1-42) self-mediated aggregation (unknown origin) after 5 days by thioflavin T fluorescence method,IC50,COc1ccc(C(=O)/C=C/c2ccc(C(=O)N3CCCC3)cc2)c(O)c1,14600.0,nM,=,CHEMBL2408098,inactive,COc1ccc(C(=O)/C=C/c2ccc(C(=O)N3CCCC3)cc2)c(O)c1,organic,4.835647144215563
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in absence of Zn2+,IC50,O=C(O)c1cccnc1,13100.0,nM,=,CHEMBL573,inactive,O=C(O)c1cccnc1,organic,4.882728704344236
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in absence of Zn2+,IC50,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O,28400.0,nM,=,CHEMBL858,inactive,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O,organic,4.546681659952962
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,IC50,O=C(O)c1cccnc1,43700.0,nM,=,CHEMBL573,inactive,O=C(O)c1cccnc1,organic,4.359518563029578
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,IC50,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O,7700.0,nM,=,CHEMBL858,active,O=C(O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O,organic,5.113509274827518
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,IC50,CCc1nc2cc(/C=C/C(=O)NO)ccc2c(=O)n1CCc1ccccc1,6800.0,nM,=,CHEMBL2425961,active,CCc1nc2cc(/C=C/C(=O)NO)ccc2c(=O)n1CCc1ccccc1,organic,5.167491087293763
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,IC50,O=C(/C=C/c1ccc2c(=O)n(CCc3ccccc3)cnc2c1)NO,5500.0,nM,=,CHEMBL2425960,active,O=C(/C=C/c1ccc2c(=O)n(CCc3ccccc3)cnc2c1)NO,organic,5.259637310505756
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,IC50,Cc1nc2cc(/C=C/C(=O)NO)ccc2c(=O)n1CCc1c[nH]c2ccccc12,7400.0,nM,=,CHEMBL2425959,active,Cc1nc2cc(/C=C/C(=O)NO)ccc2c(=O)n1CCc1c[nH]c2ccccc12,organic,5.130768280269024
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,IC50,Cc1nc2cc(/C=C/C(=O)NO)ccc2c(=O)n1CCc1ccccc1,9500.0,nM,=,CHEMBL2425958,active,Cc1nc2cc(/C=C/C(=O)NO)ccc2c(=O)n1CCc1ccccc1,organic,5.022276394711152
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,IC50,Cc1nc2cc(/C=C/C(=O)NO)ccc2c(=O)n1Cc1ccccc1,18100.0,nM,=,CHEMBL2425957,inactive,Cc1nc2cc(/C=C/C(=O)NO)ccc2c(=O)n1Cc1ccccc1,organic,4.7423214251308154
Inhibition of amyloid beta aggregation (unknown origin) after 4 hrs by thioflavin S assay in presence of Zn2+,IC50,Cc1nc2cc(/C=C/C(=O)NO)ccc2c(=O)n1-c1ccccc1,18400.0,nM,=,CHEMBL2425955,inactive,Cc1nc2cc(/C=C/C(=O)NO)ccc2c(=O)n1-c1ccccc1,organic,4.735182176990463
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,20300.0,nM,=,CHEMBL116438,inactive,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,organic,4.692503962086787
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1ccoc2cc(OCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,11500.0,nM,=,CHEMBL2436692,inactive,O=c1ccoc2cc(OCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,organic,4.939302159646388
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(OCCCN2CCN(CCCNc3c4c(nc5ccccc35)CCCC4)CC2)cc2occc(=O)c12,12600.0,nM,=,CHEMBL2436691,inactive,COc1cc(OCCCN2CCN(CCCNc3c4c(nc5ccccc35)CCCC4)CC2)cc2occc(=O)c12,organic,4.899629454882437
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1ccoc2cc(OCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)cc(O)c12,4800.0,nM,=,CHEMBL2436690,active,O=c1ccoc2cc(OCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)cc(O)c12,organic,5.318758762624412
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1cc(-c2ccc([N+](=O)[O-])cc2)oc2cc(OCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,14100.0,nM,=,CHEMBL2436710,inactive,O=c1cc(-c2ccc([N+](=O)[O-])cc2)oc2cc(OCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,organic,4.85078088734462
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(OCCCN2CCN(CCCNc3c4c(nc5ccccc35)CCCC4)CC2)cc2oc(-c3ccccc3)cc(=O)c12,9600.0,nM,=,CHEMBL2436704,active,COc1cc(OCCCN2CCN(CCCNc3c4c(nc5ccccc35)CCCC4)CC2)cc2oc(-c3ccccc3)cc(=O)c12,organic,5.017728766960431
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1cc(-c2ccccc2)oc2cc(OCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)cc(O)c12,6500.0,nM,=,CHEMBL2436703,active,O=c1cc(-c2ccccc2)oc2cc(OCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)cc(O)c12,organic,5.187086643357144
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1cc(-c2ccccc2)oc2cc(OCCCCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,13500.0,nM,=,CHEMBL2436702,inactive,O=c1cc(-c2ccccc2)oc2cc(OCCCCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,organic,4.8696662315049934
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1cc(-c2ccccc2)oc2cc(OCCCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,13200.0,nM,=,CHEMBL2436701,inactive,O=c1cc(-c2ccccc2)oc2cc(OCCCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,organic,4.87942606879415
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1cc(-c2ccccc2)oc2cc(OCCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,17300.0,nM,=,CHEMBL2436700,inactive,O=c1cc(-c2ccccc2)oc2cc(OCCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,organic,4.761953896871205
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1cc(-c2ccccc2)oc2cc(OCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,14900.0,nM,=,CHEMBL2436699,inactive,O=c1cc(-c2ccccc2)oc2cc(OCCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,organic,4.826813731587726
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1cc(-c2ccccc2)oc2cc(OCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,9800.0,nM,=,CHEMBL2436698,active,O=c1cc(-c2ccccc2)oc2cc(OCCN3CCN(CCCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,organic,5.008773924307505
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1cc(-c2ccccc2)oc2cc(OCCCCCCN3CCN(CCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,14200.0,nM,=,CHEMBL2436697,inactive,O=c1cc(-c2ccccc2)oc2cc(OCCCCCCN3CCN(CCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,organic,4.847711655616943
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1cc(-c2ccccc2)oc2cc(OCCCCCN3CCN(CCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,12800.0,nM,=,CHEMBL2436696,inactive,O=c1cc(-c2ccccc2)oc2cc(OCCCCCN3CCN(CCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,organic,4.892790030352131
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1cc(-c2ccccc2)oc2cc(OCCCCN3CCN(CCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,16400.0,nM,=,CHEMBL2436695,inactive,O=c1cc(-c2ccccc2)oc2cc(OCCCCN3CCN(CCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,organic,4.785156151952302
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1cc(-c2ccccc2)oc2cc(OCCCN3CCN(CCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,13700.0,nM,=,CHEMBL2436694,inactive,O=c1cc(-c2ccccc2)oc2cc(OCCCN3CCN(CCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,organic,4.863279432843593
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,O=c1cc(-c2ccccc2)oc2cc(OCCN3CCN(CCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,16800.0,nM,=,CHEMBL2436693,inactive,O=c1cc(-c2ccccc2)oc2cc(OCCN3CCN(CCNc4c5c(nc6ccccc46)CCCC5)CC3)ccc12,organic,4.774690718274137
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) by thioflavin T fluorescence method,IC50,CC(C(=O)NCCCNCCCNC1=CC(=O)c2ccccc2C1=O)c1ccc(-c2ccccc2)c(F)c1,6880.0,nM,=,CHEMBL3087683,active,CC(C(=O)NCCCNCCCNC1=CC(=O)c2ccccc2C1=O)c1ccc(-c2ccccc2)c(F)c1,organic,5.162411561764489
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) by thioflavin T fluorescence method,IC50,C[C@H](C(=O)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)[C@@H](C)c2ccc(-c3ccccc3)c(F)c2)=CC1=O)c1ccc(-c2ccccc2)c(F)c1,4430.0,nM,=,CHEMBL3087680,active,C[C@H](C(=O)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)[C@@H](C)c2ccc(-c3ccccc3)c(F)c2)=CC1=O)c1ccc(-c2ccccc2)c(F)c1,organic,5.3535962737769305
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) by thioflavin T fluorescence method,IC50,C[C@@H](C(=O)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)[C@H](C)c2ccc(-c3ccccc3)c(F)c2)=CC1=O)c1ccc(-c2ccccc2)c(F)c1,4770.0,nM,=,CHEMBL3087679,active,C[C@@H](C(=O)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)[C@H](C)c2ccc(-c3ccccc3)c(F)c2)=CC1=O)c1ccc(-c2ccccc2)c(F)c1,organic,5.321481620959886
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) by thioflavin T fluorescence method,IC50,COc1ccc2c(c1)c(CC(=O)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)Cc3c(C)n(C(=O)c4ccc(Cl)cc4)c4ccc(OC)cc34)=CC1=O)c(C)n2C(=O)c1ccc(Cl)cc1,6110.0,nM,=,CHEMBL3087677,active,COc1ccc2c(c1)c(CC(=O)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)Cc3c(C)n(C(=O)c4ccc(Cl)cc4)c4ccc(OC)cc34)=CC1=O)c(C)n2C(=O)c1ccc(Cl)cc1,organic,5.213958789757446
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) by thioflavin T fluorescence method,IC50,O=C(Cc1ccccc1Nc1c(Cl)cccc1Cl)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)Cc2ccccc2Nc2c(Cl)cccc2Cl)=CC1=O,3150.0,nM,=,CHEMBL3087676,active,O=C(Cc1ccccc1Nc1c(Cl)cccc1Cl)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)Cc2ccccc2Nc2c(Cl)cccc2Cl)=CC1=O,organic,5.501689446210399
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) by thioflavin T fluorescence method,IC50,CC1=C(CC(=O)NCCCNCCCNC2=CC(=O)C(NCCCNCCCNC(=O)CC3=C(C)/C(=C\c4ccc([S+](C)[O-])cc4)c4ccc(F)cc43)=CC2=O)c2cc(F)ccc2/C1=C/c1ccc([S+](C)[O-])cc1,8180.0,nM,=,CHEMBL3087675,active,CC1=C(CC(=O)NCCCNCCCNC2=CC(=O)C(NCCCNCCCNC(=O)CC3=C(C)/C(=C\c4ccc([S+](C)[O-])cc4)c4ccc(F)cc43)=CC2=O)c2cc(F)ccc2/C1=C/c1ccc([S+](C)[O-])cc1,organic,5.087246696328677
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) by thioflavin T fluorescence method,IC50,CC(C)Cc1ccc(C(C)C(=O)NCCCNCCCNC2=CC(=O)C(NCCCNCCCNC(=O)C(C)c3ccc(CC(C)C)cc3)=CC2=O)cc1,4830.0,nM,=,CHEMBL3087674,active,CC(C)Cc1ccc(C(C)C(=O)NCCCNCCCNC2=CC(=O)C(NCCCNCCCNC(=O)C(C)c3ccc(CC(C)C)cc3)=CC2=O)cc1,organic,5.316052869248487
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) by thioflavin T fluorescence method,IC50,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccccc2OC)=CC1=O)Cc1ccccc1OC,5930.0,nM,=,CHEMBL231160,active,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccccc2OC)=CC1=O)Cc1ccccc1OC,organic,5.226945306635737
Destabilization of preformed amyloid beta (1 to 40) (unknown origin),IC50,O=C(/C=C/c1cc(O)cc2c1[C@H](C(O)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O)[C@@H](c1ccc(O)c(O)c1)O2)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O,5000.0,nM,=,CHEMBL541265,active,O=C(/C=C/c1cc(O)cc2c1[C@H](C(O)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O)[C@@H](c1ccc(O)c(O)c1)O2)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O,organic,5.301029995663981
Inhibition of amyloid beta (1 to 40) aggregation (unknown origin),IC50,O=C(/C=C/c1cc(O)cc2c1[C@H](C(O)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O)[C@@H](c1ccc(O)c(O)c1)O2)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O,1540.0,nM,=,CHEMBL541265,active,O=C(/C=C/c1cc(O)cc2c1[C@H](C(O)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O)[C@@H](c1ccc(O)c(O)c1)O2)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O,organic,5.812479279163537
Inhibition of amyloid beta (unknown origin) aggregation,IC50,c1ccc2c(NCCSSCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,24200.0,nM,=,CHEMBL3235503,inactive,c1ccc2c(NCCSSCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,organic,4.616184634019569
Inhibition of amyloid beta (unknown origin) aggregation by Thiazin-red R displacement fluorescence assay,IC50,COc1cc(/C=c2\sc3nc(-c4ccncc4)cn3c2=O)cc(OC)c1O,93.0,nM,=,CHEMBL3286981,active,COc1cc(/C=c2\sc3nc(-c4ccncc4)cn3c2=O)cc(OC)c1O,organic,7.031517051446065
Inhibition of amyloid beta (unknown origin) aggregation by Thiazin-red R displacement fluorescence assay,IC50,COc1cc(/C=c2\sc3nc(-c4ccc(Cl)cc4)cn3c2=O)cc(OC)c1O,7.0,nM,=,CHEMBL3286982,active,COc1cc(/C=c2\sc3nc(-c4ccc(Cl)cc4)cn3c2=O)cc(OC)c1O,organic,8.154901959985743
Inhibition of amyloid beta (unknown origin) aggregation by Thiazin-red R displacement fluorescence assay,IC50,COc1cc(/C=c2\sc3nc(-c4ccc(Cl)cc4)cn3c2=O)cc(Cl)c1O,32.0,nM,=,CHEMBL3286983,active,COc1cc(/C=c2\sc3nc(-c4ccc(Cl)cc4)cn3c2=O)cc(Cl)c1O,organic,7.494850021680094
Inhibition of amyloid beta (unknown origin) aggregation by Thiazin-red R displacement fluorescence assay,IC50,COc1cc(/C=c2\sc3nc(-c4ccc(Cl)cc4)cn3c2=O)cc(Br)c1O,18.0,nM,=,CHEMBL3286984,active,COc1cc(/C=c2\sc3nc(-c4ccc(Cl)cc4)cn3c2=O)cc(Br)c1O,organic,7.7447274948966935
Inhibition of amyloid beta (unknown origin) aggregation by Thiazin-red R displacement fluorescence assay,IC50,COc1cc(/C=c2\sc3nc(-c4ccc(Cl)cc4)cn3c2=O)cc(O)c1O,18.0,nM,=,CHEMBL3286985,active,COc1cc(/C=c2\sc3nc(-c4ccc(Cl)cc4)cn3c2=O)cc(O)c1O,organic,7.7447274948966935
Inhibition of amyloid beta (unknown origin) aggregation by Thiazin-red R displacement fluorescence assay,IC50,COc1cc(/C=c2\sc3nc(-c4ccncc4C)cn3c2=O)cc(OC)c1O,32.0,nM,=,CHEMBL3286987,active,COc1cc(/C=c2\sc3nc(-c4ccncc4C)cn3c2=O)cc(OC)c1O,organic,7.494850021680094
Inhibition of amyloid beta (unknown origin) aggregation by Thiazin-red R displacement fluorescence assay,IC50,COc1cc(/C=c2\sc3nc(-c4cccc(Cl)c4)cn3c2=O)cc(OC)c1O,6.0,nM,=,CHEMBL3286988,active,COc1cc(/C=c2\sc3nc(-c4cccc(Cl)c4)cn3c2=O)cc(OC)c1O,organic,8.221848749616356
Inhibition of amyloid beta (unknown origin) aggregation by Thiazin-red R displacement fluorescence assay,IC50,COc1cc(/C=c2\sc3nc(-c4cccc(C(F)(F)F)c4)cn3c2=O)cc(Cl)c1O,123.0,nM,=,CHEMBL3286989,active,COc1cc(/C=c2\sc3nc(-c4cccc(C(F)(F)F)c4)cn3c2=O)cc(Cl)c1O,organic,6.910094888560602
Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,IC50,CN(C)c1ccc2nc3ccc(=[N+](C)C)cc-3sc2c1,550.0,nM,=,CHEMBL191083,active,CN(C)c1ccc2nc3ccc(=[N+](C)C)cc-3sc2c1,organic,6.259637310505756
Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,IC50,O=Cc1ccc(-c2ccc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)s2)s1,7100.0,nM,=,CHEMBL3330739,active,O=Cc1ccc(-c2ccc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)s2)s1,organic,5.1487416512809245
Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,IC50,N#C/C(=C\c1ccc(-c2ccc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)s2)s1)C(N)=O,1500.0,nM,=,CHEMBL3330740,active,N#C/C(=C\c1ccc(-c2ccc(-c3ccc(N(c4ccccc4)c4ccccc4)cc3)s2)s1)C(N)=O,organic,5.823908740944319
Inhibition of amyloid beta (1-42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorescence method,IC50,COc1ccc(-c2cc3c(s2)c2sc(-c4ccc(/C=C(\C#N)C(N)=O)s4)cc2n3C(C)(C)C)cc1,550.0,nM,=,CHEMBL3330753,active,COc1ccc(-c2cc3c(s2)c2sc(-c4ccc(/C=C(\C#N)C(N)=O)s4)cc2n3C(C)(C)C)cc1,organic,6.259637310505756
Inhibition of self mediated amyloid beta (1 to 42) aggregation (unknown origin) after 10 hrs by ThT-based fluorescence assay,IC50,Cc1ccc2oc(=O)c(C(=O)NCCCCCCNc3c4c(nc5ccccc35)CCCC4)cc2c1,5000.0,nM,=,CHEMBL3326707,active,Cc1ccc2oc(=O)c(C(=O)NCCCCCCNc3c4c(nc5ccccc35)CCCC4)cc2c1,organic,5.301029995663981
Inhibition of self mediated amyloid beta (1 to 42) aggregation (unknown origin) after 10 hrs by ThT-based fluorescence assay,IC50,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc2cc(OC(F)(F)F)ccc2oc1=O,24200.0,nM,=,CHEMBL3326709,inactive,O=C(NCCCCCCNc1c2c(nc3ccccc13)CCCC2)c1cc2cc(OC(F)(F)F)ccc2oc1=O,organic,4.616184634019569
Inhibition of self mediated amyloid beta (1 to 42) aggregation (unknown origin) after 10 hrs by ThT-based fluorescence assay,IC50,COc1ccc2oc(=O)c(C(=O)NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)cc2c1,13400.0,nM,=,CHEMBL3327246,inactive,COc1ccc2oc(=O)c(C(=O)NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)cc2c1,organic,4.872895201635193
Inhibition of self mediated amyloid beta (1 to 42) aggregation (unknown origin) after 10 hrs by ThT-based fluorescence assay,IC50,Cc1ccc2oc(=O)c(C(=O)NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)cc2c1,6100.0,nM,=,CHEMBL3327247,active,Cc1ccc2oc(=O)c(C(=O)NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)cc2c1,organic,5.214670164989233
Inhibition of self mediated amyloid beta (1 to 42) aggregation (unknown origin) after 10 hrs by ThT-based fluorescence assay,IC50,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,11000.0,nM,=,CHEMBL116438,inactive,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,organic,4.958607314841775
Inhibition of amyloid beta1-42 (unknown origin) aggregation assessed as amyloid fibril formation tested after 17 hrs by thioflavin T fluorescence method,IC50,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,4600.0,nM,=,CHEMBL297453,active,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,organic,5.337242168318426
Inhibition of amyloid beta1-42 (unknown origin) aggregation assessed as amyloid fibril formation tested after 17 hrs by thioflavin T fluorescence method,IC50,O=C1/C(=C/c2ccc(O)c(O)c2)Oc2c1ccc(O)c2O,2700.0,nM,=,CHEMBL3298066,active,O=C1/C(=C/c2ccc(O)c(O)c2)Oc2c1ccc(O)c2O,organic,5.568636235841013
Inhibition of amyloid beta1-42 (unknown origin) aggregation assessed as amyloid fibril formation tested after 17 hrs by thioflavin T fluorescence method,IC50,O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,6400.0,nM,=,CHEMBL151,active,O=c1cc(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,organic,5.1938200260161125
Inhibition of amyloid beta1-42 (unknown origin) aggregation assessed as amyloid fibril formation tested after 17 hrs by thioflavin T fluorescence method,IC50,COc1c(-c2ccc(O)c(O)c2)oc2c(O)c(O)ccc2c1=O,5400.0,nM,=,CHEMBL3297746,active,COc1c(-c2ccc(O)c(O)c2)oc2c(O)c(O)ccc2c1=O,organic,5.267606240177032
Inhibition of amyloid beta1-40 (unknown origin) aggregation,IC50,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,3000.0,nM,=,CHEMBL297453,active,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,organic,5.522878745280337
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC(=O)N6CCC6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,250.0,nM,=,CHEMBL2206986,active,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC(=O)N6CCC6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,organic,6.6020599913279625
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C(=O)C(C)C)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,170.0,nM,=,CHEMBL2206995,active,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C(=O)C(C)C)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,organic,6.769551078621726
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6COC6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,270.0,nM,=,CHEMBL2207065,active,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6COC6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,organic,6.568636235841013
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,210.0,nM,=,CHEMBL2207043,active,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,organic,6.6777807052660805
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,250.0,nM,=,CHEMBL2207042,active,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,organic,6.6020599913279625
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CNCCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,91.0,nM,=,CHEMBL2207069,active,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CNCCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,organic,7.040958607678906
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6CN(C)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,100.0,nM,=,CHEMBL2206994,active,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6CN(C)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,organic,7.0
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CCOC)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,270.0,nM,=,CHEMBL2207044,active,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CCOC)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,organic,6.568636235841013
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CCN6CCC6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,110.0,nM,=,CHEMBL2207050,active,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CCN6CCC6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,organic,6.958607314841775
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6(C)COC6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,400.0,nM,=,CHEMBL2206992,active,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6(C)COC6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,organic,6.3979400086720375
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6CNC6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,100.0,nM,=,CHEMBL2206993,active,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6CNC6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,organic,7.0
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC6CN(C)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,140.0,nM,=,CHEMBL3403815,active,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC6CN(C)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,organic,6.853871964321762
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6CN(C7CCC7)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,120.0,nM,=,CHEMBL3403817,active,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6CN(C7CCC7)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,organic,6.920818753952375
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6CN(C7COC7)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,130.0,nM,=,CHEMBL3403818,active,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6CN(C7COC7)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,organic,6.886056647693163
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6CN(CCOC)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,68.0,nM,=,CHEMBL3403819,active,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6CN(CCOC)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,organic,7.167491087293763
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6CN(CC(C)(C)O)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,120.0,nM,=,CHEMBL3403820,active,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6CN(CC(C)(C)O)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,organic,6.920818753952375
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC6CN(C(C)C)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,110.0,nM,=,CHEMBL3403822,active,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC6CN(C(C)C)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,organic,6.958607314841775
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC6CN(C7CCC7)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,210.0,nM,=,CHEMBL3403823,active,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC6CN(C7CCC7)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,organic,6.6777807052660805
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC6CN(C7COC7)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,170.0,nM,=,CHEMBL3403824,active,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC6CN(C7COC7)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,organic,6.769551078621726
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC6CN(CCOC)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,86.0,nM,=,CHEMBL3403825,active,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC6CN(CCOC)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,organic,7.0655015487564325
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC6CN(CC(C)(C)O)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,86.0,nM,=,CHEMBL3403826,active,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC6CN(CC(C)(C)O)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,organic,7.0655015487564325
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC6CN(CCO)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,120.0,nM,=,CHEMBL3403827,active,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(CC6CN(CCO)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,organic,6.920818753952375
Inhibition of production of human amyloidbeta42 expressed in CHO-2B7 cells after 5 hrs by immunoassay,IC50,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6CN(C(C)C)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,110.0,nM,=,CHEMBL3403816,active,CCO[C@@H]([C@H]1C[C@@H](C)[C@H]2[C@H](O1)[C@H](O)[C@@]1(C)[C@@H]3CC[C@H]4C(C)(C)[C@@H](O[C@H]5CN(C6CN(C(C)C)C6)CCO5)CC[C@@]45C[C@@]35CC[C@]21C)C(C)(C)O,organic,6.958607314841775
Inhibition of amyloid beta (1 to 40) (unknown origin) aggregation,IC50,O=C(Cc1ccccc1)NC(CSSCC(NC(=O)Cc1ccccc1)C(=O)O)C(=O)O,1950.0,nM,=,CHEMBL576840,active,O=C(Cc1ccccc1)NC(CSSCC(NC(=O)Cc1ccccc1)C(=O)O)C(=O)O,organic,5.709965388637482
Inhibition of amyloid beta (1 to 40) (unknown origin) aggregation,IC50,CNc1ccc(C(=O)NC(CCCCCNC(=O)OCc2ccccc2)C(=O)O)cc1,2750.0,nM,=,CHEMBL3400292,active,CNc1ccc(C(=O)NC(CCCCCNC(=O)OCc2ccccc2)C(=O)O)cc1,organic,5.560667306169737
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,IC50,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,500.0,nM,=,CHEMBL297453,active,O=C(O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c1cc(O)c(O)c(O)c1)c1cc(O)c(O)c(O)c1,organic,6.301029995663981
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,IC50,C[C@]1(O)c2ccc3c(c2C(=O)c2occ([C@@H](O)CCO)c21)CCC3=O,95900.0,nM,=,CHEMBL3582126,inactive,C[C@]1(O)c2ccc3c(c2C(=O)c2occ([C@@H](O)CCO)c21)CCC3=O,organic,4.018181392829336
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,IC50,C[C@]1(O)c2ccc3c(c2C(=O)c2occ(CCCO)c21)CCC3=O,28000.0,nM,=,CHEMBL3582127,inactive,C[C@]1(O)c2ccc3c(c2C(=O)c2occ(CCCO)c21)CCC3=O,organic,4.552841968657781
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,IC50,C[C@]1(O)c2ccc3c(c2C(=O)c2occ(CCO)c21)CCC3=O,34300.0,nM,=,CHEMBL3582128,inactive,C[C@]1(O)c2ccc3c(c2C(=O)c2occ(CCO)c21)CCC3=O,organic,4.464705879957229
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,IC50,C[C@@]1(O)c2ccc3c(c2C(=O)c2occ([C@@H](O)CCO)c21)CCC3=O,71900.0,nM,=,CHEMBL3582129,inactive,C[C@@]1(O)c2ccc3c(c2C(=O)c2occ([C@@H](O)CCO)c21)CCC3=O,organic,4.1432711096171175
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,IC50,C[C@@]12c3ccc4c(c3C(=O)c3occ(c31)[C@@H](O)C[C@@H]2O)CCC4=O,10100.0,nM,=,CHEMBL3582130,inactive,C[C@@]12c3ccc4c(c3C(=O)c3occ(c31)[C@@H](O)C[C@@H]2O)CCC4=O,organic,4.995678626217358
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,IC50,C[C@]12CCC(=O)c3coc(c31)C(=O)C1=C2[C@@H](O)C[C@]2(C)C(=O)CC[C@@H]12,1200.0,nM,=,CHEMBL3582132,active,C[C@]12CCC(=O)c3coc(c31)C(=O)C1=C2[C@@H](O)C[C@]2(C)C(=O)CC[C@@H]12,organic,5.920818753952375
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,IC50,C[C@@]12C(=O)CC[C@H]1C1=C(C[C@H]2O)[C@@]2(C)CC[C@H](O)c3coc(c32)C1=O,43500.0,nM,=,CHEMBL3582133,inactive,C[C@@]12C(=O)CC[C@H]1C1=C(C[C@H]2O)[C@@]2(C)CC[C@H](O)c3coc(c32)C1=O,organic,4.361510743045363
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated at 37 degC for 16 hrs by thioflavin T fluorescence assay,IC50,C[C@@]12c3ccc4c(c3C(=O)c3occ(c31)C(=O)C[C@H]2O)CCC4=O,13400.0,nM,=,CHEMBL549959,inactive,C[C@@]12c3ccc4c(c3C(=O)c3occ(c31)C(=O)C[C@H]2O)CCC4=O,organic,4.872895201635193
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorometric assay,IC50,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccccc2OC)=CC1=O)Cc1ccccc1OC,5930.0,nM,=,CHEMBL231160,active,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccccc2OC)=CC1=O)Cc1ccccc1OC,organic,5.226945306635737
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorometric assay,IC50,O=C(Cc1ccccc1Nc1c(Cl)cccc1Cl)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)Cc2ccccc2Nc2c(Cl)cccc2Cl)=CC1=O,3110.0,nM,=,CHEMBL3087676,active,O=C(Cc1ccccc1Nc1c(Cl)cccc1Cl)NCCCNCCCNC1=CC(=O)C(NCCCNCCCNC(=O)Cc2ccccc2Nc2c(Cl)cccc2Cl)=CC1=O,organic,5.507239610973162
Inhibition of self-mediated amyloid beta (1 to 42) aggregation (unknown origin) after 24 hrs by thioflavin T fluorometric assay,IC50,CC(C)Cc1ccc(C(C)C(=O)NCCCNCCCNC2=CC(=O)C(NCCCNCCCNC(=O)C(C)c3ccc(CC(C)C)cc3)=CC2=O)cc1,4830.0,nM,=,CHEMBL3087674,active,CC(C)Cc1ccc(C(C)C(=O)NCCCNCCCNC2=CC(=O)C(NCCCNCCCNC(=O)C(C)c3ccc(CC(C)C)cc3)=CC2=O)cc1,organic,5.316052869248487
Inhibition of Amyloid beta (1 to 40) (unknown origin) aggregation assessed as amount of fibrils formation at 100 uM after 2 hrs by thioflavin T based spectrofluorimetric method,IC50,CCN1/C(=C/C=C/c2sc3ccc(OCCCO[N+](=O)[O-])cc3[n+]2CC)Sc2ccc(OCCCO[N+](=O)[O-])cc21.O=S(=O)([O-])C(F)(F)F,26000.0,nM,=,CHEMBL3593276,inactive,CCN1/C(=C/C=C/c2sc3ccc(OCCCO[N+](=O)[O-])cc3[n+]2CC)Sc2ccc(OCCCO[N+](=O)[O-])cc21,organic,4.585026652029182
Inhibition of Amyloid beta (1 to 40) (unknown origin) aggregation assessed as amount of fibrils formation at 100 uM after 2 hrs by thioflavin T based spectrofluorimetric method,IC50,CCN1/C(=C/C=C/c2sc3ccc(OCc4no[n+]([O-])c4C(N)=O)cc3[n+]2CC)Sc2ccc(OCc3no[n+]([O-])c3C(N)=O)cc21.O=S(=O)([O-])C(F)(F)F,17000.0,nM,=,CHEMBL3593277,inactive,CCN1/C(=C/C=C/c2sc3ccc(OCc4no[n+]([O-])c4C(N)=O)cc3[n+]2CC)Sc2ccc(OCc3no[n+]([O-])c3C(N)=O)cc21,organic,4.769551078621726
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(-c2cc(-c3c(O)cccc3O)[nH]n2)ccc1O,4300.0,nM,=,CHEMBL3594076,active,COc1cc(-c2cc(-c3c(O)cccc3O)[nH]n2)ccc1O,organic,5.366531544420414
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,Oc1ccc(-c2cc(-c3c(O)cccc3O)[nH]n2)cc1,15800.0,nM,=,CHEMBL3594077,inactive,Oc1ccc(-c2cc(-c3c(O)cccc3O)[nH]n2)cc1,organic,4.801342913045577
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,Oc1ccc(-c2cc(-c3c(O)cccc3O)[nH]n2)cc1O,1300.0,nM,=,CHEMBL3594078,active,Oc1ccc(-c2cc(-c3c(O)cccc3O)[nH]n2)cc1O,organic,5.886056647693163
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(-c2cc(-c3c(O)cccc3O)[nH]n2)cc(OC)c1O,2900.0,nM,=,CHEMBL3594079,active,COc1cc(-c2cc(-c3c(O)cccc3O)[nH]n2)cc(OC)c1O,organic,5.5376020021010435
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,3900.0,nM,=,CHEMBL116438,active,COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O,organic,5.4089353929735005
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation incubated for 48 hrs by Thioflavin-T Abeta aggregation assay,IC50,O=C(O)c1c(O)cc2c([nH]c3ccccc32)c1O,15000.0,nM,=,CHEMBL3622510,inactive,O=C(O)c1c(O)cc2c([nH]c3ccccc32)c1O,organic,4.823908740944319
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by ThT assay,IC50,Oc1ccc(/C=C/c2ccc(O)c3ncccc23)cc1,8500.0,nM,=,CHEMBL3621634,active,Oc1ccc(/C=C/c2ccc(O)c3ncccc23)cc1,organic,5.070581074285707
Inhibition of amyloid beta-42 (unknown origin) self-mediated aggregation by thioflavin-T fluorescence assay,IC50,CC(C)c1c(NC(=O)/C=C/c2ccc(O)c(O)c2)cc2c(c1[N+](=O)[O-])CC[C@H]1[C@](C)(CNC(=O)/C=C/c3ccc(O)c(O)c3)CCC[C@]21C,3960.0,nM,=,CHEMBL3622258,active,CC(C)c1c(NC(=O)/C=C/c2ccc(O)c(O)c2)cc2c(c1[N+](=O)[O-])CC[C@H]1[C@](C)(CNC(=O)/C=C/c3ccc(O)c(O)c3)CCC[C@]21C,organic,5.402304814074488
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T assay,IC50,C[C@@H]1C[C@@]23C[C@H]4C(C)(C)[C@@]5(C[C@]4(CN2C1=O)NC3=O)C(=O)Nc1c5ccc2c1C=CC(C)(C)O2,244300.0,nM,=,CHEMBL3740785,inactive,C[C@@H]1C[C@@]23C[C@H]4C(C)(C)[C@@]5(C[C@]4(CN2C1=O)NC3=O)C(=O)Nc1c5ccc2c1C=CC(C)(C)O2,organic,3.6120765330265634
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T assay,IC50,C[C@H]1CN2C[C@]34C[C@@]5(C(=O)Nc6c5ccc5c6OC=CC(C)(C)O5)C(C)(C)[C@@H]3C[C@@]2(C1)C(=O)N4C,269500.0,nM,=,CHEMBL3739748,inactive,C[C@H]1CN2C[C@]34C[C@@]5(C(=O)Nc6c5ccc5c6OC=CC(C)(C)O5)C(C)(C)[C@@H]3C[C@@]2(C1)C(=O)N4C,organic,3.5694412304772425
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T assay,IC50,C[C@H]1CN2C[C@]34C[C@@]5(C(=O)Nc6c5ccc5c6C=CC(C)(C)O5)C(C)(C)[C@@H]3C[C@@]2(C1)C(=O)N4C,203700.0,nM,=,CHEMBL3741300,inactive,C[C@H]1CN2C[C@]34C[C@@]5(C(=O)Nc6c5ccc5c6C=CC(C)(C)O5)C(C)(C)[C@@H]3C[C@@]2(C1)C(=O)N4C,organic,3.6910089709998357
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T assay,IC50,CN1C(=O)[C@@]23CCC(=O)N2C[C@@]12C[C@@]1(C(=O)Nc4c1ccc1c4C=CC(C)(C)O1)C(C)(C)[C@@H]2C3,186600.0,nM,=,CHEMBL3740688,inactive,CN1C(=O)[C@@]23CCC(=O)N2C[C@@]12C[C@@]1(C(=O)Nc4c1ccc1c4C=CC(C)(C)O1)C(C)(C)[C@@H]2C3,organic,3.7290883605895186
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T assay,IC50,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O,71900.0,nM,=,CHEMBL324842,inactive,O=C(/C=C/c1ccc(O)c(O)c1)O[C@H](Cc1ccc(O)c(O)c1)C(=O)O,organic,4.1432711096171175
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,IC50,CC1=NN(c2ccc(-n3cccc3)cc2)C(=O)C1,26000.0,nM,=,CHEMBL3741643,inactive,CC1=NN(c2ccc(-n3cccc3)cc2)C(=O)C1,organic,4.585026652029182
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,IC50,CC1=NN(c2cccc(COCc3ccccc3)c2)C(=O)C1,27000.0,nM,=,CHEMBL3741680,inactive,CC1=NN(c2cccc(COCc3ccccc3)c2)C(=O)C1,organic,4.568636235841013
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,IC50,CC1=NN(c2ccc(-c3ccccc3)cc2)C(=O)C1,5600.0,nM,=,CHEMBL3741909,active,CC1=NN(c2ccc(-c3ccccc3)cc2)C(=O)C1,organic,5.251811972993799
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,IC50,COc1ccc(-c2ccc(N3N=C(C)CC3=O)cc2)cc1,3400.0,nM,=,CHEMBL3741268,active,COc1ccc(-c2ccc(N3N=C(C)CC3=O)cc2)cc1,organic,5.468521082957745
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,IC50,CC1=NN(c2ccc(-c3cccnc3)cc2)C(=O)C1,14500.0,nM,=,CHEMBL3742091,inactive,CC1=NN(c2ccc(-c3cccnc3)cc2)C(=O)C1,organic,4.838631997765025
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) aggregation incubated for 72 hrs by Thioflavin T assay,IC50,CC1=NN(c2ccc(-n3c(-c4ccccc4)cc4ccccc43)cc2)C(=O)C1,19600.0,nM,=,CHEMBL3741747,inactive,CC1=NN(c2ccc(-n3c(-c4ccccc4)cc4ccccc43)cc2)C(=O)C1,organic,4.707743928643524
Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,IC50,CC1=NN(c2ccc(-n3c(-c4ccccc4)cc4ccccc43)cc2)C(=O)C1,3500.0,nM,=,CHEMBL3741747,active,CC1=NN(c2ccc(-n3c(-c4ccccc4)cc4ccccc43)cc2)C(=O)C1,organic,5.455931955649724
Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,IC50,CC1=NN(c2ccc(-c3cccnc3)cc2)C(=O)C1,3900.0,nM,=,CHEMBL3742091,active,CC1=NN(c2ccc(-c3cccnc3)cc2)C(=O)C1,organic,5.4089353929735005
Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,IC50,COc1ccc(-c2ccc(N3N=C(C)CC3=O)cc2)cc1,5100.0,nM,=,CHEMBL3741268,active,COc1ccc(-c2ccc(N3N=C(C)CC3=O)cc2)cc1,organic,5.292429823902063
Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,IC50,CC1=NN(c2ccc(-c3ccccc3)cc2)C(=O)C1,19500.0,nM,=,CHEMBL3741909,inactive,CC1=NN(c2ccc(-c3ccccc3)cc2)C(=O)C1,organic,4.709965388637482
Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,IC50,CC1=NN(c2cccc(COCc3ccccc3)c2)C(=O)C1,2900.0,nM,=,CHEMBL3741680,active,CC1=NN(c2cccc(COCc3ccccc3)c2)C(=O)C1,organic,5.5376020021010435
Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,IC50,CC1=NN(c2ccc(-n3cccc3)cc2)C(=O)C1,4000.0,nM,=,CHEMBL3741643,active,CC1=NN(c2ccc(-n3cccc3)cc2)C(=O)C1,organic,5.3979400086720375
Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,IC50,CC1=NN(c2cccc(N3CCCC3)c2)C(=O)C1,16800.0,nM,=,CHEMBL3740581,inactive,CC1=NN(c2cccc(N3CCCC3)c2)C(=O)C1,organic,4.774690718274137
Inhibition of N-alpha-biotinyl-amyloid beta (1 to 42 residues) (unknown origin) oligomerization incubated for 1 hr by sandwich biotin-avidin assay,IC50,CC1=NN(c2ccc(N(c3ccccc3)c3ccccc3)cc2)C(=O)C1,4000.0,nM,=,CHEMBL3739861,active,CC1=NN(c2ccc(N(c3ccccc3)c3ccccc3)cc2)C(=O)C1,organic,5.3979400086720375
Inhibition of wild type Amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,IC50,O=c1c(O)c(-c2ccc(O)cc2O)oc2cc(O)cc(O)c12,30300.0,nM,=,CHEMBL28626,inactive,O=c1c(O)c(-c2ccc(O)cc2O)oc2cc(O)cc(O)c12,organic,4.518557371497695
Inhibition of wild type Amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,IC50,O=C1c2c(O)cc(O)cc2O[C@H](c2ccc(O)c(O)c2)[C@H]1O,33000.0,nM,=,CHEMBL66,inactive,O=C1c2c(O)cc(O)cc2O[C@H](c2ccc(O)c(O)c2)[C@H]1O,organic,4.481486060122113
Inhibition of wild type Amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,IC50,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,15300.0,nM,=,CHEMBL50,inactive,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,organic,4.815308569182401
Inhibition of wild type Amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,IC50,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,15100.0,nM,=,CHEMBL164,inactive,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,organic,4.82102305270683
Inhibition of wild type Amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,IC50,O=c1c(O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,75100.0,nM,=,CHEMBL150,inactive,O=c1c(O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,organic,4.124360062995832
Inhibition of wild type Amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,IC50,O=c1c(O)c(-c2ccccc2O)oc2cc(O)cc(O)c12,55400.0,nM,=,CHEMBL503168,inactive,O=c1c(O)c(-c2ccccc2O)oc2cc(O)cc(O)c12,organic,4.2564902352715706
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 10 hrs by thioflavin T based fluorometric assay,IC50,COc1ccc(CC(=O)Nc2nc(-c3ccccc3)cs2)cc1,10600.0,nM,=,CHEMBL3751854,inactive,COc1ccc(CC(=O)Nc2nc(-c3ccccc3)cs2)cc1,organic,4.97469413473523
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 10 hrs by thioflavin T based fluorometric assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,11300.0,nM,=,CHEMBL140,inactive,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,organic,4.94692155651658
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation measured after 24 hrs by Thioflavin T-based fluorometric assay,IC50,Cc1ccc(-c2cc(NCCNc3cc(-c4cccs4)[nH]n3)n[nH]2)cc1,29000.0,nM,=,CHEMBL3781419,inactive,Cc1ccc(-c2cc(NCCNc3cc(-c4cccs4)[nH]n3)n[nH]2)cc1,organic,4.5376020021010435
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation measured after 24 hrs by Thioflavin T-based fluorometric assay,IC50,CN(C)c1ccc(-c2cc(NCCNc3cc(-c4ccc(N(C)C)cc4)[nH]n3)n[nH]2)cc1,7500.0,nM,=,CHEMBL3781022,active,CN(C)c1ccc(-c2cc(NCCNc3cc(-c4ccc(N(C)C)cc4)[nH]n3)n[nH]2)cc1,organic,5.1249387366083
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation measured after 24 hrs by Thioflavin T-based fluorometric assay,IC50,Fc1ccc(-c2cc(NCCNc3cc(-c4ccc(F)cc4)[nH]n3)n[nH]2)cc1,40500.0,nM,=,CHEMBL3781026,inactive,Fc1ccc(-c2cc(NCCNc3cc(-c4ccc(F)cc4)[nH]n3)n[nH]2)cc1,organic,4.392544976785332
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1ccc(CC(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)cc1,71.28,nM,=,CHEMBL3797646,active,COc1ccc(CC(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)cc1,organic,7.147032308971181
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1ccc(CC(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)cc1OC,22.54,nM,=,CHEMBL3797706,active,COc1ccc(CC(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)cc1OC,organic,7.647046088289912
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1ccc(CC(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)c(OC)c1OC,51.81,nM,=,CHEMBL3799558,active,COc1ccc(CC(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)c(OC)c1OC,organic,7.285586407712879
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,O=C(COC(=O)Cc1ccc(O)cc1)Nc1c2c(nc3ccccc13)CCCC2,45.29,nM,=,CHEMBL3798857,active,O=C(COC(=O)Cc1ccc(O)cc1)Nc1c2c(nc3ccccc13)CCCC2,organic,7.3439976793170425
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,O=C(COC(=O)Cc1ccc(Cl)cc1)Nc1c2c(nc3ccccc13)CCCC2,77.45,nM,=,CHEMBL3797623,active,O=C(COC(=O)Cc1ccc(Cl)cc1)Nc1c2c(nc3ccccc13)CCCC2,organic,7.110978577904775
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(OC)cc(C(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)c1,55.86,nM,=,CHEMBL3798989,active,COc1cc(OC)cc(C(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)c1,organic,7.252899068635013
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(C(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)cc(OC)c1OC,30.74,nM,=,CHEMBL3797363,active,COc1cc(C(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)cc(OC)c1OC,organic,7.512296136836274
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1ccc(C(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)c(OC)c1OC,65.5,nM,=,CHEMBL3799703,active,COc1ccc(C(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)c(OC)c1OC,organic,7.183758700008217
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(C(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)ccc1O,37.36,nM,=,CHEMBL3797381,active,COc1cc(C(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)ccc1O,organic,7.427593132441944
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,O=C(COC(=O)c1ccc(O)c(O)c1)Nc1c2c(nc3ccccc13)CCCC2,17.36,nM,=,CHEMBL3800453,active,O=C(COC(=O)c1ccc(O)c(O)c1)Nc1c2c(nc3ccccc13)CCCC2,organic,7.760450279159527
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1ccc(/C=C/C(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)cc1OC,49.14,nM,=,CHEMBL3800317,active,COc1ccc(/C=C/C(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)cc1OC,organic,7.308564847855938
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)cc(OC)c1OC,45.88,nM,=,CHEMBL3799950,active,COc1cc(/C=C/C(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)cc(OC)c1OC,organic,7.33837659077077
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1ccc(/C=C/C(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)cc1O,46.12,nM,=,CHEMBL3798813,active,COc1ccc(/C=C/C(=O)OCC(=O)Nc2c3c(nc4ccccc24)CCCC3)cc1O,organic,7.336110701377339
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,O=C(COC(=O)/C=C/c1ccc(Cl)cc1)Nc1c2c(nc3ccccc13)CCCC2,51.77,nM,=,CHEMBL3799175,active,O=C(COC(=O)/C=C/c1ccc(Cl)cc1)Nc1c2c(nc3ccccc13)CCCC2,organic,7.285921835018144
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,O=C(COC(=O)Cc1c[nH]c2ccccc12)Nc1c2c(nc3ccccc13)CCCC2,38.96,nM,=,CHEMBL3799641,active,O=C(COC(=O)Cc1c[nH]c2ccccc12)Nc1c2c(nc3ccccc13)CCCC2,organic,7.409381051793422
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,Nc1c2c(nc3ccccc13)CCCC2,12.21,nM,=,CHEMBL95,active,Nc1c2c(nc3ccccc13)CCCC2,organic,7.913284336055117
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,4100.0,nM,=,CHEMBL165,active,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,organic,5.3872161432802645
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,3100.0,nM,=,CHEMBL140,active,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,organic,5.508638306165727
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(F)c2)nc2ccccc12,14700.0,nM,=,CHEMBL3813837,inactive,Nc1nc(NCc2cccc(F)c2)nc2ccccc12,organic,4.8326826652518236
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccc(Br)cc2)nc2ccccc12,1700.0,nM,=,CHEMBL3814001,active,Nc1nc(NCc2ccc(Br)cc2)nc2ccccc12,organic,5.769551078621726
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(Br)c2)nc2ccccc12,2700.0,nM,=,CHEMBL3814125,active,Nc1nc(NCc2cccc(Br)c2)nc2ccccc12,organic,5.568636235841013
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccc(Cl)cc2)nc2ccccc12,8100.0,nM,=,CHEMBL3815148,active,Nc1nc(NCc2ccc(Cl)cc2)nc2ccccc12,organic,5.0915149811213505
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(Cl)c2)nc2ccccc12,13400.0,nM,=,CHEMBL3814191,inactive,Nc1nc(NCc2cccc(Cl)c2)nc2ccccc12,organic,4.872895201635193
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccc(C(F)(F)F)cc2)nc2ccccc12,5300.0,nM,=,CHEMBL3814611,active,Nc1nc(NCc2ccc(C(F)(F)F)cc2)nc2ccccc12,organic,5.275724130399211
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(C(F)(F)F)c2)nc2ccccc12,13800.0,nM,=,CHEMBL3815150,inactive,Nc1nc(NCc2cccc(C(F)(F)F)c2)nc2ccccc12,organic,4.860120913598763
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Cc1ccc(CNc2nc(N)c3ccccc3n2)cc1,22500.0,nM,=,CHEMBL3813859,inactive,Cc1ccc(CNc2nc(N)c3ccccc3n2)cc1,organic,4.647817481888637
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccccc2)nc2ccccc12,8400.0,nM,=,CHEMBL3814134,active,Nc1nc(NCc2ccccc2)nc2ccccc12,organic,5.075720713938118
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccc(Br)cc2)c2ccccc2n1,14800.0,nM,=,CHEMBL3814631,inactive,Nc1nc(NCc2ccc(Br)cc2)c2ccccc2n1,organic,4.8297382846050425
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(Br)c2)c2ccccc2n1,22300.0,nM,=,CHEMBL3814270,inactive,Nc1nc(NCc2cccc(Br)c2)c2ccccc2n1,organic,4.651695136951839
Inhibition of self-induced amyloid beta 42 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(C(F)(F)F)c2)c2ccccc2n1,21000.0,nM,=,CHEMBL3814349,inactive,Nc1nc(NCc2cccc(C(F)(F)F)c2)c2ccccc2n1,organic,4.6777807052660805
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,2600.0,nM,=,CHEMBL165,active,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,organic,5.585026652029182
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,1500.0,nM,=,CHEMBL140,active,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,organic,5.823908740944319
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCCc2ccccc2)nc2ccccc12,14900.0,nM,=,CHEMBL3814610,inactive,Nc1nc(NCCc2ccccc2)nc2ccccc12,organic,4.826813731587726
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(F)c2)nc2ccccc12,11300.0,nM,=,CHEMBL3813837,inactive,Nc1nc(NCc2cccc(F)c2)nc2ccccc12,organic,4.94692155651658
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccc(Br)cc2)nc2ccccc12,1700.0,nM,=,CHEMBL3814001,active,Nc1nc(NCc2ccc(Br)cc2)nc2ccccc12,organic,5.769551078621726
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(Br)c2)nc2ccccc12,1500.0,nM,=,CHEMBL3814125,active,Nc1nc(NCc2cccc(Br)c2)nc2ccccc12,organic,5.823908740944319
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccc(Cl)cc2)nc2ccccc12,930.0,nM,=,CHEMBL3815148,active,Nc1nc(NCc2ccc(Cl)cc2)nc2ccccc12,organic,6.031517051446065
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(Cl)c2)nc2ccccc12,5900.0,nM,=,CHEMBL3814191,active,Nc1nc(NCc2cccc(Cl)c2)nc2ccccc12,organic,5.229147988357856
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccc(C(F)(F)F)cc2)nc2ccccc12,2300.0,nM,=,CHEMBL3814611,active,Nc1nc(NCc2ccc(C(F)(F)F)cc2)nc2ccccc12,organic,5.638272163982407
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(C(F)(F)F)c2)nc2ccccc12,12500.0,nM,=,CHEMBL3815150,inactive,Nc1nc(NCc2cccc(C(F)(F)F)c2)nc2ccccc12,organic,4.903089986991944
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,COc1ccc(CNc2nc(N)c3ccccc3n2)cc1,6800.0,nM,=,CHEMBL3814909,active,COc1ccc(CNc2nc(N)c3ccccc3n2)cc1,organic,5.167491087293763
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Cc1ccc(CNc2nc(N)c3ccccc3n2)cc1,13100.0,nM,=,CHEMBL3813859,inactive,Cc1ccc(CNc2nc(N)c3ccccc3n2)cc1,organic,4.882728704344236
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccccc2)nc2ccccc12,2200.0,nM,=,CHEMBL3814134,active,Nc1nc(NCc2ccccc2)nc2ccccc12,organic,5.657577319177793
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCC2CCCCC2)c2ccccc2n1,13600.0,nM,=,CHEMBL3815002,inactive,Nc1nc(NCC2CCCCC2)c2ccccc2n1,organic,4.866461091629782
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,CC(C)Nc1nc(N)nc2ccccc12,10200.0,nM,=,CHEMBL3814965,inactive,CC(C)Nc1nc(N)nc2ccccc12,organic,4.991399828238082
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,CCCNc1nc(N)nc2ccccc12,14900.0,nM,=,CHEMBL3814813,inactive,CCCNc1nc(N)nc2ccccc12,organic,4.826813731587726
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCCc2ccccc2)c2ccccc2n1,7800.0,nM,=,CHEMBL3814123,active,Nc1nc(NCCc2ccccc2)c2ccccc2n1,organic,5.107905397309519
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccc(F)cc2)c2ccccc2n1,3100.0,nM,=,CHEMBL3357256,active,Nc1nc(NCc2ccc(F)cc2)c2ccccc2n1,organic,5.508638306165727
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(F)c2)c2ccccc2n1,2800.0,nM,=,CHEMBL3814748,active,Nc1nc(NCc2cccc(F)c2)c2ccccc2n1,organic,5.552841968657781
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccc(Br)cc2)c2ccccc2n1,80.0,nM,=,CHEMBL3814631,active,Nc1nc(NCc2ccc(Br)cc2)c2ccccc2n1,organic,7.096910013008056
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(Br)c2)c2ccccc2n1,580.0,nM,=,CHEMBL3814270,active,Nc1nc(NCc2cccc(Br)c2)c2ccccc2n1,organic,6.236572006437063
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccc(Cl)cc2)c2ccccc2n1,620.0,nM,=,CHEMBL3813811,active,Nc1nc(NCc2ccc(Cl)cc2)c2ccccc2n1,organic,6.2076083105017466
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(Cl)c2)c2ccccc2n1,1900.0,nM,=,CHEMBL3814383,active,Nc1nc(NCc2cccc(Cl)c2)c2ccccc2n1,organic,5.721246399047171
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccc(C(F)(F)F)cc2)c2ccccc2n1,1900.0,nM,=,CHEMBL3814660,active,Nc1nc(NCc2ccc(C(F)(F)F)cc2)c2ccccc2n1,organic,5.721246399047171
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2cccc(C(F)(F)F)c2)c2ccccc2n1,3500.0,nM,=,CHEMBL3814349,active,Nc1nc(NCc2cccc(C(F)(F)F)c2)c2ccccc2n1,organic,5.455931955649724
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,COc1ccc(CNc2nc(N)nc3ccccc23)cc1,1100.0,nM,=,CHEMBL3813788,active,COc1ccc(CNc2nc(N)nc3ccccc23)cc1,organic,5.958607314841775
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,COc1cccc(CNc2nc(N)nc3ccccc23)c1,20600.0,nM,=,CHEMBL3814429,inactive,COc1cccc(CNc2nc(N)nc3ccccc23)c1,organic,4.686132779630847
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Cc1ccc(CNc2nc(N)nc3ccccc23)cc1,3900.0,nM,=,CHEMBL3813971,active,Cc1ccc(CNc2nc(N)nc3ccccc23)cc1,organic,5.4089353929735005
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Cc1cccc(CNc2nc(N)nc3ccccc23)c1,3600.0,nM,=,CHEMBL3814363,active,Cc1cccc(CNc2nc(N)nc3ccccc23)c1,organic,5.443697499232712
Inhibition of self-induced amyloid beta 40 (unknown origin) aggregation measured for 24 hrs by thioflavin T-based fluorescence spectroscopic analysis,IC50,Nc1nc(NCc2ccccc2)c2ccccc2n1,4800.0,nM,=,CHEMBL3815078,active,Nc1nc(NCc2ccccc2)c2ccccc2n1,organic,5.318758762624412
Inhibition of Abeta42 (unknown origin) aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,9000.0,nM,=,CHEMBL140,active,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,organic,5.045757490560675
Inhibition of Abeta42 (unknown origin) aggregation measured after 24 hrs by ThT fluorescence assay,IC50,CNc1cccc(CCNc2cccc(NCCc3ccccn3)n2)n1,35000.0,nM,=,CHEMBL3815004,inactive,CNc1cccc(CCNc2cccc(NCCc3ccccn3)n2)n1,organic,4.455931955649724
Inhibition of Abeta42 (unknown origin) aggregation measured after 24 hrs by ThT fluorescence assay,IC50,CNc1cccc(NCCCc2cccc(NCCCc3ccccn3)n2)n1,17000.0,nM,=,CHEMBL3814529,inactive,CNc1cccc(NCCCc2cccc(NCCCc3ccccn3)n2)n1,organic,4.769551078621726
Inhibition of Abeta42 (unknown origin) aggregation measured after 24 hrs by ThT fluorescence assay,IC50,CNc1cccc(NCCc2cccc(NCCc3ccccn3)n2)n1,25000.0,nM,=,CHEMBL3814719,inactive,CNc1cccc(NCCc2cccc(NCCc3ccccn3)n2)n1,organic,4.6020599913279625
Inhibition of Abeta42 (unknown origin) aggregation measured after 24 hrs by ThT fluorescence assay,IC50,CNc1cccc(NCCc2cccc(NCc3ccccn3)n2)n1,13000.0,nM,=,CHEMBL3814159,inactive,CNc1cccc(NCCc2cccc(NCc3ccccn3)n2)n1,organic,4.886056647693163
Inhibition of Abeta42 (unknown origin) aggregation measured after 24 hrs by ThT fluorescence assay,IC50,CNc1cccc(CCNc2cccc(CCN(c3ccccn3)c3ccccn3)n2)n1,240000.0,nM,=,CHEMBL3813916,inactive,CNc1cccc(CCNc2cccc(CCN(c3ccccn3)c3ccccn3)n2)n1,organic,3.619788758288394
Inhibition of Abeta42 (unknown origin) aggregation measured after 24 hrs by ThT fluorescence assay,IC50,CNc1cccc(CCNc2cccc(CCNc3ccccn3)n2)n1,280000.0,nM,=,CHEMBL3814563,inactive,CNc1cccc(CCNc2cccc(CCNc3ccccn3)n2)n1,organic,3.5528419686577806
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation incubated for 48 hrs measured after 5 mins by thioflavin-T fluorescence assay,IC50,O=C1C(=Cc2ccc(N3CCN(C(=O)c4ccco4)CC3)cc2)C(=O)c2ccccc21,9200.0,nM,=,CHEMBL3818600,active,O=C1C(=Cc2ccc(N3CCN(C(=O)c4ccco4)CC3)cc2)C(=O)c2ccccc21,organic,5.036212172654444
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation incubated for 48 hrs measured after 5 mins by thioflavin-T fluorescence assay,IC50,O=C1C(=Cc2ccc(N3CCN(C(c4ccccc4)c4ccccc4)CC3)cc2)C(=O)c2ccccc21,11750.0,nM,=,CHEMBL3819454,inactive,O=C1C(=Cc2ccc(N3CCN(C(c4ccccc4)c4ccccc4)CC3)cc2)C(=O)c2ccccc21,organic,4.9299621333922445
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation incubated for 48 hrs measured after 5 mins by thioflavin-T fluorescence assay,IC50,O=C1C(=Cc2ccc(N3CCN(c4ncccn4)CC3)cc2)C(=O)c2ccccc21,10110.0,nM,=,CHEMBL3818053,inactive,O=C1C(=Cc2ccc(N3CCN(c4ncccn4)CC3)cc2)C(=O)c2ccccc21,organic,4.995248844408999
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation incubated for 48 hrs measured after 5 mins by thioflavin-T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,21810.0,nM,=,CHEMBL140,inactive,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,organic,4.661344334421299
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(O)ccc1/C=C/C(=O)CC(=O)/C=C/c1ccc(O)cc1OC,4600.0,nM,=,CHEMBL3942680,active,COc1cc(O)ccc1/C=C/C(=O)CC(=O)/C=C/c1ccc(O)cc1OC,organic,5.337242168318426
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(OCc2ccccn2)ccc1/C=C/c1cc(/C=C/c2ccc3cc[nH]c3c2)[nH]n1,1200.0,nM,=,CHEMBL3953399,active,COc1cc(OCc2ccccn2)ccc1/C=C/c1cc(/C=C/c2ccc3cc[nH]c3c2)[nH]n1,organic,5.920818753952375
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(OCc2ccccn2)ccc1/C=C/C(=O)CC(=O)/C=C/c1ccc2cc[nH]c2c1,470.0,nM,=,CHEMBL3948937,active,COc1cc(OCc2ccccn2)ccc1/C=C/C(=O)CC(=O)/C=C/c1ccc2cc[nH]c2c1,organic,6.327902142064283
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(OCc2ccccc2)ccc1/C=C/C(=O)CC(=O)/C=C/c1ccc2cc[nH]c2c1,5400.0,nM,=,CHEMBL3901022,active,COc1cc(OCc2ccccc2)ccc1/C=C/C(=O)CC(=O)/C=C/c1ccc2cc[nH]c2c1,organic,5.267606240177032
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(OCC2CCCO2)ccc1/C=C/C(=O)CC(=O)/C=C/c1ccc2cc[nH]c2c1,2500.0,nM,=,CHEMBL3938007,active,COc1cc(OCC2CCCO2)ccc1/C=C/C(=O)CC(=O)/C=C/c1ccc2cc[nH]c2c1,organic,5.6020599913279625
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1ccc(/C=C/C(=O)CC(=O)/C=C/c2ccc3cc[nH]c3c2)c(OC)c1,610.0,nM,=,CHEMBL3965306,active,COc1ccc(/C=C/C(=O)CC(=O)/C=C/c2ccc3cc[nH]c3c2)c(OC)c1,organic,6.214670164989233
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(O)ccc1/C=C/C(=O)CC(=O)/C=C/c1ccc2cc[nH]c2c1,520.0,nM,=,CHEMBL3911126,active,COc1cc(O)ccc1/C=C/C(=O)CC(=O)/C=C/c1ccc2cc[nH]c2c1,organic,6.2839966563652006
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccco2)ccc1O,760.0,nM,=,CHEMBL3981143,active,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccco2)ccc1O,organic,6.119186407719209
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccccc2)ccc1O,2200.0,nM,=,CHEMBL3892054,active,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccccc2)ccc1O,organic,5.657577319177793
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc3cc[nH]c3c2)ccc1O,420.0,nM,=,CHEMBL3950384,active,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc3cc[nH]c3c2)ccc1O,organic,6.376750709602099
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc3ccccc3c2)ccc1O,590.0,nM,=,CHEMBL3922663,active,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc3ccccc3c2)ccc1O,organic,6.229147988357855
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc3c(c2)OCO3)ccc1O,3700.0,nM,=,CHEMBL3978488,active,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc3c(c2)OCO3)ccc1O,organic,5.431798275933005
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1ccc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)c(O)c1,930.0,nM,=,CHEMBL3672436,active,COc1ccc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)c(O)c1,organic,6.031517051446065
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(O)cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)c1,1100.0,nM,=,CHEMBL3970179,active,COc1cc(O)cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)c1,organic,5.958607314841775
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1ccc(O)c(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)c1,1800.0,nM,=,CHEMBL3940632,active,COc1ccc(O)c(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)c1,organic,5.7447274948966935
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)cc2OC)ccc1O,920.0,nM,=,CHEMBL3672401,active,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)cc2OC)ccc1O,organic,6.036212172654444
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2cc(O)ccc2OC)ccc1O,1300.0,nM,=,CHEMBL3969106,active,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2cc(O)ccc2OC)ccc1O,organic,5.886056647693163
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2c(O)cccc2OC)ccc1O,1600.0,nM,=,CHEMBL3672439,active,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2c(O)cccc2OC)ccc1O,organic,5.795880017344075
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1ccc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)cc1O,2100.0,nM,=,CHEMBL3958051,active,COc1ccc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)cc1O,organic,5.6777807052660805
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2cccc(O)c2OC)ccc1O,1900.0,nM,=,CHEMBL3911667,active,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2cccc(O)c2OC)ccc1O,organic,5.721246399047171
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2cccc(OC)c2O)ccc1O,5400.0,nM,=,CHEMBL3986412,active,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2cccc(OC)c2O)ccc1O,organic,5.267606240177032
Inhibition of amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,5400.0,nM,=,CHEMBL140,active,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,organic,5.267606240177032
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,CN(C)c1ccc(-c2cc(=O)c3ccc(OCC(=O)NCCCCCCNc4c5c(nc6ccccc46)CCCC5)cc3o2)cc1,9470.0,nM,=,CHEMBL3922564,active,CN(C)c1ccc(-c2cc(=O)c3ccc(OCC(=O)NCCCCCCNc4c5c(nc6ccccc46)CCCC5)cc3o2)cc1,organic,5.023650020996727
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation after 48 hrs by thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,18250.0,nM,=,CHEMBL140,inactive,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,organic,4.738737131207507
Inhibition of human amyloid beta (1 to 42) aggregation incubated for 48 hrs under dark condition by ThT fluorescence assay,IC50,OC[C@@H]1Cc2c([nH]c3ccccc23)CN1Cc1cn(C[C@@H]2Cc3c([nH]c4ccccc34)CN2)nn1,66360.0,nM,=,CHEMBL3883958,inactive,OC[C@@H]1Cc2c([nH]c3ccccc23)CN1Cc1cn(C[C@@H]2Cc3c([nH]c4ccccc34)CN2)nn1,organic,4.178093622647677
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin) by ThT fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,630.0,nM,=,CHEMBL140,active,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,organic,6.200659450546418
Inhibition of amyloid beta (1 to 42) aggregation (unknown origin),IC50,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,7940.0,nM,=,CHEMBL50,active,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,organic,5.100179497572904
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin-T fluorescence assay,IC50,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(C(c4ccccc4)c4ccccc4)CC3)cc1)C2,12200.0,nM,=,CHEMBL3944195,inactive,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(C(c4ccccc4)c4ccccc4)CC3)cc1)C2,organic,4.913640169325252
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin-T fluorescence assay,IC50,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(C(c4ccc(F)cc4)c4ccc(F)cc4)CC3)cc1)C2,7400.0,nM,=,CHEMBL3925265,active,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(C(c4ccc(F)cc4)c4ccc(F)cc4)CC3)cc1)C2,organic,5.130768280269024
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin-T fluorescence assay,IC50,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(C(=O)c4ccoc4)CC3)cc1)C2,10900.0,nM,=,CHEMBL3913721,inactive,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(C(=O)c4ccoc4)CC3)cc1)C2,organic,4.962573502059376
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin-T fluorescence assay,IC50,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(c4ncccn4)CC3)cc1)C2,9900.0,nM,=,CHEMBL3951861,active,COc1cc2c(cc1OC)C(=O)/C(=C/c1ccc(N3CCN(c4ncccn4)CC3)cc1)C2,organic,5.00436480540245
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin-T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,21810.0,nM,=,CHEMBL140,inactive,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,organic,4.661344334421299
"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",IC50,CCS(=O)(=O)NC[C@@H]1CCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@@H]12,1.0,nM,=,CHEMBL1086286,active,CCS(=O)(=O)NC[C@@H]1CCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@@H]12,organic,9.0
"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",IC50,O=S(=O)(NC[C@@H]1CCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@@H]12)C(F)(F)F,14.0,nM,=,CHEMBL1086287,active,O=S(=O)(NC[C@@H]1CCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@@H]12)C(F)(F)F,organic,7.853871964321762
"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",IC50,CC(=O)CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@@H]12,7.0,nM,=,CHEMBL3659993,active,CC(=O)CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@@H]12,organic,8.154901959985743
"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",IC50,O=S(=O)(c1ccc(Cl)cc1)[C@@]12CCO[C@@H](CCC(O)CO)[C@@H]1COc1c(F)ccc(F)c12,15.0,nM,=,CHEMBL3659994,active,O=S(=O)(c1ccc(Cl)cc1)[C@@]12CCO[C@@H](CCC(O)CO)[C@@H]1COc1c(F)ccc(F)c12,organic,7.823908740944319
"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",IC50,O=S(=O)(N[C@@H]1CC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@H]2C1)C1CC1,8.0,nM,=,CHEMBL1090210,active,O=S(=O)(N[C@@H]1CC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@H]2C1)C1CC1,organic,8.096910013008056
"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",IC50,O=C(C[C@@H]1CC[C@@]2(S(=O)(=O)c3ccc(C(F)(F)F)cc3)c3c(F)ccc(F)c3OC[C@H]2C1)NCC(F)(F)F,25.0,nM,=,CHEMBL3659995,active,O=C(C[C@@H]1CC[C@@]2(S(=O)(=O)c3ccc(C(F)(F)F)cc3)c3c(F)ccc(F)c3OC[C@H]2C1)NCC(F)(F)F,organic,7.6020599913279625
"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",IC50,CCS(=O)(=O)CC[C@@H]1CCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@@H]12,10.0,nM,=,CHEMBL3659992,active,CCS(=O)(=O)CC[C@@H]1CCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@@H]12,organic,8.0
"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",IC50,O=S(=O)(N[C@@H]1CC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@H]2C1)C(F)(F)F,27.0,nM,=,CHEMBL1090209,active,O=S(=O)(N[C@@H]1CC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@H]2C1)C(F)(F)F,organic,7.568636235841013
"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",IC50,O=S(=O)(N[C@@H]1CC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@@]2(O)C1)C1CC1,29.0,nM,=,CHEMBL1778349,active,O=S(=O)(N[C@@H]1CC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@@]2(O)C1)C1CC1,organic,7.5376020021010435
"Pharmacological Assay: Gamma-secretase activity was determined as described by Zhang et al. (Biochemistry, 40(16), 5049-5055, 2001).",IC50,O=S(=O)(NC[C@@H]1CCC[C@@]2(S(=O)(=O)c3ccc(C(F)(F)F)cc3)c3c(F)ccc(F)c3OC[C@@H]12)C(F)(F)F,54.0,nM,=,CHEMBL1085076,active,O=S(=O)(NC[C@@H]1CCC[C@@]2(S(=O)(=O)c3ccc(C(F)(F)F)cc3)c3c(F)ccc(F)c3OC[C@@H]12)C(F)(F)F,organic,7.267606240177032
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,O=C(/C=C/c1ccc(O)c(OC(F)(F)F)c1)CC(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,210.0,nM,=,CHEMBL3667019,active,O=C(/C=C/c1ccc(O)c(OC(F)(F)F)c1)CC(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,organic,6.6777807052660805
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,COC(=O)CCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,440.0,nM,=,CHEMBL3667020,active,COC(=O)CCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,organic,6.356547323513812
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,COC(=O)CC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,520.0,nM,=,CHEMBL3667022,active,COC(=O)CC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,organic,6.2839966563652006
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,COC(=O)CCCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,310.0,nM,=,CHEMBL3667023,active,COC(=O)CCCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,organic,6.508638306165727
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,CCOC(=O)CCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,380.0,nM,=,CHEMBL3667024,active,CCOC(=O)CCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,organic,6.42021640338319
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,CC(C)(C)OC(=O)CCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,650.0,nM,=,CHEMBL3667025,active,CC(C)(C)OC(=O)CCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,organic,6.187086643357144
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,O=C(O)CCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,1300.0,nM,=,CHEMBL3667026,active,O=C(O)CCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,organic,5.886056647693163
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,CCOC(=O)C(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,140.0,nM,=,CHEMBL3667027,active,CCOC(=O)C(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,organic,6.853871964321762
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,COCOCCCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,500.0,nM,=,CHEMBL3667029,active,COCOCCCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,organic,6.301029995663981
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,CN(C)C(=O)CCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,500.0,nM,=,CHEMBL3667030,active,CN(C)C(=O)CCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,organic,6.301029995663981
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,O=C(/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(CCOCCO)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,700.0,nM,=,CHEMBL3667031,active,O=C(/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(CCOCCO)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,organic,6.154901959985743
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,COC(=O)COc1ccc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)cc1OC,140.0,nM,=,CHEMBL3667032,active,COC(=O)COc1ccc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)cc1OC,organic,6.853871964321762
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(OCC(=O)O)c(OC)c2)ccc1O,310.0,nM,=,CHEMBL3667033,active,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(OCC(=O)O)c(OC)c2)ccc1O,organic,6.508638306165727
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(C(F)(F)F)c2)ccc1O,130.0,nM,=,CHEMBL3639383,active,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(C(F)(F)F)c2)ccc1O,organic,6.886056647693163
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,CNc1ccc(/C=C/C(=O)CC(=O)/C=C/c2ccc(NC)c(C(F)(F)F)c2)cc1C(F)(F)F,5800.0,nM,=,CHEMBL3667034,active,CNc1ccc(/C=C/C(=O)CC(=O)/C=C/c2ccc(NC)c(C(F)(F)F)c2)cc1C(F)(F)F,organic,5.236572006437063
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2cncc(C(F)(F)F)c2)ccc1O,100.0,nM,=,CHEMBL3667035,active,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2cncc(C(F)(F)F)c2)ccc1O,organic,7.0
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,COC(=O)CCC(C(=O)/C=C/c1ccc(O)c(C(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(C(F)(F)F)c1,360.0,nM,=,CHEMBL3667036,active,COC(=O)CCC(C(=O)/C=C/c1ccc(O)c(C(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(C(F)(F)F)c1,organic,6.443697499232712
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,N#CCCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,300.0,nM,=,CHEMBL3667037,active,N#CCCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,organic,6.522878745280337
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,CC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,320.0,nM,=,CHEMBL3667038,active,CC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1,organic,6.494850021680094
"Binidng Assay: First, amyloid beta peptides (1-40, Peptide Institute, Minoh-shi, Osaka) were dissolved in a 50 mM phosphate buffer containing 100 mM sodium chloride (pH 7.5) such that the concentration of the amyloid beta peptides was 100 mM, and then the solution was left to stand for 16 hours at 30 C., thereby producing amyloid beta peptide aggregates. To these amyloid beta peptide, amyloid beta peptide aggregates that had been prepared in advance by the same method and sonicated for 30 minutes under 28-45-100 KHz variation were added by a 1/1000 quantity, whereby uniform amyloid beta peptide aggregates were prepared.The amyloid beta peptide aggregates prepared by the above method, thioflavin-T, and a measurement compound were added in a 50 mM phosphate buffer (pH 7.4) such that the final concentrations thereof were 1 uM, 3 uM, and 0.02 to 20 uM, respectively. The resultant solution was cause to react for 30 minutes at 23 C. with the light shielded.",IC50,COC(=O)CCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccco1,650.0,nM,=,CHEMBL3667039,active,COC(=O)CCC(C(=O)/C=C/c1ccc(O)c(OC(F)(F)F)c1)C(=O)/C=C/c1ccco1,organic,6.187086643357144
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(C#CC3CCC3)cc1[C@]21N=C(C)C(N)=N1,2.0,nM,=,CHEMBL4112651,active,CO[C@H]1CC[C@]2(CC1)Cc1ccc(C#CC3CCC3)cc1[C@]21N=C(C)C(N)=N1,organic,8.698970004336019
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(C#CC(C)C)cc1[C@@]21N=C(C)C(N)=N1,1.6,nM,=,CHEMBL3893021,active,CO[C@H]1CC[C@]2(CC1)Cc1ccc(C#CC(C)C)cc1[C@@]21N=C(C)C(N)=N1,organic,8.795880017344075
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCCC(F)(F)F)cc1C21N=C(C)C(N)=N1,56.0,nM,=,CHEMBL3959097,active,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCCC(F)(F)F)cc1C21N=C(C)C(N)=N1,organic,7.251811972993799
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCCC(F)(F)F)cc1[C@@]21N=C(C)C(N)=N1,0.7,nM,=,CHEMBL3898248,active,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCCC(F)(F)F)cc1[C@@]21N=C(C)C(N)=N1,organic,9.154901959985743
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC1=N[C@]2(N=C1N)c1cc(-c3cc(Cl)cc(C#N)c3)ccc1C[C@]21CC[C@@H](O)CC1,1.6,nM,=,CHEMBL3672698,active,CC1=N[C@]2(N=C1N)c1cc(-c3cc(Cl)cc(C#N)c3)ccc1C[C@]21CC[C@@H](O)CC1,organic,8.795880017344075
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC[C@@H](C)Oc1ccc2c(c1)C1(N=C(C)C(N)=N1)[C@]1(CC[C@H](OC)CC1)C2,16.0,nM,=,CHEMBL3672702,active,CC[C@@H](C)Oc1ccc2c(c1)C1(N=C(C)C(N)=N1)[C@]1(CC[C@H](OC)CC1)C2,organic,7.795880017344075
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC1=NC2(N=C1N)c1cc(Br)ccc1C[C@]21CC[C@@H](O)CC1,2.4,nM,=,CHEMBL3672687,active,CC1=NC2(N=C1N)c1cc(Br)ccc1C[C@]21CC[C@@H](O)CC1,organic,8.619788758288394
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC1=N[C@@]2(N=C1N)c1cc(Br)ccc1C[C@]21CC[C@@H](O)CC1,96.0,nM,=,CHEMBL3672688,active,CC1=N[C@@]2(N=C1N)c1cc(Br)ccc1C[C@]21CC[C@@H](O)CC1,organic,7.017728766960431
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(C#CC3CCC3)cc1[C@@]21N=C(C)C(N)=N1,2.1,nM,=,CHEMBL3891777,active,CO[C@H]1CC[C@]2(CC1)Cc1ccc(C#CC3CCC3)cc1[C@@]21N=C(C)C(N)=N1,organic,8.67778070526608
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(C#CC(C)C)cc1C21N=C(C)C(N)=N1,678.0,nM,=,CHEMBL3945110,active,CO[C@H]1CC[C@]2(CC1)Cc1ccc(C#CC(C)C)cc1C21N=C(C)C(N)=N1,organic,6.168770306132936
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(C#CC(C)C)cc1[C@]21N=C(C)C(N)=N1,0.7,nM,=,CHEMBL4110988,active,CO[C@H]1CC[C@]2(CC1)Cc1ccc(C#CC(C)C)cc1[C@]21N=C(C)C(N)=N1,organic,9.154901959985743
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCCC(F)(F)F)cc1C21N=C(C)C(N)=N1,0.6,nM,=,CHEMBL3959097,active,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCCC(F)(F)F)cc1C21N=C(C)C(N)=N1,organic,9.221848749616356
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC1=N[C@]2(N=C1N)c1cc(OCCCF)ccc1C[C@]21CC[C@@H](OC(F)F)CC1,1.6,nM,=,CHEMBL3672695,active,CC1=N[C@]2(N=C1N)c1cc(OCCCF)ccc1C[C@]21CC[C@@H](OC(F)F)CC1,organic,8.795880017344075
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC(C)F)cc1C21N=C(C)C(N)=N1,2.5,nM,=,CHEMBL3899321,active,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC(C)F)cc1C21N=C(C)C(N)=N1,organic,8.602059991327963
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC1=N[C@@]2(N=C1N)c1cc(-c3cc(Cl)cc(C#N)c3)ccc1C[C@]21CC[C@@H](O)CC1,216.0,nM,=,CHEMBL3672699,active,CC1=N[C@@]2(N=C1N)c1cc(-c3cc(Cl)cc(C#N)c3)ccc1C[C@]21CC[C@@H](O)CC1,organic,6.665546248849069
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC#Cc1cncc(-c2ccc3c(c2)[C@@]2(N=C(C)C(N)=N2)[C@]2(CC[C@H](O)CC2)C3)c1,1.0,nM,=,CHEMBL3653726,active,CC#Cc1cncc(-c2ccc3c(c2)[C@@]2(N=C(C)C(N)=N2)[C@]2(CC[C@H](O)CC2)C3)c1,organic,9.0
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,[C-]#[N+]c1cc(Cl)cc(-c2cc3c(cc2C)C[C@]2(CC[C@@H](OC)CC2)C32N=C(C)C(N)=N2)c1,12.0,nM,=,CHEMBL3937729,active,[C-]#[N+]c1cc(Cl)cc(-c2cc3c(cc2C)C[C@]2(CC[C@@H](OC)CC2)C32N=C(C)C(N)=N2)c1,organic,7.920818753952375
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1cc(F)c(-c3cc(Cl)cc(C#N)c3)cc1C21N=C(C)C(N)=N1,1.7,nM,=,CHEMBL3947671,active,CO[C@H]1CC[C@]2(CC1)Cc1cc(F)c(-c3cc(Cl)cc(C#N)c3)cc1C21N=C(C)C(N)=N1,organic,8.769551078621726
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1cc(F)c(-c3cc(Cl)cc(C#N)c3)cc1[C@]21N=C(C)C(N)=N1,986.0,nM,=,CHEMBL4113193,active,CO[C@H]1CC[C@]2(CC1)Cc1cc(F)c(-c3cc(Cl)cc(C#N)c3)cc1[C@]21N=C(C)C(N)=N1,organic,6.006123085058789
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1cc(F)c(-c3cc(F)cc(C#N)c3)cc1C21N=C(C)C(N)=N1,4.8,nM,=,CHEMBL3943188,active,CO[C@H]1CC[C@]2(CC1)Cc1cc(F)c(-c3cc(F)cc(C#N)c3)cc1C21N=C(C)C(N)=N1,organic,8.318758762624412
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC#Cc1cncc(-c2cc3c(cc2C)C[C@]2(CC[C@@H](OC)CC2)C32N=C(C)C(N)=N2)c1,17.0,nM,=,CHEMBL3913223,active,CC#Cc1cncc(-c2cc3c(cc2C)C[C@]2(CC[C@@H](OC)CC2)C32N=C(C)C(N)=N2)c1,organic,7.769551078621726
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,COC1CCC2(CC1)Cc1cc(F)c(Br)cc1C21N=C(C)C(N)=N1,176.0,nM,=,CHEMBL3672708,active,COC1CCC2(CC1)Cc1cc(F)c(Br)cc1C21N=C(C)C(N)=N1,organic,6.7544873321858505
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1cc(F)c(-c3cc(Cl)cc(C#N)c3)cc1[C@@]21N=C(C)C(N)=N1,0.8,nM,=,CHEMBL3902640,active,CO[C@H]1CC[C@]2(CC1)Cc1cc(F)c(-c3cc(Cl)cc(C#N)c3)cc1[C@@]21N=C(C)C(N)=N1,organic,9.096910013008056
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1cc(F)c(-c3cncc(Cl)c3)cc1C21N=C(C)C(N)=N1,3.0,nM,=,CHEMBL3969309,active,CO[C@H]1CC[C@]2(CC1)Cc1cc(F)c(-c3cncc(Cl)c3)cc1C21N=C(C)C(N)=N1,organic,8.522878745280337
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1cc(F)c(-c3cc(F)cc(C#N)c3)cc1[C@@]21N=C(C)C(N)=N1,7.4,nM,=,CHEMBL3916194,active,CO[C@H]1CC[C@]2(CC1)Cc1cc(F)c(-c3cc(F)cc(C#N)c3)cc1[C@@]21N=C(C)C(N)=N1,organic,8.130768280269024
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC1=NC2(N=C1N)c1cc(-c3cc(F)cc(C#N)c3)ccc1CCC21CC1,23.0,nM,=,CHEMBL3672718,active,CC1=NC2(N=C1N)c1cc(-c3cc(F)cc(C#N)c3)ccc1CCC21CC1,organic,7.638272163982407
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC1=NC2(N=C1N)c1cc(-c3cc(F)cc(F)c3)ccc1CCC21CC1,118.0,nM,=,CHEMBL3672719,active,CC1=NC2(N=C1N)c1cc(-c3cc(F)cc(F)c3)ccc1CCC21CC1,organic,6.928117992693875
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC1=NC2(N=C1N)c1cc(-c3cncc(Cl)c3)ccc1CCC21CC1,11.0,nM,=,CHEMBL3672720,active,CC1=NC2(N=C1N)c1cc(-c3cncc(Cl)c3)ccc1CCC21CC1,organic,7.958607314841775
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@@]2(CCc3ccc(Br)cc3C23N=C(C)C(N)=N3)CC1,78.0,nM,=,CHEMBL3672721,active,CO[C@H]1CC[C@@]2(CCc3ccc(Br)cc3C23N=C(C)C(N)=N3)CC1,organic,7.107905397309519
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,COc1cc(C#N)cc(-c2ccc3c(c2)C2(N=C(C)C(N)=N2)[C@]2(CC3)CC[C@@H](OC)CC2)c1,1.0,nM,=,CHEMBL3672723,active,COc1cc(C#N)cc(-c2ccc3c(c2)C2(N=C(C)C(N)=N2)[C@]2(CC3)CC[C@@H](OC)CC2)c1,organic,9.0
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,COc1cc(C#N)cc(-c2ccc3c(c2)C2(N=C(C)C(N)=N2)[C@]2(CC3)CC[C@H](OC)CC2)c1,80.0,nM,=,CHEMBL3672724,active,COc1cc(C#N)cc(-c2ccc3c(c2)C2(N=C(C)C(N)=N2)[C@]2(CC3)CC[C@H](OC)CC2)c1,organic,7.096910013008056
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@@]2(CCc3ccc(-c4cncc(Cl)c4)cc3C23N=C(C)C(N)=N3)CC1,2.5,nM,=,CHEMBL3672725,active,CO[C@H]1CC[C@@]2(CCc3ccc(-c4cncc(Cl)c4)cc3C23N=C(C)C(N)=N3)CC1,organic,8.602059991327963
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CCc3ccc(-c4cncc(Cl)c4)cc3C23N=C(C)C(N)=N3)CC1,19.0,nM,=,CHEMBL3672726,active,CO[C@H]1CC[C@]2(CCc3ccc(-c4cncc(Cl)c4)cc3C23N=C(C)C(N)=N3)CC1,organic,7.721246399047171
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC#Cc1cncc(-c2ccc3c(c2)C2(N=C(C)C(N)=N2)[C@]2(CC3)CC[C@H](OC)CC2)c1,81.0,nM,=,CHEMBL3672727,active,CC#Cc1cncc(-c2ccc3c(c2)C2(N=C(C)C(N)=N2)[C@]2(CC3)CC[C@H](OC)CC2)c1,organic,7.0915149811213505
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC#Cc1cncc(-c2ccc3c(c2)C2(N=C(C)C(N)=N2)[C@]2(CC3)CC[C@@H](OC)CC2)c1,2.4,nM,=,CHEMBL3672728,active,CC#Cc1cncc(-c2ccc3c(c2)C2(N=C(C)C(N)=N2)[C@]2(CC3)CC[C@@H](OC)CC2)c1,organic,8.619788758288394
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CC1=NC2(N=C1N)c1cc(-c3cc(Cl)cc(C#N)c3)ccc1CCC21CC1,16.0,nM,=,CHEMBL3672729,active,CC1=NC2(N=C1N)c1cc(-c3cc(Cl)cc(C#N)c3)ccc1CCC21CC1,organic,7.795880017344075
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,COC1CCC2(CCc3ccc(-c4cc(Cl)cc(C#N)c4)cc3C23N=C(C)C(N)=N3)CC1,3.1,nM,=,CHEMBL3672730,active,COC1CCC2(CCc3ccc(-c4cc(Cl)cc(C#N)c4)cc3C23N=C(C)C(N)=N3)CC1,organic,8.508638306165727
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@@]2(CCc3ccc(-c4cc(Cl)cc(C#N)c4)cc3C23N=C(C)C(N)=N3)CC1,92.0,nM,=,CHEMBL3672731,active,CO[C@H]1CC[C@@]2(CCc3ccc(-c4cc(Cl)cc(C#N)c4)cc3C23N=C(C)C(N)=N3)CC1,organic,7.036212172654444
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 100 uL cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CCc3ccc(-c4cc(Cl)cc(C#N)c4)cc3C23N=C(C)C(N)=N3)CC1,4.5,nM,=,CHEMBL3672732,active,CO[C@H]1CC[C@]2(CCc3ccc(-c4cc(Cl)cc(C#N)c4)cc3C23N=C(C)C(N)=N3)CC1,organic,8.346787486224656
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 1004, cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC3(C)CC3)cc1C21N=C(C)C(N)=N1,2.8,nM,=,CHEMBL3915935,active,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC3(C)CC3)cc1C21N=C(C)C(N)=N1,organic,8.55284196865778
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 1004, cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC3CC(F)(F)C3)cc1C21N=C(C)C(N)=N1,8.4,nM,=,CHEMBL3891403,active,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC3CC(F)(F)C3)cc1C21N=C(C)C(N)=N1,organic,8.075720713938118
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 1004, cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC3CC3)cc1C21N=C(C)C(N)=N1,1.6,nM,=,CHEMBL3923244,active,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC3CC3)cc1C21N=C(C)C(N)=N1,organic,8.795880017344075
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 1004, cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC3CC3)cc1[C@@]21N=C(C)C(N)=N1,0.9,nM,=,CHEMBL3937398,active,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC3CC3)cc1[C@@]21N=C(C)C(N)=N1,organic,9.045757490560675
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 1004, cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC3CC3(F)F)cc1C21N=C(C)C(N)=N1,2.3,nM,=,CHEMBL3905816,active,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC3CC3(F)F)cc1C21N=C(C)C(N)=N1,organic,8.638272163982407
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 1004, cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC3CCC3)cc1C21N=C(C)C(N)=N1,1.5,nM,=,CHEMBL3961886,active,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC3CCC3)cc1C21N=C(C)C(N)=N1,organic,8.823908740944319
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 1004, cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC3CCC3)cc1[C@@]21N=C(C)C(N)=N1,1.3,nM,=,CHEMBL3927449,active,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCC3CCC3)cc1[C@@]21N=C(C)C(N)=N1,organic,8.886056647693163
"Release Assay: SH-SY5Y cells were cultured in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids and cryopreserved and stored at -140 C. at a concentration of 7.5-9.5x106 cells per vial. Thaw cells and seed at a conc. of around 10000 cells/well in DMEM/F-12 with Glutamax, 10% FCS and 1% non-essential amino acids to a 384-well tissue culture treated plate, 1004, cell susp/well. The cell plates were then incubated for 7-24 h at 37 C., 5% CO2. The cell medium was removed, followed by addition of 30 uL compound diluted in DMEM/F-12 with Glutamax, 10% FCS, 1% non-essential amino acids and 1% PeSt to a final conc. of 1% DMSO. The compounds were incubated with the cells for 17 h (overnight) at 37 C., 5% CO2. Meso Scale Discovery (MSD) plates were used for the detection of sAPPbeta release. MSD sAPPbeta plates were blocked in 1% BSA in Tris wash buffer (40 uL/well) for 1 h on shake at r.t. and washed 1 time in Tris wash buffer (40 uL/well).",IC50,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCCC3CC3)cc1C21N=C(C)C(N)=N1,0.8,nM,=,CHEMBL3939963,active,CO[C@H]1CC[C@]2(CC1)Cc1ccc(OCCC3CC3)cc1C21N=C(C)C(N)=N1,organic,9.096910013008056
"In Vitro Inhibition Assay: The assay protocol employed was a modified version of that described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643, incorporated herein by reference. Briefly, recombinant peptide substrate was incubated with γ-secretase (40 μg/ml) in the presence or absence of test compound. The reaction mixture contained 0.25% CHAPSO, 0.1 μg/μl BSA, protease inhibitor, 50 mM PIPES, pH 7.0, 5 mM MgCl2, 5 mM CaCl2 and 150 mM KCl. The reaction was incubated for 2.5 hr at 37° C. and stopped by adding RIPA buffer (150 mM NaCl, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris HCl, pH 8.0). The products were detected with various antibody combinations using electrochemiluminescence (ECL) technology as previously described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643; Lai et al., 2003, J. Biol. Chem. 278: 22475-22481; and Yin et al., 2007, J. Biol. Chem. 282:23639-23644.",IC50,O=C(Nc1ccc2c(c1)C[C@H]1CC[C@@H](C2)[C@H]1NS(=O)(=O)c1ccc(Cl)s1)c1ccc(C(F)(F)F)cc1,1000.0,nM,=,CHEMBL3692695,active,O=C(Nc1ccc2c(c1)C[C@H]1CC[C@@H](C2)[C@H]1NS(=O)(=O)c1ccc(Cl)s1)c1ccc(C(F)(F)F)cc1,organic,6.0
"In Vitro Inhibition Assay: The assay protocol employed was a modified version of that described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643, incorporated herein by reference. Briefly, recombinant peptide substrate was incubated with γ-secretase (40 μg/ml) in the presence or absence of test compound. The reaction mixture contained 0.25% CHAPSO, 0.1 μg/μl BSA, protease inhibitor, 50 mM PIPES, pH 7.0, 5 mM MgCl2, 5 mM CaCl2 and 150 mM KCl. The reaction was incubated for 2.5 hr at 37° C. and stopped by adding RIPA buffer (150 mM NaCl, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris HCl, pH 8.0). The products were detected with various antibody combinations using electrochemiluminescence (ECL) technology as previously described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643; Lai et al., 2003, J. Biol. Chem. 278: 22475-22481; and Yin et al., 2007, J. Biol. Chem. 282:23639-23644.",IC50,O=C(Cc1ccc(C(F)(F)F)cc1)Nc1ccc2c(c1)C[C@H]1CC[C@@H](C2)[C@H]1NS(=O)(=O)c1ccc(Cl)s1,800.0,nM,=,CHEMBL3692696,active,O=C(Cc1ccc(C(F)(F)F)cc1)Nc1ccc2c(c1)C[C@H]1CC[C@@H](C2)[C@H]1NS(=O)(=O)c1ccc(Cl)s1,organic,6.096910013008056
"In Vitro Inhibition Assay: The assay protocol employed was a modified version of that described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643, incorporated herein by reference. Briefly, recombinant peptide substrate was incubated with γ-secretase (40 μg/ml) in the presence or absence of test compound. The reaction mixture contained 0.25% CHAPSO, 0.1 μg/μl BSA, protease inhibitor, 50 mM PIPES, pH 7.0, 5 mM MgCl2, 5 mM CaCl2 and 150 mM KCl. The reaction was incubated for 2.5 hr at 37° C. and stopped by adding RIPA buffer (150 mM NaCl, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris HCl, pH 8.0). The products were detected with various antibody combinations using electrochemiluminescence (ECL) technology as previously described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643; Lai et al., 2003, J. Biol. Chem. 278: 22475-22481; and Yin et al., 2007, J. Biol. Chem. 282:23639-23644.",IC50,O=C(CCc1cc(C(F)(F)F)ccc1C(F)(F)F)Nc1ccc2c(c1)C[C@H]1CC[C@@H](C2)[C@H]1NS(=O)(=O)c1ccc(Cl)s1,630000.0,nM,=,CHEMBL3692697,inactive,O=C(CCc1cc(C(F)(F)F)ccc1C(F)(F)F)Nc1ccc2c(c1)C[C@H]1CC[C@@H](C2)[C@H]1NS(=O)(=O)c1ccc(Cl)s1,organic,3.2006594505464183
"In Vitro Inhibition Assay: The assay protocol employed was a modified version of that described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643, incorporated herein by reference. Briefly, recombinant peptide substrate was incubated with γ-secretase (40 μg/ml) in the presence or absence of test compound. The reaction mixture contained 0.25% CHAPSO, 0.1 μg/μl BSA, protease inhibitor, 50 mM PIPES, pH 7.0, 5 mM MgCl2, 5 mM CaCl2 and 150 mM KCl. The reaction was incubated for 2.5 hr at 37° C. and stopped by adding RIPA buffer (150 mM NaCl, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris HCl, pH 8.0). The products were detected with various antibody combinations using electrochemiluminescence (ECL) technology as previously described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643; Lai et al., 2003, J. Biol. Chem. 278: 22475-22481; and Yin et al., 2007, J. Biol. Chem. 282:23639-23644.",IC50,O=C(CCOc1ccc(F)cc1)Nc1ccc2c(c1)C[C@H]1CC[C@@H](C2)[C@H]1NS(=O)(=O)c1ccc(Cl)s1,20000.0,nM,=,CHEMBL3692698,inactive,O=C(CCOc1ccc(F)cc1)Nc1ccc2c(c1)C[C@H]1CC[C@@H](C2)[C@H]1NS(=O)(=O)c1ccc(Cl)s1,organic,4.698970004336019
"In Vitro Inhibition Assay: The assay protocol employed was a modified version of that described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643, incorporated herein by reference. Briefly, recombinant peptide substrate was incubated with γ-secretase (40 μg/ml) in the presence or absence of test compound. The reaction mixture contained 0.25% CHAPSO, 0.1 μg/μl BSA, protease inhibitor, 50 mM PIPES, pH 7.0, 5 mM MgCl2, 5 mM CaCl2 and 150 mM KCl. The reaction was incubated for 2.5 hr at 37° C. and stopped by adding RIPA buffer (150 mM NaCl, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris HCl, pH 8.0). The products were detected with various antibody combinations using electrochemiluminescence (ECL) technology as previously described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643; Lai et al., 2003, J. Biol. Chem. 278: 22475-22481; and Yin et al., 2007, J. Biol. Chem. 282:23639-23644.",IC50,O=C(/C=C/c1ccc(F)cc1)Nc1ccc2c(c1)C[C@H]1CC[C@@H](C2)[C@H]1NS(=O)(=O)c1ccc(Cl)s1,84000.0,nM,=,CHEMBL3692699,inactive,O=C(/C=C/c1ccc(F)cc1)Nc1ccc2c(c1)C[C@H]1CC[C@@H](C2)[C@H]1NS(=O)(=O)c1ccc(Cl)s1,organic,4.075720713938118
"In Vitro Inhibition Assay: The assay protocol employed was a modified version of that described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643, incorporated herein by reference. Briefly, recombinant peptide substrate was incubated with γ-secretase (40 μg/ml) in the presence or absence of test compound. The reaction mixture contained 0.25% CHAPSO, 0.1 μg/μl BSA, protease inhibitor, 50 mM PIPES, pH 7.0, 5 mM MgCl2, 5 mM CaCl2 and 150 mM KCl. The reaction was incubated for 2.5 hr at 37° C. and stopped by adding RIPA buffer (150 mM NaCl, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris HCl, pH 8.0). The products were detected with various antibody combinations using electrochemiluminescence (ECL) technology as previously described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643; Lai et al., 2003, J. Biol. Chem. 278: 22475-22481; and Yin et al., 2007, J. Biol. Chem. 282:23639-23644.",IC50,O=C(/C=C/c1ccc(C(F)(F)F)cc1)Nc1ccc2c(c1)C[C@H]1CC[C@@H](C2)[C@H]1NS(=O)(=O)c1ccc(Cl)s1,200000.0,nM,=,CHEMBL3692700,inactive,O=C(/C=C/c1ccc(C(F)(F)F)cc1)Nc1ccc2c(c1)C[C@H]1CC[C@@H](C2)[C@H]1NS(=O)(=O)c1ccc(Cl)s1,organic,3.6989700043360187
"In Vitro Inhibition Assay: The assay protocol employed was a modified version of that described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643, incorporated herein by reference. Briefly, recombinant peptide substrate was incubated with γ-secretase (40 μg/ml) in the presence or absence of test compound. The reaction mixture contained 0.25% CHAPSO, 0.1 μg/μl BSA, protease inhibitor, 50 mM PIPES, pH 7.0, 5 mM MgCl2, 5 mM CaCl2 and 150 mM KCl. The reaction was incubated for 2.5 hr at 37° C. and stopped by adding RIPA buffer (150 mM NaCl, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris HCl, pH 8.0). The products were detected with various antibody combinations using electrochemiluminescence (ECL) technology as previously described in Li et al., 2000, Proc. Nat'l Acad. Sci. USA 97:6183-643; Lai et al., 2003, J. Biol. Chem. 278: 22475-22481; and Yin et al., 2007, J. Biol. Chem. 282:23639-23644.",IC50,CN1C(=O)[C@@H](NCC(=O)Nc2ccc3c(c2)C[C@H]2CC[C@@H](C3)[C@H]2NS(=O)(=O)c2ccc(Cl)s2)N=C(c2ccccc2)c2ccccc21,800000.0,nM,=,CHEMBL3692701,inactive,CN1C(=O)[C@@H](NCC(=O)Nc2ccc3c(c2)C[C@H]2CC[C@@H](C3)[C@H]2NS(=O)(=O)c2ccc(Cl)s2)N=C(c2ccccc2)c2ccccc21,organic,3.0969100130080562
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,CCOc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(N)n1,840.0,nM,=,CHEMBL4111029,active,CCOc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(N)n1,organic,6.075720713938118
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@@]2(C)N=C(N)OCC2(F)F)n1,7.0,nM,=,CHEMBL4114267,active,Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@@]2(C)N=C(N)OCC2(F)F)n1,organic,8.154901959985743
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(C#N)cc3Cl)ccc2F)N=C(N)OCC1(F)F,8.0,nM,=,CHEMBL2386720,active,C[C@]1(c2nc(NC(=O)c3ncc(C#N)cc3Cl)ccc2F)N=C(N)OCC1(F)F,organic,8.096910013008056
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,CC1(C)OC(N)=N[C@](C)(c2nc(NC(=O)c3ncc(C#N)cc3Cl)ccc2F)C1(F)F,7.0,nM,=,CHEMBL2386721,active,CC1(C)OC(N)=N[C@](C)(c2nc(NC(=O)c3ncc(C#N)cc3Cl)ccc2F)C1(F)F,organic,8.154901959985743
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,COCC[C@]1(c2nc(NC(=O)c3ncc(C#N)cc3C)ccc2F)N=C(N)OCC1(F)F,49.0,nM,=,CHEMBL2386722,active,COCC[C@]1(c2nc(NC(=O)c3ncc(C#N)cc3C)ccc2F)N=C(N)OCC1(F)F,organic,7.309803919971486
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,COCC[C@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3Cl)ccc2F)N=C(N)OCC1(F)F,380.0,nM,=,CHEMBL4108431,active,COCC[C@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3Cl)ccc2F)N=C(N)OCC1(F)F,organic,6.42021640338319
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3Cl)ccc2F)N=C(N)OCC1(F)F,27.0,nM,=,CHEMBL2386723,active,C[C@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3Cl)ccc2F)N=C(N)OCC1(F)F,organic,7.568636235841013
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)nc3N)ccc2F)N=C(N)OCC1(F)F,140.0,nM,=,CHEMBL4110279,active,C[C@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)nc3N)ccc2F)N=C(N)OCC1(F)F,organic,6.853871964321762
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(Cl)cc3Cl)ccc2F)N=C(N)OCC1(F)F,12.0,nM,=,CHEMBL2386724,active,C[C@]1(c2nc(NC(=O)c3ncc(Cl)cc3Cl)ccc2F)N=C(N)OCC1(F)F,organic,7.920818753952375
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(OCC(F)(F)F)nc3N)ccc2F)N=C(N)OCC1(F)F,600.0,nM,=,CHEMBL4108635,active,C[C@]1(c2nc(NC(=O)c3ncc(OCC(F)(F)F)nc3N)ccc2F)N=C(N)OCC1(F)F,organic,6.221848749616356
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(OCC(F)F)nc3N)ccc2F)N=C(N)OCC1(F)F,440.0,nM,=,CHEMBL2386725,active,C[C@]1(c2nc(NC(=O)c3ncc(OCC(F)F)nc3N)ccc2F)N=C(N)OCC1(F)F,organic,6.356547323513812
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(OCCCF)nc3N)ccc2F)N=C(N)OCC1(F)F,310.0,nM,=,CHEMBL4114995,active,C[C@]1(c2nc(NC(=O)c3ncc(OCCCF)nc3N)ccc2F)N=C(N)OCC1(F)F,organic,6.508638306165727
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,COc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(C)c1,82.0,nM,=,CHEMBL4111654,active,COc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(C)c1,organic,7.086186147616283
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,COCC#Cc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(N)c1,540.0,nM,=,CHEMBL4110143,active,COCC#Cc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(N)c1,organic,6.267606240177032
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(OCF)nc3N)ccc2F)N=C(N)OCC1(F)F,30.0,nM,=,CHEMBL4110172,active,C[C@]1(c2nc(NC(=O)c3ncc(OCF)nc3N)ccc2F)N=C(N)OCC1(F)F,organic,7.522878745280337
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(C#CCO)cc3N)ccc2F)N=C(N)OCC1(F)F,62.0,nM,=,CHEMBL4107314,active,C[C@]1(c2nc(NC(=O)c3ncc(C#CCO)cc3N)ccc2F)N=C(N)OCC1(F)F,organic,7.2076083105017466
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(F)cc3N)ccc2F)N=C(N)OCC1(F)F,88.0,nM,=,CHEMBL4109969,active,C[C@]1(c2nc(NC(=O)c3ncc(F)cc3N)ccc2F)N=C(N)OCC1(F)F,organic,7.055517327849832
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(Cl)cc3N)ccc2F)N=C(N)OCC1(F)F,45.0,nM,=,CHEMBL4115329,active,C[C@]1(c2nc(NC(=O)c3ncc(Cl)cc3N)ccc2F)N=C(N)OCC1(F)F,organic,7.346787486224656
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncccc3Cl)ccc2F)N=C(N)OCC1(F)F,88.0,nM,=,CHEMBL4106556,active,C[C@]1(c2nc(NC(=O)c3ncccc3Cl)ccc2F)N=C(N)OCC1(F)F,organic,7.055517327849832
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,COCC#Cc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(Cl)c1,81.0,nM,=,CHEMBL4107875,active,COCC#Cc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(Cl)c1,organic,7.0915149811213505
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(C(F)F)nc3N)ccc2F)N=C(N)OCC1(F)F,60.0,nM,=,CHEMBL4112705,active,C[C@]1(c2nc(NC(=O)c3ncc(C(F)F)nc3N)ccc2F)N=C(N)OCC1(F)F,organic,7.221848749616356
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(OCCCl)nc3N)ccc2F)N=C(N)OCC1(F)F,2900.0,nM,=,CHEMBL4114553,active,C[C@]1(c2nc(NC(=O)c3ncc(OCCCl)nc3N)ccc2F)N=C(N)OCC1(F)F,organic,5.5376020021010435
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(OCC(F)F)cc3Cl)ccc2F)N=C(N)OCC1(F)F,250.0,nM,=,CHEMBL4115141,active,C[C@]1(c2nc(NC(=O)c3ncc(OCC(F)F)cc3Cl)ccc2F)N=C(N)OCC1(F)F,organic,6.6020599913279625
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(OCCF)nc3N)ccc2F)N=C(N)OCC1(F)F,480.0,nM,=,CHEMBL4108335,active,C[C@]1(c2nc(NC(=O)c3ncc(OCCF)nc3N)ccc2F)N=C(N)OCC1(F)F,organic,6.318758762624412
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(OCF)cc3Cl)ccc2F)N=C(N)OCC1(F)F,57.0,nM,=,CHEMBL4111699,active,C[C@]1(c2nc(NC(=O)c3ncc(OCF)cc3Cl)ccc2F)N=C(N)OCC1(F)F,organic,7.2441251443275085
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,CCOc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(Cl)c1,450.0,nM,=,CHEMBL4109860,active,CCOc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(Cl)c1,organic,6.346787486224656
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,COCCc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(N)n1,70.0,nM,=,CHEMBL4110497,active,COCCc1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(N)n1,organic,7.154901959985743
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3nn(C(F)F)cc3Cl)ccc2F)N=C(N)OCC1(F)F,13.0,nM,=,CHEMBL2386726,active,C[C@]1(c2nc(NC(=O)c3nn(C(F)F)cc3Cl)ccc2F)N=C(N)OCC1(F)F,organic,7.886056647693163
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3nccnc3N)ccc2F)N=C(N)OCC1(F)F,180.0,nM,=,CHEMBL4110655,active,C[C@]1(c2nc(NC(=O)c3nccnc3N)ccc2F)N=C(N)OCC1(F)F,organic,6.7447274948966935
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(C#CCO)cc3Cl)ccc2F)N=C(N)OCC1(F)F,19.0,nM,=,CHEMBL4113786,active,C[C@]1(c2nc(NC(=O)c3ncc(C#CCO)cc3Cl)ccc2F)N=C(N)OCC1(F)F,organic,7.721246399047171
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ncc(C(F)F)cc3N)ccc2F)N=C(N)OCC1(F)F,66.0,nM,=,CHEMBL4112589,active,C[C@]1(c2nc(NC(=O)c3ncc(C(F)F)cc3N)ccc2F)N=C(N)OCC1(F)F,organic,7.180456064458132
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,CC(F)(F)c1nc(N)c(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)nc1Cl,6500.0,nM,=,CHEMBL4108644,active,CC(F)(F)c1nc(N)c(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)nc1Cl,organic,5.187086643357144
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,C[C@]1(c2nc(NC(=O)c3ccc(C#N)cn3)ccc2F)N=C(N)OCC1(F)F,14.0,nM,=,CHEMBL2386719,active,C[C@]1(c2nc(NC(=O)c3ccc(C#N)cn3)ccc2F)N=C(N)OCC1(F)F,organic,7.853871964321762
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,CC(F)(F)c1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(Cl)c1,58.0,nM,=,CHEMBL4111183,active,CC(F)(F)c1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(Cl)c1,organic,7.236572006437063
"Inhibition Assay: Chinese hamster ovary cells are transfected with the human gene for amyloid precursor protein. The cells are plated at a density of 8000 cells/well into 96-well microtiter plates and cultivated for 24 hours in DMEM cell culture medium containing 10% FCS. The test compound is added to the cells at various concentrations, and the cells are cultivated for 24 hours in the presence of the test compound. The supernatants are collected, and the concentration of amyloid peptide 1-40 is determined using state of the art immunoassay techniques, for example sandwich ELISA, homogenous time-resolved fluorescence (HTRF) immunoassay, or electro-chemiluminescence immunoassay. The potency of the compound is calculated from the percentage of inhibition of amyloid peptide release as a function of the test compound concentration.",IC50,CC(F)(F)c1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(N)n1,310.0,nM,=,CHEMBL4111103,active,CC(F)(F)c1cnc(C(=O)Nc2ccc(F)c([C@@]3(C)N=C(N)OCC3(F)F)n2)c(N)n1,organic,6.508638306165727
"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)CCn1cccn1,1.4,nM,=,CHEMBL3943313,active,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)CCn1cccn1,organic,8.853871964321762
"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)Cc1ccccn1,1.9,nM,=,CHEMBL3934479,active,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)Cc1ccccn1,organic,8.721246399047171
"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)Cc1cccnc1,6.6,nM,=,CHEMBL3961972,active,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)Cc1cccnc1,organic,8.18045606445813
"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)Cc1ncon1,1.7,nM,=,CHEMBL3956918,active,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)Cc1ncon1,organic,8.769551078621726
"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,Cc1nc(CS(=O)(=O)CC[C@@H]2OCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OCC23)no1,5.8,nM,=,CHEMBL3957316,active,Cc1nc(CS(=O)(=O)CC[C@@H]2OCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OCC23)no1,organic,8.236572006437063
"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=c1ccc(S(=O)(=O)CC[C@@H]2OCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OCC23)c[nH]1,18.7,nM,=,CHEMBL3971184,active,O=c1ccc(S(=O)(=O)CC[C@@H]2OCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OCC23)c[nH]1,organic,7.728158393463501
"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)c1cccnn1,4.5,nM,=,CHEMBL3948649,active,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)c1cccnn1,organic,8.346787486224656
"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)c1cnccn1,5.5,nM,=,CHEMBL3904071,active,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)c1cnccn1,organic,8.259637310505756
"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)c1ccnnc1,10.2,nM,=,CHEMBL3935559,active,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)c1ccnnc1,organic,7.991399828238082
"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)c1ncccn1,6.4,nM,=,CHEMBL3928118,active,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)c1ncccn1,organic,8.193820026016112
"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)c1ccncn1,2.9,nM,=,CHEMBL3900140,active,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)c1ccncn1,organic,8.537602002101044
"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)c1cncnc1,12.9,nM,=,CHEMBL3909054,active,O=S(=O)(CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12)c1cncnc1,organic,7.889410289700751
"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,COc1ccc(S(=O)(=O)CC[C@@H]2OCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OCC23)cn1,16.5,nM,=,CHEMBL3905561,active,COc1ccc(S(=O)(=O)CC[C@@H]2OCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OCC23)cn1,organic,7.782516055786093
"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=c1[nH]cccc1S(=O)(=O)CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12,2.8,nM,=,CHEMBL3941787,active,O=c1[nH]cccc1S(=O)(=O)CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12,organic,8.55284196865778
"Electrochemiluminescence (ECL)-based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,Nc1ncccc1S(=O)(=O)CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12,18.0,nM,=,CHEMBL3984227,active,Nc1ncccc1S(=O)(=O)CC[C@@H]1OCC[C@@]2(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OCC12,organic,7.7447274948966935
"Electrochemiluminescence (ECL)-Based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,CC1(C)OCC2(CCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OC[C@@H]23)CO1,66.6,nM,=,CHEMBL3629737,active,CC1(C)OCC2(CCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OC[C@@H]23)CO1,organic,7.176525770829699
"Electrochemiluminescence (ECL)-Based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(c1ccc(Cl)cc1)[C@@]12CCCC3(COC3)[C@@H]1COc1c(F)ccc(F)c12,10.1,nM,=,CHEMBL3629739,active,O=S(=O)(c1ccc(Cl)cc1)[C@@]12CCCC3(COC3)[C@@H]1COc1c(F)ccc(F)c12,organic,7.995678626217358
"Electrochemiluminescence (ECL)-Based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(c1ccc(Cl)cc1)[C@@]12CCC[C@]3(CCOC3)[C@@H]1COc1c(F)ccc(F)c12,13.9,nM,=,CHEMBL3629738,active,O=S(=O)(c1ccc(Cl)cc1)[C@@]12CCC[C@]3(CCOC3)[C@@H]1COc1c(F)ccc(F)c12,organic,7.856985199745905
"Electrochemiluminescence (ECL)-Based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=C1OCC[C@]12CCC[C@@]1(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@@H]21,228.0,nM,=,CHEMBL3629740,active,O=C1OCC[C@]12CCC[C@@]1(S(=O)(=O)c3ccc(Cl)cc3)c3c(F)ccc(F)c3OC[C@@H]21,organic,6.642065152999546
"Electrochemiluminescence (ECL)-Based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(c1ccc(Cl)cc1)[C@@]12CCCC3(CCSCC3)[C@@H]1COc1c(F)ccc(F)c12,26.4,nM,=,CHEMBL3629742,active,O=S(=O)(c1ccc(Cl)cc1)[C@@]12CCCC3(CCSCC3)[C@@H]1COc1c(F)ccc(F)c12,organic,7.578396073130169
"Electrochemiluminescence (ECL)-Based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S1(=O)CCC2(CCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OC[C@@H]23)CC1,57.7,nM,=,CHEMBL3629741,active,O=S1(=O)CCC2(CCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OC[C@@H]23)CC1,organic,7.238824186844268
"Electrochemiluminescence (ECL)-Based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,O=S(=O)(N1CC[C@]2(CCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OC[C@@H]23)C1)C(F)(F)F,23.3,nM,=,CHEMBL3629743,active,O=S(=O)(N1CC[C@]2(CCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OC[C@@H]23)C1)C(F)(F)F,organic,7.632644078973981
"Electrochemiluminescence (ECL)-Based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,C[P@]1(=O)OC[C@]2(CCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OC[C@@H]23)CO1,9.5,nM,=,CHEMBL3899794,active,C[P@]1(=O)OC[C@]2(CCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OC[C@@H]23)CO1,organic,8.022276394711152
"Electrochemiluminescence (ECL)-Based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,C[P@]1(=O)OC[C@@]2(CCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OC[C@@H]23)CO1,421.0,nM,=,CHEMBL3936795,active,C[P@]1(=O)OC[C@@]2(CCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OC[C@@H]23)CO1,organic,6.375717904164332
"Electrochemiluminescence (ECL)-Based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,C[P@]1(=O)OC[C@@]2(CCC[C@@]3(S(=O)(=O)c4ccc(C(F)(F)F)cc4)c4c(F)ccc(F)c4OC[C@@H]23)CO1,397.0,nM,=,CHEMBL3905228,active,C[P@]1(=O)OC[C@@]2(CCC[C@@]3(S(=O)(=O)c4ccc(C(F)(F)F)cc4)c4c(F)ccc(F)c4OC[C@@H]23)CO1,organic,6.401209493236885
"Electrochemiluminescence (ECL)-Based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,C[P@]1(=O)OC[C@]2(CCC[C@@]3(S(=O)(=O)c4ccc(C(F)(F)F)cc4)c4c(F)ccc(F)c4OC[C@@H]23)CO1,79.0,nM,=,CHEMBL3942223,active,C[P@]1(=O)OC[C@]2(CCC[C@@]3(S(=O)(=O)c4ccc(C(F)(F)F)cc4)c4c(F)ccc(F)c4OC[C@@H]23)CO1,organic,7.102372908709558
"Electrochemiluminescence (ECL)-Based Immunoassay: To measure γ-secretase activity, membranes were incubated at 37° C. for 1 h in 50 μL of buffer containing 20 mM Hepes (pH 7.0) and 2 mM EDTA. At the end of the incubation, Aβ 40 and Aβ 42 were measured using an electrochemiluminescence (ECL)-based immunoassay. Aβ 40 was identified with antibody pairs TAG-G2-10 and biotin-W02, while Aβ 42 was identified with TAG-G2-11 and biotin-4G8. The ECL signal was measured using an ECL-M8 instrument (IGEN International, Inc.) according to the manufacturer's instructions.",IC50,CP1(=O)OCC[C@]2(CCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OC[C@@H]23)CO1,5.4,nM,=,CHEMBL3629745,active,CP1(=O)OCC[C@]2(CCC[C@@]3(S(=O)(=O)c4ccc(Cl)cc4)c4c(F)ccc(F)c4OC[C@@H]23)CO1,organic,8.267606240177031
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,O=c1cc(/C=C/c2cccc(F)c2)[nH]cc1O,18970.0,nM,=,CHEMBL4059796,inactive,O=c1cc(/C=C/c2cccc(F)c2)[nH]cc1O,organic,4.721932669111338
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,Cn1cc(O)c(=O)cc1/C=C/c1cccc(F)c1,19440.0,nM,=,CHEMBL4077009,inactive,Cn1cc(O)c(=O)cc1/C=C/c1cccc(F)c1,organic,4.711303739409744
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,CN(C)c1ccc(/C=C/c2cc(=O)c(O)c[nH]2)cc1,29220.0,nM,=,CHEMBL4092433,inactive,CN(C)c1ccc(/C=C/c2cc(=O)c(O)c[nH]2)cc1,organic,4.534319788401722
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,CCOc1ccc(/C=C/c2cc(=O)c(O)c[nH]2)cc1,23390.0,nM,=,CHEMBL4074429,inactive,CCOc1ccc(/C=C/c2cc(=O)c(O)c[nH]2)cc1,organic,4.630969778190847
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,CCOc1ccc(/C=C/c2cc(=O)c(O)cn2C)cc1,8940.0,nM,=,CHEMBL4097746,active,CCOc1ccc(/C=C/c2cc(=O)c(O)cn2C)cc1,organic,5.048662481204082
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,COc1ccccc1/C=C/c1cc(=O)c(O)c[nH]1,16500.0,nM,=,CHEMBL4070599,inactive,COc1ccccc1/C=C/c1cc(=O)c(O)c[nH]1,organic,4.782516055786093
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,COc1ccccc1/C=C/c1cc(=O)c(O)cn1C,12480.0,nM,=,CHEMBL4086825,inactive,COc1ccccc1/C=C/c1cc(=O)c(O)cn1C,organic,4.903785414653595
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,O=c1cc(/C=C/c2ccc(O)cc2)[nH]cc1O,10720.0,nM,=,CHEMBL4074006,inactive,O=c1cc(/C=C/c2ccc(O)cc2)[nH]cc1O,organic,4.969805214643249
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,Cn1cc(O)c(=O)cc1/C=C/c1ccc(O)cc1,15380.0,nM,=,CHEMBL4068105,inactive,Cn1cc(O)c(=O)cc1/C=C/c1ccc(O)cc1,organic,4.813043664534588
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,O=c1cc(/C=C/c2ccccc2O)[nH]cc1O,21760.0,nM,=,CHEMBL4095488,inactive,O=c1cc(/C=C/c2ccccc2O)[nH]cc1O,organic,4.662341108973858
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,11890.0,nM,=,CHEMBL165,inactive,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,organic,4.924818145381308
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs under dark condition by thioflavin-T based fluorometric assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,18730.0,nM,=,CHEMBL140,inactive,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,organic,4.727462222624762
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,IC50,c1cc2ncc(Nc3ccc4cc[nH]c4n3)cc2[nH]1,23800.0,nM,=,CHEMBL4069995,inactive,c1cc2ncc(Nc3ccc4cc[nH]c4n3)cc2[nH]1,organic,4.623423042943488
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,IC50,N#Cc1c[nH]c2nc(Nc3ccc4c(C5CCNCC5)c[nH]c4c3)ccc12,17800.0,nM,=,CHEMBL4072261,inactive,N#Cc1c[nH]c2nc(Nc3ccc4c(C5CCNCC5)c[nH]c4c3)ccc12,organic,4.749579997691106
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,IC50,c1cc2c(C3CCNCC3)c[nH]c2cc1Nc1ccc2[nH]cc(C3CCNCC3)c2c1,26600.0,nM,=,CHEMBL4066527,inactive,c1cc2c(C3CCNCC3)c[nH]c2cc1Nc1ccc2[nH]cc(C3CCNCC3)c2c1,organic,4.575118363368933
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,IC50,c1cc2c(C3CCNCC3)c[nH]c2cc1Nc1ccc2c(C3CCNCC3)c[nH]c2n1,25600.0,nM,=,CHEMBL4104210,inactive,c1cc2c(C3CCNCC3)c[nH]c2cc1Nc1ccc2c(C3CCNCC3)c[nH]c2n1,organic,4.59176003468815
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,IC50,CN1CCC(c2c[nH]c3cc(Nc4ccc5[nH]cc(C6CCN(C)CC6)c5c4)ccc23)CC1,15300.0,nM,=,CHEMBL4096474,inactive,CN1CCC(c2c[nH]c3cc(Nc4ccc5[nH]cc(C6CCN(C)CC6)c5c4)ccc23)CC1,organic,4.815308569182401
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,IC50,Fc1ccc(Nc2ccc3c(C4CCNCC4)c[nH]c3c2)cc1F,24000.0,nM,=,CHEMBL4088780,inactive,Fc1ccc(Nc2ccc3c(C4CCNCC4)c[nH]c3c2)cc1F,organic,4.619788758288394
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,IC50,Fc1ccc(Nc2ccc3c(C4CCNCC4)c[nH]c3n2)cc1F,30000.0,nM,=,CHEMBL4098927,inactive,Fc1ccc(Nc2ccc3c(C4CCNCC4)c[nH]c3n2)cc1F,organic,4.522878745280337
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,IC50,FC(F)(F)c1ccc(Nc2ccc3c(C4CCNCC4)c[nH]c3c2)cn1,24000.0,nM,=,CHEMBL4104620,inactive,FC(F)(F)c1ccc(Nc2ccc3c(C4CCNCC4)c[nH]c3c2)cn1,organic,4.619788758288394
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,IC50,CN1CCC(c2c[nH]c3cc(Nc4ccc(F)c(F)c4)ccc23)CC1,48000.0,nM,=,CHEMBL4063009,inactive,CN1CCC(c2c[nH]c3cc(Nc4ccc(F)c(F)c4)ccc23)CC1,organic,4.318758762624412
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,IC50,COc1ccc(Nc2ccc3c(C4CCN(C)CC4)c[nH]c3c2)cc1OC,25000.0,nM,=,CHEMBL4084675,inactive,COc1ccc(Nc2ccc3c(C4CCN(C)CC4)c[nH]c3c2)cc1OC,organic,4.6020599913279625
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,IC50,Cn1cc(C2CCNCC2)c2ccc(Nc3ccc(F)c(F)c3)cc21,42000.0,nM,=,CHEMBL4101130,inactive,Cn1cc(C2CCNCC2)c2ccc(Nc3ccc(F)c(F)c3)cc21,organic,4.376750709602099
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) aggregation after 24 hrs by ThT fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,9000.0,nM,=,CHEMBL140,active,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,organic,5.045757490560675
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,Clc1nc(NCc2ccccc2)c2ccccc2n1,16700.0,nM,=,CHEMBL118193,inactive,Clc1nc(NCc2ccccc2)c2ccccc2n1,organic,4.777283528852417
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CCNc2nc(Cl)nc3ccccc23)cc1OC,8200.0,nM,=,CHEMBL4087140,active,COc1ccc(CCNc2nc(Cl)nc3ccccc23)cc1OC,organic,5.086186147616283
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,Clc1nc(NCCc2ccccc2)c2ccccc2n1,5000.0,nM,=,CHEMBL4065718,active,Clc1nc(NCCc2ccccc2)c2ccccc2n1,organic,5.301029995663981
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CNc2nc(NC3CCN(Cc4ccccc4)CC3)nc3ccccc23)cc1OC,2300.0,nM,=,CHEMBL4070983,active,COc1ccc(CNc2nc(NC3CCN(Cc4ccccc4)CC3)nc3ccccc23)cc1OC,organic,5.638272163982407
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CCNc2ncnc3ccccc23)cc1OC,12000.0,nM,=,CHEMBL4092601,inactive,COc1ccc(CCNc2ncnc3ccccc23)cc1OC,organic,4.920818753952375
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,c1ccc(CCNc2ncnc3ccccc23)cc1,11900.0,nM,=,CHEMBL117804,inactive,c1ccc(CCNc2ncnc3ccccc23)cc1,organic,4.924453038607469
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CNc2nc(N=[N+]=[N-])nc3ccccc23)cc1OC,7200.0,nM,=,CHEMBL4089722,active,COc1ccc(CNc2nc(N=[N+]=[N-])nc3ccccc23)cc1OC,organic,5.142667503568732
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,[N-]=[N+]=Nc1nc(NCc2ccccc2)c2ccccc2n1,2600.0,nM,=,CHEMBL4079415,active,[N-]=[N+]=Nc1nc(NCc2ccccc2)c2ccccc2n1,organic,5.585026652029182
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CNc2nc(N)nc3ccccc23)cc1OC,8400.0,nM,=,CHEMBL4097449,active,COc1ccc(CNc2nc(N)nc3ccccc23)cc1OC,organic,5.075720713938118
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,Nc1nc(NCc2ccccc2)c2ccccc2n1,4800.0,nM,=,CHEMBL3815078,active,Nc1nc(NCc2ccccc2)c2ccccc2n1,organic,5.318758762624412
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CCNc2nc(N)nc3ccccc23)cc1OC,2700.0,nM,=,CHEMBL4071318,active,COc1ccc(CCNc2nc(N)nc3ccccc23)cc1OC,organic,5.568636235841013
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,Nc1nc(NCCc2ccccc2)c2ccccc2n1,7800.0,nM,=,CHEMBL3814123,active,Nc1nc(NCCc2ccccc2)c2ccccc2n1,organic,5.107905397309519
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CNc2nc(O)nc3ccccc23)cc1OC,7800.0,nM,=,CHEMBL4081859,active,COc1ccc(CNc2nc(O)nc3ccccc23)cc1OC,organic,5.107905397309519
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,Oc1nc(NCc2ccccc2)c2ccccc2n1,270.0,nM,=,CHEMBL4082825,active,Oc1nc(NCc2ccccc2)c2ccccc2n1,organic,6.568636235841013
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CCNc2nc(O)nc3ccccc23)cc1OC,10400.0,nM,=,CHEMBL4100806,inactive,COc1ccc(CCNc2nc(O)nc3ccccc23)cc1OC,organic,4.982966660701219
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,Oc1nc(NCCc2ccccc2)c2ccccc2n1,11200.0,nM,=,CHEMBL4096595,inactive,Oc1nc(NCCc2ccccc2)c2ccccc2n1,organic,4.950781977329818
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,Nc1nc(NCc2ccccc2)nc2ccccc12,2200.0,nM,=,CHEMBL3814134,active,Nc1nc(NCc2ccccc2)nc2ccccc12,organic,5.657577319177793
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,Nc1nc(NCCc2ccccc2)nc2ccccc12,14900.0,nM,=,CHEMBL3814610,inactive,Nc1nc(NCCc2ccccc2)nc2ccccc12,organic,4.826813731587726
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CNc2nc(NC(N)=O)nc3ccccc23)cc1OC,8300.0,nM,=,CHEMBL4060687,active,COc1ccc(CNc2nc(NC(N)=O)nc3ccccc23)cc1OC,organic,5.080921907623926
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,NC(=O)Nc1nc(NCc2ccccc2)c2ccccc2n1,13300.0,nM,=,CHEMBL4081013,inactive,NC(=O)Nc1nc(NCc2ccccc2)c2ccccc2n1,organic,4.876148359032914
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CCNc2nc(NC(N)=O)nc3ccccc23)cc1OC,14400.0,nM,=,CHEMBL4099046,inactive,COc1ccc(CCNc2nc(NC(N)=O)nc3ccccc23)cc1OC,organic,4.841637507904751
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,NC(=O)Nc1nc(NCCc2ccccc2)c2ccccc2n1,1000.0,nM,=,CHEMBL4070380,active,NC(=O)Nc1nc(NCCc2ccccc2)c2ccccc2n1,organic,6.0
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CNc2nc(NC(C)=O)nc3ccccc23)cc1OC,3100.0,nM,=,CHEMBL4091317,active,COc1ccc(CNc2nc(NC(C)=O)nc3ccccc23)cc1OC,organic,5.508638306165727
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,CC(=O)Nc1nc(NCc2ccccc2)c2ccccc2n1,1900.0,nM,=,CHEMBL4061746,active,CC(=O)Nc1nc(NCc2ccccc2)c2ccccc2n1,organic,5.721246399047171
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,CCCNc1nc(NCc2ccc(OC)c(OC)c2)c2ccccc2n1,1700.0,nM,=,CHEMBL4083524,active,CCCNc1nc(NCc2ccc(OC)c(OC)c2)c2ccccc2n1,organic,5.769551078621726
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CNc2nc(NC3CC3)nc3ccccc23)cc1OC,8300.0,nM,=,CHEMBL4097374,active,COc1ccc(CNc2nc(NC3CC3)nc3ccccc23)cc1OC,organic,5.080921907623926
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,CCNc1nc(NCc2ccccc2)c2ccccc2n1,7000.0,nM,=,CHEMBL4079345,active,CCNc1nc(NCc2ccccc2)c2ccccc2n1,organic,5.154901959985743
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,CCCNc1nc(NCc2ccccc2)c2ccccc2n1,5000.0,nM,=,CHEMBL4105088,active,CCCNc1nc(NCc2ccccc2)c2ccccc2n1,organic,5.301029995663981
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,CC(C)Nc1nc(NCc2ccccc2)c2ccccc2n1,4400.0,nM,=,CHEMBL3262251,active,CC(C)Nc1nc(NCc2ccccc2)c2ccccc2n1,organic,5.356547323513812
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,c1ccc(CNc2nc(NC3CC3)nc3ccccc23)cc1,5700.0,nM,=,CHEMBL4067481,active,c1ccc(CNc2nc(NC3CC3)nc3ccccc23)cc1,organic,5.2441251443275085
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,CNc1nc(NCCc2ccc(OC)c(OC)c2)c2ccccc2n1,6600.0,nM,=,CHEMBL4094911,active,CNc1nc(NCCc2ccc(OC)c(OC)c2)c2ccccc2n1,organic,5.180456064458132
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,CCNc1nc(NCCc2ccc(OC)c(OC)c2)c2ccccc2n1,2900.0,nM,=,CHEMBL4078382,active,CCNc1nc(NCCc2ccc(OC)c(OC)c2)c2ccccc2n1,organic,5.5376020021010435
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,CCCNc1nc(NCCc2ccc(OC)c(OC)c2)c2ccccc2n1,4300.0,nM,=,CHEMBL4102655,active,CCCNc1nc(NCCc2ccc(OC)c(OC)c2)c2ccccc2n1,organic,5.366531544420414
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CCNc2nc(NC3CC3)nc3ccccc23)cc1OC,4900.0,nM,=,CHEMBL4086248,active,COc1ccc(CCNc2nc(NC3CC3)nc3ccccc23)cc1OC,organic,5.309803919971486
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,CNc1nc(NCCc2ccccc2)c2ccccc2n1,2000.0,nM,=,CHEMBL4064773,active,CNc1nc(NCCc2ccccc2)c2ccccc2n1,organic,5.698970004336019
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,CCNc1nc(NCCc2ccccc2)c2ccccc2n1,1400.0,nM,=,CHEMBL4061837,active,CCNc1nc(NCCc2ccccc2)c2ccccc2n1,organic,5.853871964321762
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,CCCNc1nc(NCCc2ccccc2)c2ccccc2n1,4400.0,nM,=,CHEMBL4083601,active,CCCNc1nc(NCCc2ccccc2)c2ccccc2n1,organic,5.356547323513812
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,CC(C)Nc1nc(NCCc2ccccc2)c2ccccc2n1,3800.0,nM,=,CHEMBL4070462,active,CC(C)Nc1nc(NCCc2ccccc2)c2ccccc2n1,organic,5.42021640338319
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,c1ccc(CCNc2nc(NC3CC3)nc3ccccc23)cc1,790.0,nM,=,CHEMBL4091385,active,c1ccc(CCNc2nc(NC3CC3)nc3ccccc23)cc1,organic,6.102372908709558
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,3300.0,nM,=,CHEMBL140,active,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,organic,5.481486060122113
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 40 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,1100.0,nM,=,CHEMBL165,active,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,organic,5.958607314841775
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1ccc(CCNc2nc(Cl)nc3ccccc23)cc1OC,13000.0,nM,=,CHEMBL4087140,inactive,COc1ccc(CCNc2nc(Cl)nc3ccccc23)cc1OC,organic,4.886056647693163
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,Nc1nc(NCc2ccccc2)nc2ccccc12,8400.0,nM,=,CHEMBL3814134,active,Nc1nc(NCc2ccccc2)nc2ccccc12,organic,5.075720713938118
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,9900.0,nM,=,CHEMBL140,active,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,organic,5.00436480540245
Inhibition of HFIP-induced human recombinant amyloid beta (1 to 42 residues) aggregation expressed in Escherichia coli measured over 24 hrs by ThT-based fluorescence spectroscopic method,IC50,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,15300.0,nM,=,CHEMBL165,inactive,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,organic,4.815308569182401
Inhibition of amyloid beta (1 to 40 residues) (unknown origin) fibril formation by thioflavin-T fluorescence based assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,1000.0,nM,=,CHEMBL140,active,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,organic,6.0
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,IC50,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,124600.0,nM,=,CHEMBL50,inactive,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,organic,3.904481957676849
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,IC50,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,14800.0,nM,=,CHEMBL164,inactive,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,organic,4.8297382846050425
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,IC50,O=C1c2c(O)cc(O)cc2O[C@H](c2cc(O)c(O)c(O)c2)[C@H]1O,12800.0,nM,=,CHEMBL3348861,inactive,O=C1c2c(O)cc(O)cc2O[C@H](c2cc(O)c(O)c(O)c2)[C@H]1O,organic,4.892790030352131
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,IC50,O=c1c(O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,75100.0,nM,=,CHEMBL150,inactive,O=c1c(O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,organic,4.124360062995832
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation by Thioflavin-T fluorescence assay,IC50,O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,176200.0,nM,=,CHEMBL28,inactive,O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,organic,3.753994095923971
Inhibition of human amyloid beta (1 to 40) aggregation after 1 hr by thioflavin-T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,800.0,nM,=,CHEMBL140,active,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,organic,6.096910013008056
Inhibition of human amyloid beta (1 to 42) aggregation after 46 to 48 hrs by Thioflavin T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,10000.0,nM,=,CHEMBL140,active,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,organic,5.0
Inhibition of recombinant amyloid beta (1 to 42) fibrils (unknown origin) by thioflavin-T fluorescence assay,IC50,O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,23000.0,nM,=,CHEMBL28,inactive,O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,organic,4.638272163982407
Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation after 24 hrs by thioflavin T fluorescence assay,IC50,COC(=O)[C@H](Cc1ccc(O)c(O)c1)NC(=O)/C=C/c1ccc(O)c(O)c1,4900.0,nM,=,CHEMBL2296789,active,COC(=O)[C@H](Cc1ccc(O)c(O)c1)NC(=O)/C=C/c1ccc(O)c(O)c1,organic,5.309803919971486
Displacement of [125I]IMPY from fibrillar amyloid beta 42 (unknown origin) after 3 hrs,IC50,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)on2)ccc1O,138.0,nM,=,CHEMBL181529,active,COc1cc(/C=C/c2cc(/C=C/c3ccc(O)c(OC)c3)on2)ccc1O,organic,6.860120913598763
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by thioflavin T-based fluorometric assay,IC50,O=C(/C=C/c1ccc(O)c(O)c1)c1cccnc1,9000.0,nM,=,CHEMBL4166095,active,O=C(/C=C/c1ccc(O)c(O)c1)c1cccnc1,organic,5.045757490560675
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by thioflavin T-based fluorometric assay,IC50,c1ccc2c(NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,8400.0,nM,=,CHEMBL32823,active,c1ccc2c(NCCCCCCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,organic,5.075720713938118
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by thioflavin T-based fluorometric assay,IC50,C=CCOC(=S)/C=C/c1ccc(O)c(O)c1,12500.0,nM,=,CHEMBL4175715,inactive,C=CCOC(=S)/C=C/c1ccc(O)c(O)c1,organic,4.903089986991944
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,Cc1cc(N2CCN(c3nc(Cl)nc(Nc4cccc(C(F)(F)F)c4)n3)CC2)n2ncnc2n1,10430.0,nM,=,CHEMBL4176742,inactive,Cc1cc(N2CCN(c3nc(Cl)nc(Nc4cccc(C(F)(F)F)c4)n3)CC2)n2ncnc2n1,organic,4.981715691573469
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,COc1ccc(Nc2nc(Cl)nc(N3CCN(c4cc(C)nc5ncnn45)CC3)n2)cc1,11550.0,nM,=,CHEMBL4172159,inactive,COc1ccc(Nc2nc(Cl)nc(N3CCN(c4cc(C)nc5ncnn45)CC3)n2)cc1,organic,4.937418015771837
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,Cc1cc(N2CCN(c3nc(Cl)nc(Nc4ccc(F)cc4)n3)CC2)n2ncnc2n1,15890.0,nM,=,CHEMBL4161552,inactive,Cc1cc(N2CCN(c3nc(Cl)nc(Nc4ccc(F)cc4)n3)CC2)n2ncnc2n1,organic,4.798876102792621
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,Cc1cc(N2CCN(c3nc(Cl)nc(Nc4ccccc4F)n3)CC2)n2ncnc2n1,13400.0,nM,=,CHEMBL4168812,inactive,Cc1cc(N2CCN(c3nc(Cl)nc(Nc4ccccc4F)n3)CC2)n2ncnc2n1,organic,4.872895201635193
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,Cc1cc(N2CCN(c3nc(Nc4cccc(C(F)(F)F)c4)nc(Nc4ccc(F)c(Cl)c4)n3)CC2)n2ncnc2n1,16290.0,nM,=,CHEMBL4173299,inactive,Cc1cc(N2CCN(c3nc(Nc4cccc(C(F)(F)F)c4)nc(Nc4ccc(F)c(Cl)c4)n3)CC2)n2ncnc2n1,organic,4.78807891569149
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,Cc1cc(N2CCN(c3nc(Nc4ccc(F)cc4)nc(Nc4cccc(C(F)(F)F)c4)n3)CC2)n2ncnc2n1,18310.0,nM,=,CHEMBL4161947,inactive,Cc1cc(N2CCN(c3nc(Nc4ccc(F)cc4)nc(Nc4cccc(C(F)(F)F)c4)n3)CC2)n2ncnc2n1,organic,4.737311655698304
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,Cc1ccc(Nc2nc(Nc3ccc(F)c(Cl)c3)nc(N3CCN(c4cc(C)nc5ncnn45)CC3)n2)cc1,25000.0,nM,=,CHEMBL4169871,inactive,Cc1ccc(Nc2nc(Nc3ccc(F)c(Cl)c3)nc(N3CCN(c4cc(C)nc5ncnn45)CC3)n2)cc1,organic,4.6020599913279625
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,FC(F)(F)c1cccc(Nc2nc(NC3CC3)nc(N3CCNCC3)n2)c1,23540.0,nM,=,CHEMBL4167322,inactive,FC(F)(F)c1cccc(Nc2nc(NC3CC3)nc(N3CCNCC3)n2)c1,organic,4.628193541492584
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,Fc1ccc(Nc2nc(Cl)nc(Nc3cccc(C(F)(F)F)c3)n2)c(F)c1,17850.0,nM,=,CHEMBL4175196,inactive,Fc1ccc(Nc2nc(Cl)nc(Nc3cccc(C(F)(F)F)c3)n2)c(F)c1,organic,4.748361779551788
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,Fc1ccc(Nc2nc(Cl)nc(Nc3cccc(C(F)(F)F)c3)n2)cc1,18550.0,nM,=,CHEMBL4170265,inactive,Fc1ccc(Nc2nc(Cl)nc(Nc3cccc(C(F)(F)F)c3)n2)cc1,organic,4.731656086048935
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,Cc1ccc(Nc2nc(Cl)nc(Nc3cccc(C(F)(F)F)c3)n2)cc1,20720.0,nM,=,CHEMBL4162346,inactive,Cc1ccc(Nc2nc(Cl)nc(Nc3cccc(C(F)(F)F)c3)n2)cc1,organic,4.683610248926804
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,COc1ccc(Nc2nc(Cl)nc(Nc3cccc(C(F)(F)F)c3)n2)cc1,17600.0,nM,=,CHEMBL4166865,inactive,COc1ccc(Nc2nc(Cl)nc(Nc3cccc(C(F)(F)F)c3)n2)cc1,organic,4.7544873321858505
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,Cc1ccc(Nc2nc(Cl)nc(Nc3ccc(F)c(Cl)c3)n2)cc1,18050.0,nM,=,CHEMBL4163412,inactive,Cc1ccc(Nc2nc(Cl)nc(Nc3ccc(F)c(Cl)c3)n2)cc1,organic,4.7435227937583235
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,COc1ccc(Nc2nc(Cl)nc(Nc3ccc(F)c(Cl)c3)n2)cc1,23800.0,nM,=,CHEMBL4174114,inactive,COc1ccc(Nc2nc(Cl)nc(Nc3ccc(F)c(Cl)c3)n2)cc1,organic,4.623423042943488
Inhibition of HFIP-pretreated amyloid beta (1 to 42 residues) (unknown origin) self aggregation after 24 hrs by ThT-based fluorometric method,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,22510.0,nM,=,CHEMBL140,inactive,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,organic,4.64762450499948
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,COc1ccc(Cn2cc(CNC(=O)[C@@H](C)CC[C@H]3O[C@H]4C[C@H]5[C@@H]6CC[C@@H]7C[C@@H](OCc8ccccc8)CC[C@]7(C)[C@H]6CC[C@]5(C)[C@H]4[C@@H]3C)nn2)cc1,5840.0,nM,=,CHEMBL4176559,active,COc1ccc(Cn2cc(CNC(=O)[C@@H](C)CC[C@H]3O[C@H]4C[C@H]5[C@@H]6CC[C@@H]7C[C@@H](OCc8ccccc8)CC[C@]7(C)[C@H]6CC[C@]5(C)[C@H]4[C@@H]3C)nn2)cc1,organic,5.2335871528876
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,C[C@H]1[C@H]2[C@H](C[C@H]3[C@@H]4CC[C@@H]5C[C@@H](OCc6ccccc6)CC[C@]5(C)[C@H]4CC[C@]23C)O[C@@H]1CC[C@H](C)C(=O)NCc1cn(Cc2cscn2)nn1,8280.0,nM,=,CHEMBL4161849,active,C[C@H]1[C@H]2[C@H](C[C@H]3[C@@H]4CC[C@@H]5C[C@@H](OCc6ccccc6)CC[C@]5(C)[C@H]4CC[C@]23C)O[C@@H]1CC[C@H](C)C(=O)NCc1cn(Cc2cscn2)nn1,organic,5.08196966321512
Inhibition of amyloid beta (1 to 42) (unknown origin) self-aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,14990.0,nM,=,CHEMBL140,inactive,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,organic,4.824198367151721
Inhibition of amyloid beta 42 (unknown origin) expressed in Escherichia coli BL21 (DE3) aggregation incubated for overnight by Th-S fluorescence staining based UV-Vis spectrophotometer,IC50,COc1cc(/C=C/C(=O)Oc2cc(O)c3c(c2)O[C@H](c2ccc4c(c2)O[C@@H](c2ccc(O)c(OC)c2)[C@H](CO)O4)[C@@H](O)C3=O)ccc1O,43600.0,nM,=,CHEMBL4217978,inactive,COc1cc(/C=C/C(=O)Oc2cc(O)c3c(c2)O[C@H](c2ccc4c(c2)O[C@@H](c2ccc(O)c(OC)c2)[C@H](CO)O4)[C@@H](O)C3=O)ccc1O,organic,4.360513510731414
Inhibition of amyloid beta 42 (unknown origin) expressed in Escherichia coli BL21 (DE3) aggregation incubated for overnight by Th-S fluorescence staining based UV-Vis spectrophotometer,IC50,COc1cc(/C=C/C(=O)Oc2cc(O)c3c(c2)O[C@H](c2ccc4c(c2)O[C@H](c2ccc(O)c(OC)c2)[C@@H](CO)O4)[C@@H](O)C3=O)ccc1O,85500.0,nM,=,CHEMBL4207221,inactive,COc1cc(/C=C/C(=O)Oc2cc(O)c3c(c2)O[C@H](c2ccc4c(c2)O[C@H](c2ccc(O)c(OC)c2)[C@@H](CO)O4)[C@@H](O)C3=O)ccc1O,organic,4.068033885271827
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,7000.0,nM,=,CHEMBL76,active,CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,organic,5.154901959985743
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O,4000.0,nM,=,CHEMBL682,active,CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O,organic,5.3979400086720375
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,CCN(CC)Cc1cccc(Nc2ccnc3cc(Cl)ccc23)c1,4500.0,nM,=,CHEMBL138623,active,CCN(CC)Cc1cccc(Nc2ccnc3cc(Cl)ccc23)c1,organic,5.346787486224656
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,CCN(CC)Cc1cc(NC(=O)CN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,1500.0,nM,=,CHEMBL317760,active,CCN(CC)Cc1cc(NC(=O)CN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,organic,5.823908740944319
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,CCN(CC)Cc1cc(NCCN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,10000.0,nM,=,CHEMBL451753,active,CCN(CC)Cc1cc(NCCN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,organic,5.0
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,O=C(CN1CCCCC1)Nc1cc(CN2CCOCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,3100.0,nM,=,CHEMBL94521,active,O=C(CN1CCCCC1)Nc1cc(CN2CCOCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,organic,5.508638306165727
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,Clc1ccc2c(Nc3cc(CN4CCOCC4)cc(NCCN4CCCCC4)c3)ccnc2c1,2500.0,nM,=,CHEMBL4227472,active,Clc1ccc2c(Nc3cc(CN4CCOCC4)cc(NCCN4CCCCC4)c3)ccnc2c1,organic,5.6020599913279625
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,CN(C)CCN(C)Cc1cc(NC(=O)CN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,1700.0,nM,=,CHEMBL97247,active,CN(C)CCN(C)Cc1cc(NC(=O)CN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,organic,5.769551078621726
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,CN(C)CCNCc1cc(NC(=O)CN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,2000.0,nM,=,CHEMBL319756,active,CN(C)CCNCc1cc(NC(=O)CN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,organic,5.698970004336019
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,Oc1c(CN2CCCC2)cc(Nc2ccnc3cc(Cl)ccc23)cc1CN1CCCC1,5100.0,nM,=,CHEMBL167970,active,Oc1c(CN2CCCC2)cc(Nc2ccnc3cc(Cl)ccc23)cc1CN1CCCC1,organic,5.292429823902063
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,CN1CCN(c2cc(Nc3ccnc4cc(Cl)ccc34)cc(N3CCN(C)CC3)c2)CC1,2300.0,nM,=,CHEMBL4226945,active,CN1CCN(c2cc(Nc3ccnc4cc(Cl)ccc34)cc(N3CCN(C)CC3)c2)CC1,organic,5.638272163982407
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,O=C(NCCN1CCCCC1)c1cc(Nc2ccccc2CN2CCCCC2)cc(C(=O)NCCN2CCCCC2)c1,4100.0,nM,=,CHEMBL4226951,active,O=C(NCCN1CCCCC1)c1cc(Nc2ccccc2CN2CCCCC2)cc(C(=O)NCCN2CCCCC2)c1,organic,5.3872161432802645
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,CN(C)Cc1ccccc1Nc1cc(C(=O)NCCN2CCCCC2)cc(C(=O)NCCN2CCCCC2)c1,8200.0,nM,=,CHEMBL4225842,active,CN(C)Cc1ccccc1Nc1cc(C(=O)NCCN2CCCCC2)cc(C(=O)NCCN2CCCCC2)c1,organic,5.086186147616283
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,c1ccc(Nc2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)c(CN2CCCCC2)c1,4600.0,nM,=,CHEMBL4226025,active,c1ccc(Nc2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)c(CN2CCCCC2)c1,organic,5.337242168318426
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,c1ccc(Nc2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)c(CN2CCOCC2)c1,6600.0,nM,=,CHEMBL4225563,active,c1ccc(Nc2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)c(CN2CCOCC2)c1,organic,5.180456064458132
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 40 residues) production measured after 24 hrs,IC50,O=C(NCCN1CCCCC1)c1cc(C(=O)NCCN2CCCCC2)cc(-c2ccccc2CN2CCCCC2)c1,6200.0,nM,=,CHEMBL4228998,active,O=C(NCCN1CCCCC1)c1cc(C(=O)NCCN2CCCCC2)cc(-c2ccccc2CN2CCCCC2)c1,organic,5.207608310501746
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,12800.0,nM,=,CHEMBL76,inactive,CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12,organic,4.892790030352131
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O,5400.0,nM,=,CHEMBL682,active,CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O,organic,5.267606240177032
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,CCN(CC)Cc1cccc(Nc2ccnc3cc(Cl)ccc23)c1,10400.0,nM,=,CHEMBL138623,inactive,CCN(CC)Cc1cccc(Nc2ccnc3cc(Cl)ccc23)c1,organic,4.982966660701219
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,CCN(CC)Cc1cc(NC(=O)CN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,2800.0,nM,=,CHEMBL317760,active,CCN(CC)Cc1cc(NC(=O)CN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,organic,5.552841968657781
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,CCN(CC)Cc1cc(NCCN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,13800.0,nM,=,CHEMBL451753,inactive,CCN(CC)Cc1cc(NCCN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,organic,4.860120913598763
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,O=C(CN1CCCCC1)Nc1cc(CN2CCOCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,7100.0,nM,=,CHEMBL94521,active,O=C(CN1CCCCC1)Nc1cc(CN2CCOCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,organic,5.1487416512809245
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,Clc1ccc2c(Nc3cc(CN4CCOCC4)cc(NCCN4CCCCC4)c3)ccnc2c1,4900.0,nM,=,CHEMBL4227472,active,Clc1ccc2c(Nc3cc(CN4CCOCC4)cc(NCCN4CCCCC4)c3)ccnc2c1,organic,5.309803919971486
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,CN(C)CCN(C)Cc1cc(NC(=O)CN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,2900.0,nM,=,CHEMBL97247,active,CN(C)CCN(C)Cc1cc(NC(=O)CN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,organic,5.5376020021010435
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,CN(C)CCNCc1cc(NC(=O)CN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,2100.0,nM,=,CHEMBL319756,active,CN(C)CCNCc1cc(NC(=O)CN2CCCCC2)cc(Nc2ccnc3cc(Cl)ccc23)c1,organic,5.6777807052660805
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,Oc1c(CN2CCCC2)cc(Nc2ccnc3cc(Cl)ccc23)cc1CN1CCCC1,11200.0,nM,=,CHEMBL167970,inactive,Oc1c(CN2CCCC2)cc(Nc2ccnc3cc(Cl)ccc23)cc1CN1CCCC1,organic,4.950781977329818
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,CN1CCN(c2cc(Nc3ccnc4cc(Cl)ccc34)cc(N3CCN(C)CC3)c2)CC1,1900.0,nM,=,CHEMBL4226945,active,CN1CCN(c2cc(Nc3ccnc4cc(Cl)ccc34)cc(N3CCN(C)CC3)c2)CC1,organic,5.721246399047171
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,O=C(NCCN1CCCCC1)c1cc(Nc2ccccc2CN2CCCCC2)cc(C(=O)NCCN2CCCCC2)c1,4700.0,nM,=,CHEMBL4226951,active,O=C(NCCN1CCCCC1)c1cc(Nc2ccccc2CN2CCCCC2)cc(C(=O)NCCN2CCCCC2)c1,organic,5.327902142064283
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,c1ccc(Nc2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)c(CN2CCCCC2)c1,6000.0,nM,=,CHEMBL4226025,active,c1ccc(Nc2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)c(CN2CCCCC2)c1,organic,5.221848749616356
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,c1ccc(Nc2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)c(CN2CCOCC2)c1,7900.0,nM,=,CHEMBL4225563,active,c1ccc(Nc2cc(CNCCN3CCCCC3)cc(CNCCN3CCCCC3)c2)c(CN2CCOCC2)c1,organic,5.102372908709558
Modulation of human wild-type APP695 expressed in SH-SY5Y cells assessed as inhibition of amyloid beta (1 to 42 residues) production measured after 24 hrs by ELISA,IC50,O=C(NCCN1CCCCC1)c1cc(C(=O)NCCN2CCCCC2)cc(-c2ccccc2CN2CCCCC2)c1,9400.0,nM,=,CHEMBL4228998,active,O=C(NCCN1CCCCC1)c1cc(C(=O)NCCN2CCCCC2)cc(-c2ccccc2CN2CCCCC2)c1,organic,5.026872146400302
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,12430.0,nM,=,CHEMBL165,inactive,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,organic,4.905528871358356
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,O=C(/C=C/c1ccccc1)N1CCN(Cc2ccc(O)c3ncccc23)CC1,8860.0,nM,=,CHEMBL4228823,active,O=C(/C=C/c1ccccc1)N1CCN(Cc2ccc(O)c3ncccc23)CC1,organic,5.052566278112949
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,COc1ccc(/C=C/C(=O)N2CCN(Cc3ccc(O)c4ncccc34)CC2)cc1OC,18940.0,nM,=,CHEMBL4226059,inactive,COc1ccc(/C=C/C(=O)N2CCN(Cc3ccc(O)c4ncccc34)CC2)cc1OC,organic,4.722620025332746
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,O=C(/C=C/c1ccc(F)cc1)N1CCN(Cc2ccc(O)c3ncccc23)CC1,11440.0,nM,=,CHEMBL4227890,inactive,O=C(/C=C/c1ccc(F)cc1)N1CCN(Cc2ccc(O)c3ncccc23)CC1,organic,4.941573975542995
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,O=C(/C=C/c1ccc(F)cc1F)N1CCN(Cc2ccc(O)c3ncccc23)CC1,5050.0,nM,=,CHEMBL4227615,active,O=C(/C=C/c1ccc(F)cc1F)N1CCN(Cc2ccc(O)c3ncccc23)CC1,organic,5.296708621881339
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,N#Cc1ccc(/C=C/C(=O)N2CCN(Cc3ccc(O)c4ncccc34)CC2)cc1,16810.0,nM,=,CHEMBL4226505,inactive,N#Cc1ccc(/C=C/C(=O)N2CCN(Cc3ccc(O)c4ncccc34)CC2)cc1,organic,4.774432286560529
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,O=C(/C=C/c1ccccc1Cl)N1CCN(Cc2ccc(O)c3ncccc23)CC1,7350.0,nM,=,CHEMBL4227357,active,O=C(/C=C/c1ccccc1Cl)N1CCN(Cc2ccc(O)c3ncccc23)CC1,organic,5.133712660915805
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,Cc1ccccc1/C=C/C(=O)N1CCN(Cc2ccc(O)c3ncccc23)CC1,17330.0,nM,=,CHEMBL4228027,inactive,Cc1ccccc1/C=C/C(=O)N1CCN(Cc2ccc(O)c3ncccc23)CC1,organic,4.761201437286083
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,O=C(/C=C/c1ccc(Cl)cc1)N1CCN(Cc2ccc(O)c3ncccc23)CC1,22550.0,nM,=,CHEMBL4225226,inactive,O=C(/C=C/c1ccc(Cl)cc1)N1CCN(Cc2ccc(O)c3ncccc23)CC1,organic,4.64685345378602
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,O=C(CCc1ccccc1)N1CCN(Cc2ccc(O)c3ncccc23)CC1,19740.0,nM,=,CHEMBL4225986,inactive,O=C(CCc1ccccc1)N1CCN(Cc2ccc(O)c3ncccc23)CC1,organic,4.704652851666382
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,O=C(CCc1ccccc1Cl)N1CCN(Cc2ccc(O)c3ncccc23)CC1,5640.0,nM,=,CHEMBL4226827,active,O=C(CCc1ccccc1Cl)N1CCN(Cc2ccc(O)c3ncccc23)CC1,organic,5.248720896016658
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,COc1ccc(CCC(=O)N2CCN(Cc3ccc(O)c4ncccc34)CC2)cc1,18280.0,nM,=,CHEMBL4226831,inactive,COc1ccc(CCC(=O)N2CCN(Cc3ccc(O)c4ncccc34)CC2)cc1,organic,4.738023808602187
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,O=C(CCc1ccc(F)cc1)N1CCN(Cc2ccc(O)c3ncccc23)CC1,20610.0,nM,=,CHEMBL4225989,inactive,O=C(CCc1ccc(F)cc1)N1CCN(Cc2ccc(O)c3ncccc23)CC1,organic,4.685922008220787
Inhibition of beta amyloid (unknown origin) deposition,IC50,O=C(CCCCC1CCSS1)NCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,45000.0,nM,=,CHEMBL194823,inactive,O=C(CCCCC1CCSS1)NCCCNc1c2c(nc3cc(Cl)ccc13)CCCC2,organic,4.346787486224656
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,O=c1cc(/C=C/c2cccc(F)c2)occ1O,17680.0,nM,=,CHEMBL4282190,inactive,O=c1cc(/C=C/c2cccc(F)c2)occ1O,organic,4.752517739322946
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,CN(C)c1ccc(/C=C/c2cc(=O)c(O)co2)cc1,5920.0,nM,=,CHEMBL4294375,active,CN(C)c1ccc(/C=C/c2cc(=O)c(O)co2)cc1,organic,5.22767829327708
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,COc1ccccc1/C=C/c1cc(=O)c(O)co1,7930.0,nM,=,CHEMBL4286002,active,COc1ccccc1/C=C/c1cc(=O)c(O)co1,organic,5.100726812682396
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,O=c1cc(/C=C/c2ccc(O)cc2)occ1O,7200.0,nM,=,CHEMBL4287929,active,O=c1cc(/C=C/c2ccc(O)cc2)occ1O,organic,5.142667503568732
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,O=c1cc(/C=C/c2ccccc2O)occ1O,8290.0,nM,=,CHEMBL4284208,active,O=c1cc(/C=C/c2ccccc2O)occ1O,organic,5.081445469449727
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,O=c1cc(/C=C/c2cc(O)cc(O)c2)occ1O,17950.0,nM,=,CHEMBL4294830,inactive,O=c1cc(/C=C/c2cc(O)cc(O)c2)occ1O,organic,4.745935547085662
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,11890.0,nM,=,CHEMBL165,inactive,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,organic,4.924818145381308
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 24 hrs by thioflavin-T fluorescence assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,18730.0,nM,=,CHEMBL140,inactive,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,organic,4.727462222624762
Disaggregation of amyloid beta (1 to 42 residues) (unknown origin) preformed fibrils incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay,IC50,O=C(/C=C/c1ccc(O)c(O)c1)NCCCNC(=O)/C=C/c1ccc(O)c(O)c1,4200.0,nM,=,CHEMBL197478,active,O=C(/C=C/c1ccc(O)c(O)c1)NCCCNC(=O)/C=C/c1ccc(O)c(O)c1,organic,5.376750709602099
Inhibition of amyloid beta (1 to 42) fibrillization (unknown origin) incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay,IC50,O=C(O)/C=C/c1ccc(O)c(O)c1,15600.0,nM,=,CHEMBL145,inactive,O=C(O)/C=C/c1ccc(O)c(O)c1,organic,4.806875401645539
Inhibition of amyloid beta (1 to 42) fibrillization (unknown origin) incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,3400.0,nM,=,CHEMBL140,active,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,organic,5.468521082957745
Inhibition of amyloid beta (1 to 42) fibrillization (unknown origin) incubated with agitation for 1 min every hr measured over 80 hrs by thioflavin-T assay,IC50,O=C(/C=C/c1ccc(O)c(O)c1)NCCCNC(=O)/C=C/c1ccc(O)c(O)c1,4900.0,nM,=,CHEMBL197478,active,O=C(/C=C/c1ccc(O)c(O)c1)NCCCNC(=O)/C=C/c1ccc(O)c(O)c1,organic,5.309803919971486
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) incubated for 24 hrs by TEM analysis,IC50,CCN(CC)CCCOc1ccc(-n2ccc(=O)c(O)c2C)cc1,17230.0,nM,=,CHEMBL4462662,inactive,CCN(CC)CCCOc1ccc(-n2ccc(=O)c(O)c2C)cc1,organic,4.763714722551971
Inhibition of amyloid beta (1 to 40) (unknown origin) self aggregation,IC50,CCN(CC)CCCCC(C)Nc1c2ccccc2nc2c(C(=O)NCCCO/N=C/C(=O)NCCCC[C@@H]3NC(=O)CNC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCCN)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCCN)NC(=O)[C@@H]4CCCN4C3=O)cccc12,2000.0,nM,=,CHEMBL4465480,active,CCN(CC)CCCCC(C)Nc1c2ccccc2nc2c(C(=O)NCCCO/N=C/C(=O)NCCCC[C@@H]3NC(=O)CNC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCCN)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCCN)NC(=O)[C@@H]4CCCN4C3=O)cccc12,organic,5.698970004336019
Inhibition of HFIP pretreated amyloid beta (1-42) (unknown origin) self aggregation by thioflavin T based fluorescence assay,IC50,c1ccc2c(NCCSSCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,24200.0,nM,=,CHEMBL3235503,inactive,c1ccc2c(NCCSSCCNc3c4c(nc5ccccc35)CCCC4)c3c(nc2c1)CCCC3,organic,4.616184634019569
Inhibition of amyloid beta 1 to 42 aggregation in human SH-SY5Y cells incubated for 48 hrs by fluorescence microscopy,IC50,CN1c2ccccc2Sc2cc(/C=C3/SC(=S)N(CC(=O)OCC4COC(C)(C)O4)C3=O)ccc21,60.0,nM,=,CHEMBL4475538,active,CN1c2ccccc2Sc2cc(/C=C3/SC(=S)N(CC(=O)OCC4COC(C)(C)O4)C3=O)ccc21,organic,7.221848749616356
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation,IC50,CCOC(=O)C(Cc1cn(-c2ccccc2C(F)(F)F)nn1)(Cc1cn(-c2ccccc2C(F)(F)F)nn1)NC(C)=O,8065.0,nM,=,CHEMBL4522050,active,CCOC(=O)C(Cc1cn(-c2ccccc2C(F)(F)F)nn1)(Cc1cn(-c2ccccc2C(F)(F)F)nn1)NC(C)=O,organic,5.09339562827502
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,6385.0,nM,=,CHEMBL140,active,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,organic,5.194839098400566
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,CCOc1cc(CNc2ccc(OC)cc2)ccc1Oc1ccnc2cc(Cl)ccc12,46420.0,nM,=,CHEMBL4568384,inactive,CCOc1cc(CNc2ccc(OC)cc2)ccc1Oc1ccnc2cc(Cl)ccc12,organic,4.333294863880101
Inhibition of HFIP-pretreated amyloid beta (1 to 42) (unknown origin) self-induced aggregation after 48 hrs by thioflavin T-based fluorometric assay,IC50,CCOc1cc(CNc2ccccc2)ccc1Oc1ccnc2cc(Cl)ccc12,44520.0,nM,=,CHEMBL4439214,inactive,CCOc1cc(CNc2ccccc2)ccc1Oc1ccnc2cc(Cl)ccc12,organic,4.35144484433733
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) after 48 hrs by thioflavin T-based fluorescence method,IC50,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,16800.0,nM,=,CHEMBL165,inactive,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,organic,4.774690718274137
Inhibition of self-induced aggregation of amyloid beta (1 to 42) (unknown origin) after 48 hrs by thioflavin T-based fluorescence method,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,13700.0,nM,=,CHEMBL140,inactive,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,organic,4.863279432843593
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,CN(CCCNC(=O)c1cc(O)c(C(=O)NCCCN(C)Cc2ccccc2)cc1O)Cc1ccccc1,3980.0,nM,=,CHEMBL4524631,active,CN(CCCNC(=O)c1cc(O)c(C(=O)NCCCN(C)Cc2ccccc2)cc1O)Cc1ccccc1,organic,5.400116927926312
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,CCN(CCCNC(=O)c1cc(O)c(C(=O)NCCCN(CC)Cc2ccccc2)cc1O)Cc1ccccc1,4200.0,nM,=,CHEMBL4516540,active,CCN(CCCNC(=O)c1cc(O)c(C(=O)NCCCN(CC)Cc2ccccc2)cc1O)Cc1ccccc1,organic,5.376750709602099
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,COc1ccccc1CN(C)CCCNC(=O)c1cc(O)c(C(=O)NCCCN(C)Cc2ccccc2OC)cc1O,3630.0,nM,=,CHEMBL4439936,active,COc1ccccc1CN(C)CCCNC(=O)c1cc(O)c(C(=O)NCCCN(C)Cc2ccccc2OC)cc1O,organic,5.440093374963888
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,CCN(CCCNC(=O)c1cc(O)c(C(=O)NCCCN(CC)Cc2ccccc2OC)cc1O)Cc1ccccc1OC,2410.0,nM,=,CHEMBL4562198,active,CCN(CCCNC(=O)c1cc(O)c(C(=O)NCCCN(CC)Cc2ccccc2OC)cc1O)Cc1ccccc1OC,organic,5.617982957425132
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,CN(CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(C)Cc2ccccc2)cc1O)Cc1ccccc1,3550.0,nM,=,CHEMBL4440350,active,CN(CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(C)Cc2ccccc2)cc1O)Cc1ccccc1,organic,5.449771646944906
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,CCN(CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(CC)Cc2ccccc2)cc1O)Cc1ccccc1,3860.0,nM,=,CHEMBL4527242,active,CCN(CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(CC)Cc2ccccc2)cc1O)Cc1ccccc1,organic,5.413412695328245
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,COc1ccccc1CN(C)CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(C)Cc2ccccc2OC)cc1O,3450.0,nM,=,CHEMBL4474151,active,COc1ccccc1CN(C)CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(C)Cc2ccccc2OC)cc1O,organic,5.462180904926726
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,CCN(CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(CC)Cc2ccccc2OC)cc1O)Cc1ccccc1OC,3050.0,nM,=,CHEMBL4553651,active,CCN(CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(CC)Cc2ccccc2OC)cc1O)Cc1ccccc1OC,organic,5.515700160653214
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,CCN(CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(CC)Cc2ccccc2N(C)C)cc1O)Cc1ccccc1N(C)C,3710.0,nM,=,CHEMBL4554367,active,CCN(CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(CC)Cc2ccccc2N(C)C)cc1O)Cc1ccccc1N(C)C,organic,5.430626090384954
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,CCN(CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(CC)Cc2ccc(N(C)C)cc2)cc1O)Cc1ccc(N(C)C)cc1,3160.0,nM,=,CHEMBL4463164,active,CCN(CCCCNC(=O)c1cc(O)c(C(=O)NCCCCN(CC)Cc2ccc(N(C)C)cc2)cc1O)Cc1ccc(N(C)C)cc1,organic,5.5003129173815966
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,O=C(NCCCCN1CCOc2ccccc2C1)c1cc(O)c(C(=O)NCCCCN2CCOc3ccccc3C2)cc1O,5470.0,nM,=,CHEMBL4467746,active,O=C(NCCCCN1CCOc2ccccc2C1)c1cc(O)c(C(=O)NCCCCN2CCOc3ccccc3C2)cc1O,organic,5.262012673666569
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,CN(CCCCCCNC(=O)c1cc(O)c(C(=O)NCCCCCCN(C)Cc2ccccc2)cc1O)Cc1ccccc1,2370.0,nM,=,CHEMBL4552250,active,CN(CCCCCCNC(=O)c1cc(O)c(C(=O)NCCCCCCN(C)Cc2ccccc2)cc1O)Cc1ccccc1,organic,5.6252516539898965
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,CCN(CCCCCCNC(=O)c1cc(O)c(C(=O)NCCCCCCN(CC)Cc2ccccc2)cc1O)Cc1ccccc1,2800.0,nM,=,CHEMBL4520323,active,CCN(CCCCCCNC(=O)c1cc(O)c(C(=O)NCCCCCCN(CC)Cc2ccccc2)cc1O)Cc1ccccc1,organic,5.552841968657781
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,COc1ccccc1CN(C)CCCCCCNC(=O)c1cc(O)c(C(=O)NCCCCCCN(C)Cc2ccccc2OC)cc1O,2310.0,nM,=,CHEMBL4475678,active,COc1ccccc1CN(C)CCCCCCNC(=O)c1cc(O)c(C(=O)NCCCCCCN(C)Cc2ccccc2OC)cc1O,organic,5.636388020107856
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,CCN(CCCCCCNC(=O)c1cc(O)c(C(=O)NCCCCCCN(CC)Cc2ccccc2OC)cc1O)Cc1ccccc1OC,3310.0,nM,=,CHEMBL4451935,active,CCN(CCCCCCNC(=O)c1cc(O)c(C(=O)NCCCCCCN(CC)Cc2ccccc2OC)cc1O)Cc1ccccc1OC,organic,5.480172006224281
Inhibition of human amyloid beta (1 to 42) self-induced aggregation after 24 hrs by Thioflavin T based fluorometric assay,IC50,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccccc2OC)=CC1=O)Cc1ccccc1OC,5930.0,nM,=,CHEMBL231160,active,CCN(CCCCCCNC1=CC(=O)C(NCCCCCCN(CC)Cc2ccccc2OC)=CC1=O)Cc1ccccc1OC,organic,5.226945306635737
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,O=c1cc(-c2ccc(Oc3c(O)cc4oc(-c5ccc(O)cc5)cc(=O)c4c3O)cc2)oc2cc(O)cc(O)c12,9500.0,nM,=,CHEMBL291426,active,O=c1cc(-c2ccc(Oc3c(O)cc4oc(-c5ccc(O)cc5)cc(=O)c4c3O)cc2)oc2cc(O)cc(O)c12,organic,5.022276394711152
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1ccc(-c2cc(=O)c3c(O)cc(OC)c(-c4c(OC)cc(O)c5c(=O)cc(-c6ccc(O)cc6)oc45)c3o2)cc1,45600.0,nM,=,CHEMBL4513568,inactive,COc1ccc(-c2cc(=O)c3c(O)cc(OC)c(-c4c(OC)cc(O)c5c(=O)cc(-c6ccc(O)cc6)oc45)c3o2)cc1,organic,4.341035157335565
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc2c1-c1c(OC)cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc12,17300.0,nM,=,CHEMBL4463033,inactive,COc1cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc2c1-c1c(OC)cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc12,organic,4.761953896871205
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1ccc(-c2cc(=O)c3c(O)cc(O)c(-c4c(OC)cc5oc(-c6ccc(O)cc6)cc(=O)c5c4O)c3o2)cc1,15900.0,nM,=,CHEMBL4554693,inactive,COc1ccc(-c2cc(=O)c3c(O)cc(O)c(-c4c(OC)cc5oc(-c6ccc(O)cc6)cc(=O)c5c4O)c3o2)cc1,organic,4.798602875679548
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1cc2oc(-c3ccc(O)cc3)cc(=O)c2c(O)c1-c1c(OC)cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc12,32800.0,nM,=,CHEMBL4545404,inactive,COc1cc2oc(-c3ccc(O)cc3)cc(=O)c2c(O)c1-c1c(OC)cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc12,organic,4.484126156288321
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1cc2oc(-c3ccc(O)cc3)cc(=O)c2c(O)c1-c1c(O)cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc12,13000.0,nM,=,CHEMBL4449738,inactive,COc1cc2oc(-c3ccc(O)cc3)cc(=O)c2c(O)c1-c1c(O)cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc12,organic,4.886056647693163
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1cc2oc(-c3ccc(O)cc3)cc(=O)c2c(O)c1-c1cc(-c2cc(=O)c3c(O)cc(O)cc3o2)ccc1O,21300.0,nM,=,CHEMBL3589107,inactive,COc1cc2oc(-c3ccc(O)cc3)cc(=O)c2c(O)c1-c1cc(-c2cc(=O)c3c(O)cc(O)cc3o2)ccc1O,organic,4.671620396561262
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1ccc(-c2cc(=O)c3c(O)cc(OC)c(-c4cc(-c5cc(=O)c6c(O)cc(O)cc6o5)ccc4O)c3o2)cc1,20100.0,nM,=,CHEMBL374055,inactive,COc1ccc(-c2cc(=O)c3c(O)cc(OC)c(-c4cc(-c5cc(=O)c6c(O)cc(O)cc6o5)ccc4O)c3o2)cc1,organic,4.696803942579511
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1ccc(-c2cc(=O)c3c(O)cc(O)c(-c4cc(-c5cc(=O)c6c(O)cc(O)cc6o5)ccc4OC)c3o2)cc1,10100.0,nM,=,CHEMBL1208903,inactive,COc1ccc(-c2cc(=O)c3c(O)cc(O)c(-c4cc(-c5cc(=O)c6c(O)cc(O)cc6o5)ccc4OC)c3o2)cc1,organic,4.995678626217358
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1cc(O)c2c(=O)cc(-c3ccc(OC)c(-c4c(O)cc(O)c5c(=O)cc(-c6ccc(O)cc6)oc45)c3)oc2c1,13200.0,nM,=,CHEMBL377324,inactive,COc1cc(O)c2c(=O)cc(-c3ccc(OC)c(-c4c(O)cc(O)c5c(=O)cc(-c6ccc(O)cc6)oc45)c3)oc2c1,organic,4.87942606879415
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1ccc(-c2cc(=O)c3c(O)cc(O)c(-c4cc(-c5cc(=O)c6c(O)cc(O)cc6o5)ccc4O)c3o2)cc1,4900.0,nM,=,CHEMBL220745,active,COc1ccc(-c2cc(=O)c3c(O)cc(O)c(-c4cc(-c5cc(=O)c6c(O)cc(O)cc6o5)ccc4O)c3o2)cc1,organic,5.309803919971486
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1ccc(-c2cc(=O)c3c(O)cc(O)cc3o2)cc1-c1c(O)cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc12,4700.0,nM,=,CHEMBL378188,active,COc1ccc(-c2cc(=O)c3c(O)cc(O)cc3o2)cc1-c1c(O)cc(O)c2c(=O)cc(-c3ccc(O)cc3)oc12,organic,5.327902142064283
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,COc1cc(O)c2c(=O)cc(-c3ccc(O)c(-c4c(O)cc(O)c5c(=O)cc(-c6ccc(O)cc6)oc45)c3)oc2c1,4900.0,nM,=,CHEMBL255493,active,COc1cc(O)c2c(=O)cc(-c3ccc(O)c(-c4c(O)cc(O)c5c(=O)cc(-c6ccc(O)cc6)oc45)c3)oc2c1,organic,5.309803919971486
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,O=c1cc(-c2ccc(O)c(-c3c(O)cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc34)c2)oc2cc(O)cc(O)c12,4800.0,nM,=,CHEMBL63354,active,O=c1cc(-c2ccc(O)c(-c3c(O)cc(O)c4c(=O)cc(-c5ccc(O)cc5)oc34)c2)oc2cc(O)cc(O)c12,organic,5.318758762624412
Inhibition of human amyloid beta (1 to 40) assessed as reduction in aggregation measured after 24 hrs by ThT fluorescence assay,IC50,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,4100.0,nM,=,CHEMBL164,active,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,organic,5.3872161432802645
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation measured after 48 hrs by ThT fluorescence assay,IC50,O=[N+]([O-])c1cccc(C2C=C(c3cccc4ccccc34)Nc3nncn32)c1,17440.0,nM,=,CHEMBL4436866,inactive,O=[N+]([O-])c1cccc(C2C=C(c3cccc4ccccc34)Nc3nncn32)c1,organic,4.758453519403451
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation measured after 48 hrs by ThT fluorescence assay,IC50,Fc1ccc(C2C=C(c3cccc4ccccc34)Nc3nncn32)cc1,3870.0,nM,=,CHEMBL4444043,active,Fc1ccc(C2C=C(c3cccc4ccccc34)Nc3nncn32)cc1,organic,5.412289034981089
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation incubated for 48 hrs by thioflavin-T fluorescence assay,IC50,O=C(CN1CCN(CC(=O)Nc2n[nH]c3ncccc23)CC1)Nc1n[nH]c2ncccc12,17890.0,nM,=,CHEMBL4444093,inactive,O=C(CN1CCN(CC(=O)Nc2n[nH]c3ncccc23)CC1)Nc1n[nH]c2ncccc12,organic,4.747389659432627
Inhibition of self-mediated amyloid beta (1 to 42) (unknown origin) aggregation incubated for 48 hrs by thioflavin-T fluorescence assay,IC50,CCOC(=O)c1cnc2ccccc2c1N1CCN(CC(=O)Nc2n[nH]c3ncccc23)CC1,15720.0,nM,=,CHEMBL4453548,inactive,CCOC(=O)c1cnc2ccccc2c1N1CCN(CC(=O)Nc2n[nH]c3ncccc23)CC1,organic,4.8035474582966105
Inhibition of beta amyloid in human SH-SY5Y cells,IC50,O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23,300000.0,nM,=,CHEMBL6246,inactive,O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23,organic,3.5228787452803374
Inhibition of beta amyloid (unknown origin) after 12 to 24 hrs,IC50,O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23,100000.0,nM,=,CHEMBL6246,inactive,O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23,organic,4.0
Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,IC50,CC(C)=CCC/C(C)=C/CCC1(C)C=Cc2c(O)cc(C)cc2O1,68000.0,nM,=,CHEMBL4645437,inactive,CC(C)=CCC/C(C)=C/CCC1(C)C=Cc2c(O)cc(C)cc2O1,organic,4.167491087293763
Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,IC50,CC(C)=CCC/C(C)=C/CC/C(C)=C/Cc1c(C)cc(O)c(O)c1O,16700.0,nM,=,CHEMBL4640668,inactive,CC(C)=CCC/C(C)=C/CC/C(C)=C/Cc1c(C)cc(O)c(O)c1O,organic,4.777283528852417
Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,IC50,CC(C)=CCC/C(C)=C/CC[C@@]1(C)C=Cc2c(cc(C)c(C(=O)O)c2O)O1,24700.0,nM,=,CHEMBL1171643,inactive,CC(C)=CCC/C(C)=C/CC[C@@]1(C)C=Cc2c(cc(C)c(C(=O)O)c2O)O1,organic,4.607303046740334
Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,IC50,CCCCCCCCCCCCCCC[C@@H](O)C(=O)N[C@@H](CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H](O)/C=C/CC/C=C(\C)CCCCCCCCC,62700.0,nM,=,CHEMBL2012313,inactive,CCCCCCCCCCCCCCC[C@@H](O)C(=O)N[C@@H](CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H](O)/C=C/CC/C=C(\C)CCCCCCCCC,organic,4.202732459169283
Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,IC50,COC(=O)c1c(C)cc(O)c(C/C=C(\C)CC/C=C(\C)CCC=C(C)C)c1O,221000.0,nM,=,CHEMBL4643713,inactive,COC(=O)c1c(C)cc(O)c(C/C=C(\C)CC/C=C(\C)CCC=C(C)C)c1O,organic,3.6556077263148894
Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,IC50,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,7400.0,nM,=,CHEMBL164,active,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,organic,5.130768280269024
Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,IC50,COc1c(O)c(O)cc(C)c1C/C=C(\C)CC/C=C(\C)CCC=C(C)C,29300.0,nM,=,CHEMBL4646459,inactive,COc1c(O)c(O)cc(C)c1C/C=C(\C)CC/C=C(\C)CCC=C(C)C,organic,4.533132379645891
Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,IC50,CC(C)=CC(=O)C/C(C)=C/CC/C(C)=C/Cc1c(O)cc(C)c(C(=O)O)c1O,150800.0,nM,=,CHEMBL4644047,inactive,CC(C)=CC(=O)C/C(C)=C/CC/C(C)=C/Cc1c(O)cc(C)c(C(=O)O)c1O,organic,3.821598658466245
Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,IC50,COc1c(O)c(O)c(-c2c(C)c(C/C=C(\C)CC/C=C(\C)CCC=C(C)C)c(OC)c(O)c2O)c(C)c1C/C=C(\C)CC/C=C(\C)CCC=C(C)C,12300.0,nM,=,CHEMBL4638539,inactive,COc1c(O)c(O)c(-c2c(C)c(C/C=C(\C)CC/C=C(\C)CCC=C(C)C)c(OC)c(O)c2O)c(C)c1C/C=C(\C)CC/C=C(\C)CCC=C(C)C,organic,4.910094888560602
Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,IC50,CC(C)=CCC/C(C)=C/CC/C(C)=C/Cc1c(O)cc(C)cc1O,148800.0,nM,=,CHEMBL487804,inactive,CC(C)=CCC/C(C)=C/CC/C(C)=C/Cc1c(O)cc(C)cc1O,organic,3.82739706879014
Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,IC50,CC(C)=CCC/C(C)=C/CC/C(C)=C/Cc1c(O)cc(C)c(C(=O)O)c1O,20300.0,nM,=,CHEMBL513978,inactive,CC(C)=CCC/C(C)=C/CC/C(C)=C/Cc1c(O)cc(C)c(C(=O)O)c1O,organic,4.692503962086787
Inhibition of human amyloid beta (1 to 40) aggregation after 24 hrs by ThT fluorescence assay,IC50,CC(C)=CCC/C(C)=C/CC/C(C)=C/Cc1c(C)cc(O)cc1O,19900.0,nM,=,CHEMBL4641877,inactive,CC(C)=CCC/C(C)=C/CC/C(C)=C/Cc1c(C)cc(O)cc1O,organic,4.701146923590294
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation after 24 hrs by thioflavin-T fluorescence method,IC50,O=C(NO)c1ccc(Nc2c3ccccc3nc3ccccc23)cc1,3000.0,nM,=,CHEMBL4762873,active,O=C(NO)c1ccc(Nc2c3ccccc3nc3ccccc23)cc1,organic,5.522878745280337
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation after 24 hrs by thioflavin-T fluorescence method,IC50,O=C(NO)c1ccc(Nc2c3ccccc3nc3ccc(Br)cc23)cc1,1100.0,nM,=,CHEMBL4796066,active,O=C(NO)c1ccc(Nc2c3ccccc3nc3ccc(Br)cc23)cc1,organic,5.958607314841775
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation after 24 hrs by thioflavin-T fluorescence method,IC50,O=C(NO)c1ccc(Nc2c3ccccc3nc3ccc(OC(F)(F)F)cc23)cc1,3500.0,nM,=,CHEMBL4751082,active,O=C(NO)c1ccc(Nc2c3ccccc3nc3ccc(OC(F)(F)F)cc23)cc1,organic,5.455931955649724
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation after 24 hrs by thioflavin-T fluorescence method,IC50,O=C(NO)c1ccc(Nc2c3ccccc3nc3ccc(OCc4ccccc4)cc23)cc1,3000.0,nM,=,CHEMBL4761847,active,O=C(NO)c1ccc(Nc2c3ccccc3nc3ccc(OCc4ccccc4)cc23)cc1,organic,5.522878745280337
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation after 24 hrs by thioflavin-T fluorescence method,IC50,COc1cc2nc3ccccc3c(Nc3ccc(C(=O)NO)cc3)c2c(OC)c1OC,13000.0,nM,=,CHEMBL4753795,inactive,COc1cc2nc3ccccc3c(Nc3ccc(C(=O)NO)cc3)c2c(OC)c1OC,organic,4.886056647693163
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation after 24 hrs by thioflavin-T fluorescence method,IC50,COc1ccc2nc3cc(Cl)ccc3c(Nc3ccc(C(=O)NO)cc3)c2n1,34900.0,nM,=,CHEMBL4750838,inactive,COc1ccc2nc3cc(Cl)ccc3c(Nc3ccc(C(=O)NO)cc3)c2n1,organic,4.45717457304082
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation after 24 hrs by thioflavin-T fluorescence method,IC50,O=c1c(O)c(-c2ccc(O)cc2O)oc2cc(O)cc(O)c12,8500.0,nM,=,CHEMBL28626,active,O=c1c(O)c(-c2ccc(O)cc2O)oc2cc(O)cc(O)c12,organic,5.070581074285707
Inhibition of amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs to 7 days by thioflavin S based fluorescence assay,IC50,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C=O)C(C)(C)CCC1,180.0,nM,=,CHEMBL81379,active,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C=O)C(C)(C)CCC1,organic,6.7447274948966935
Inhibition of amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs to 7 days by thioflavin S based fluorescence assay,IC50,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/CO)C(C)(C)CCC1,180.0,nM,=,CHEMBL986,active,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/CO)C(C)(C)CCC1,organic,6.7447274948966935
Inhibition of amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs to 7 days by thioflavin S based fluorescence assay,IC50,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)CCCC2(C)C)CCCC1,180.0,nM,=,CHEMBL4787961,active,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C)CCCC2(C)C)CCCC1,organic,6.7447274948966935
Inhibition of amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs to 7 days by thioflavin S based fluorescence assay,IC50,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1,180.0,nM,=,CHEMBL38,active,CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1,organic,6.7447274948966935
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation incubated for 48 hrs by thioflavin-T fluorescence method,IC50,O=C(CCN1CCC2c3ccccc3NC2C1)Oc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1,19710.0,nM,=,CHEMBL4755968,inactive,O=C(CCN1CCC2c3ccccc3NC2C1)Oc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1,organic,4.705313375720556
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation incubated for 48 hrs by thioflavin-T fluorescence method,IC50,O=C(CCCCN1CCC2c3ccccc3NC2C1)Oc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1,2050.0,nM,=,CHEMBL4791642,active,O=C(CCCCN1CCC2c3ccccc3NC2C1)Oc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1,organic,5.688246138944246
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation incubated for 48 hrs by thioflavin-T fluorescence method,IC50,O=C(CCCCCN1CCC2c3ccccc3NC2C1)Oc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1,15120.0,nM,=,CHEMBL4750451,inactive,O=C(CCCCCN1CCC2c3ccccc3NC2C1)Oc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1,organic,4.820448208834812
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation incubated for 48 hrs by thioflavin-T fluorescence method,IC50,O=C(CCCCCN1CCC2c3ccccc3NC2C1)Nc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1,18300.0,nM,=,CHEMBL4763981,inactive,O=C(CCCCCN1CCC2c3ccccc3NC2C1)Nc1ccc(/C=C2\CCn3c2nc2ccccc2c3=O)cc1,organic,4.73754891026957
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation incubated for 48 hrs by thioflavin-T fluorescence method,IC50,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,13430.0,nM,=,CHEMBL165,inactive,Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1,organic,4.871923987331285
Inhibition of amyloid beta (1 to 42) (unknown origin) self aggregation incubated for 48 hrs by thioflavin-T fluorescence method,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,16250.0,nM,=,CHEMBL140,inactive,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,organic,4.789146634685107
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by ThT fluorescence assay,IC50,O=c1cc(/C=C/c2nc3ccccc3o2)occ1O,7050.0,nM,=,CHEMBL4755924,active,O=c1cc(/C=C/c2nc3ccccc3o2)occ1O,organic,5.151810883008602
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by ThT fluorescence assay,IC50,O=c1cc(/C=C/c2nc3ccc(O)cc3s2)occ1O,5060.0,nM,=,CHEMBL4744947,active,O=c1cc(/C=C/c2nc3ccc(O)cc3s2)occ1O,organic,5.295849483160201
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation incubated for 24 hrs by ThT fluorescence assay,IC50,C#CCN(C)CCCn1ccc(=O)c(O)c1C,2850.0,nM,=,CHEMBL4740154,active,C#CCN(C)CCCn1ccc(=O)c(O)c1C,organic,5.54515513999149
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,O=C(Nc1ccc2nc3n(c(=O)c2c1)CCC3)c1cc2ccccc2[nH]1,2160.0,nM,=,CHEMBL4874567,active,O=C(Nc1ccc2nc3n(c(=O)c2c1)CCC3)c1cc2ccccc2[nH]1,organic,5.665546248849069
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,COc1ccc2[nH]c(C(=O)Nc3ccc4nc5n(c(=O)c4c3)CCC5)cc2c1,1210.0,nM,=,CHEMBL4861956,active,COc1ccc2[nH]c(C(=O)Nc3ccc4nc5n(c(=O)c4c3)CCC5)cc2c1,organic,5.91721462968355
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,O=C(Nc1ccc2nc3n(c(=O)c2c1)CCC3)c1cc2cc(F)ccc2[nH]1,1560.0,nM,=,CHEMBL4854341,active,O=C(Nc1ccc2nc3n(c(=O)c2c1)CCC3)c1cc2cc(F)ccc2[nH]1,organic,5.806875401645538
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,O=C(Nc1ccc2nc3n(c(=O)c2c1)CCC3)c1cc2cc(Cl)ccc2[nH]1,1690.0,nM,=,CHEMBL4871461,active,O=C(Nc1ccc2nc3n(c(=O)c2c1)CCC3)c1cc2cc(Cl)ccc2[nH]1,organic,5.772113295386326
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,O=C(Nc1ccc2nc3n(c(=O)c2c1)CCC3)c1cc2ccccc2o1,3260.0,nM,=,CHEMBL4864253,active,O=C(Nc1ccc2nc3n(c(=O)c2c1)CCC3)c1cc2ccccc2o1,organic,5.486782399932061
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,O=C(Nc1ccc2nc3n(c(=O)c2c1)CCC3)c1cc2ccccc2s1,2300.0,nM,=,CHEMBL4871713,active,O=C(Nc1ccc2nc3n(c(=O)c2c1)CCC3)c1cc2ccccc2s1,organic,5.638272163982407
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,O=C(Cc1cc2ccccc2[nH]1)Nc1ccc2nc3n(c(=O)c2c1)CCC3,1620.0,nM,=,CHEMBL4878452,active,O=C(Cc1cc2ccccc2[nH]1)Nc1ccc2nc3n(c(=O)c2c1)CCC3,organic,5.790484985457369
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,O=C(/C=C/c1cc2ccccc2[nH]1)Nc1ccc2nc3n(c(=O)c2c1)CCC3,3090.0,nM,=,CHEMBL4853181,active,O=C(/C=C/c1cc2ccccc2[nH]1)Nc1ccc2nc3n(c(=O)c2c1)CCC3,organic,5.510041520575165
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,O=C(CCCc1cc2ccccc2[nH]1)Nc1ccc2nc3n(c(=O)c2c1)CCC3,5270.0,nM,=,CHEMBL4870177,active,O=C(CCCc1cc2ccccc2[nH]1)Nc1ccc2nc3n(c(=O)c2c1)CCC3,organic,5.278189384787454
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,COc1ccc2[nH]c(C(=O)Nc3cc4c(=O)n5c(nc4cc3C)CCC5)cc2c1,6100.0,nM,=,CHEMBL4861631,active,COc1ccc2[nH]c(C(=O)Nc3cc4c(=O)n5c(nc4cc3C)CCC5)cc2c1,organic,5.214670164989233
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,Cc1cc2nc3n(c(=O)c2cc1NC(=O)c1cc2cc(F)ccc2[nH]1)CCC3,3270.0,nM,=,CHEMBL4856921,active,Cc1cc2nc3n(c(=O)c2cc1NC(=O)c1cc2cc(F)ccc2[nH]1)CCC3,organic,5.485452247339714
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,Cc1cc2nc3n(c(=O)c2cc1NC(=O)c1cc2cc(Cl)ccc2[nH]1)CCC3,5100.0,nM,=,CHEMBL4854859,active,Cc1cc2nc3n(c(=O)c2cc1NC(=O)c1cc2cc(Cl)ccc2[nH]1)CCC3,organic,5.292429823902063
Inhibition of self-induced amyloid beta(1 to 42) (unknown origin) aggregation by thioflavin-T fluorescence assay,IC50,Oc1c(I)cc(Cl)c2cccnc12,9800.0,nM,=,CHEMBL497,active,Oc1c(I)cc(Cl)c2cccnc12,organic,5.008773924307505
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)O)ccc1O,226230.0,nM,=,CHEMBL32749,inactive,COc1cc(/C=C/C(=O)O)ccc1O,organic,3.645449804492118
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N(C)C)ccc1OCc1ccccc1,24600.0,nM,=,CHEMBL4864402,inactive,COc1cc(/C=C/C(=O)N(C)C)ccc1OCc1ccccc1,organic,4.609064892896621
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,CCN(CC)C(=O)/C=C/c1ccc(OCc2ccccc2)c(OC)c1,39270.0,nM,=,CHEMBL4860315,inactive,CCN(CC)C(=O)/C=C/c1ccc(OCc2ccccc2)c(OC)c1,organic,4.405939098729582
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,CCN(CC)C(=O)CCc1ccc(OCc2ccccc2)c(OC)c1,34930.0,nM,=,CHEMBL4848839,inactive,CCN(CC)C(=O)CCc1ccc(OCc2ccccc2)c(OC)c1,organic,4.456801414362353
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,CCN(CC)C(=O)/C=C/c1ccc(O)c(O)c1,119160.0,nM,=,CHEMBL68672,inactive,CCN(CC)C(=O)/C=C/c1ccc(O)c(O)c1,organic,3.923869505456994
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,CCCN(CCC)C(=O)/C=C/c1ccc(OCc2ccccc2)c(OC)c1,12380.0,nM,=,CHEMBL4876981,inactive,CCCN(CCC)C(=O)/C=C/c1ccc(OCc2ccccc2)c(OC)c1,organic,4.907279355315901
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N(C)OC)ccc1OCc1ccccc1,79870.0,nM,=,CHEMBL4878181,inactive,COc1cc(/C=C/C(=O)N(C)OC)ccc1OCc1ccccc1,organic,4.097616315567529
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CC(F)(F)C2)ccc1OCc1ccccc1,106820.0,nM,=,CHEMBL4847323,inactive,COc1cc(/C=C/C(=O)N2CC(F)(F)C2)ccc1OCc1ccccc1,organic,3.9713474263668815
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CCCC2)ccc1OCc1ccccc1,65090.0,nM,=,CHEMBL4849442,inactive,COc1cc(/C=C/C(=O)N2CCCC2)ccc1OCc1ccccc1,organic,4.186485728458117
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CCCCC2)ccc1OCc1ccccc1,27940.0,nM,=,CHEMBL4862182,inactive,COc1cc(/C=C/C(=O)N2CCCCC2)ccc1OCc1ccccc1,organic,4.553773598221837
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,3850.0,nM,=,CHEMBL140,active,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,organic,5.414539270491499
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/CN2CCCCC2)ccc1OCc1ccccc1,10640.0,nM,=,CHEMBL4846673,inactive,COc1cc(/C=C/CN2CCCCC2)ccc1OCc1ccccc1,organic,4.9730583720409705
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc([C@H]2C[C@@H]2C(=O)N2CCCCC2)ccc1OCc1ccccc1,18650.0,nM,=,CHEMBL4873786,inactive,COc1cc([C@H]2C[C@@H]2C(=O)N2CCCCC2)ccc1OCc1ccccc1,organic,4.729321163855293
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc([C@H]2C[C@@H]2C(=O)N(C)C)ccc1OCc1ccccc1,45780.0,nM,=,CHEMBL4867164,inactive,COc1cc([C@H]2C[C@@H]2C(=O)N(C)C)ccc1OCc1ccccc1,organic,4.339324211661475
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CCOCC2)ccc1OCc1ccccc1,78070.0,nM,=,CHEMBL1511811,inactive,COc1cc(/C=C/C(=O)N2CCOCC2)ccc1OCc1ccccc1,organic,4.107515820635312
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CCC[C@H]2C(=O)N2CCCCC2)ccc1OCc1ccccc1,17080.0,nM,=,CHEMBL4846812,inactive,COc1cc(/C=C/C(=O)N2CCC[C@H]2C(=O)N2CCCCC2)ccc1OCc1ccccc1,organic,4.767512133647013
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CCC[C@H]2C(=O)NCc2ccccc2)ccc1OCc1ccccc1,18720.0,nM,=,CHEMBL4878858,inactive,COc1cc(/C=C/C(=O)N2CCC[C@H]2C(=O)NCc2ccccc2)ccc1OCc1ccccc1,organic,4.727694155597914
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CCC[C@@H]2C(=O)NCc2ccccc2)ccc1OCc1ccccc1,17750.0,nM,=,CHEMBL4868950,inactive,COc1cc(/C=C/C(=O)N2CCC[C@@H]2C(=O)NCc2ccccc2)ccc1OCc1ccccc1,organic,4.750801642608887
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1ccc(CNC(=O)[C@@H]2CCCN2C(=O)/C=C/c2ccc(OCc3ccccc3)c(OC)c2)cc1,19240.0,nM,=,CHEMBL4856483,inactive,COc1ccc(CNC(=O)[C@@H]2CCCN2C(=O)/C=C/c2ccc(OCc3ccccc3)c(OC)c2)cc1,organic,4.715794932298206
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CCC[C@@H]2C(=O)NCCOc2ccccc2)ccc1OCc1ccccc1,16830.0,nM,=,CHEMBL4877271,inactive,COc1cc(/C=C/C(=O)N2CCC[C@@H]2C(=O)NCCOc2ccccc2)ccc1OCc1ccccc1,organic,4.773915884024176
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CCC[C@H]2C(=O)NCCOc2ccccc2)ccc1OCc1ccccc1,8590.0,nM,=,CHEMBL4877129,active,COc1cc(/C=C/C(=O)N2CCC[C@H]2C(=O)NCCOc2ccccc2)ccc1OCc1ccccc1,organic,5.066006836168758
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,CCN(CC)C(=O)C1CN(C(=O)/C=C/c2ccc(OCc3ccccc3)c(OC)c2)C1,12780.0,nM,=,CHEMBL4877193,inactive,CCN(CC)C(=O)C1CN(C(=O)/C=C/c2ccc(OCc3ccccc3)c(OC)c2)C1,organic,4.893469146177619
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CC(C(=O)N3CC(F)(F)C3)C2)ccc1OCc1ccccc1,21830.0,nM,=,CHEMBL4876605,inactive,COc1cc(/C=C/C(=O)N2CC(C(=O)N3CC(F)(F)C3)C2)ccc1OCc1ccccc1,organic,4.66094626429086
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CC(C(=O)N3CCCCC3)C2)ccc1OCc1ccccc1,10550.0,nM,=,CHEMBL4868565,inactive,COc1cc(/C=C/C(=O)N2CC(C(=O)N3CCCCC3)C2)ccc1OCc1ccccc1,organic,4.976747540366288
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CC(C(=O)N3CCOCC3)C2)ccc1OCc1ccccc1,35670.0,nM,=,CHEMBL4874507,inactive,COc1cc(/C=C/C(=O)N2CC(C(=O)N3CCOCC3)C2)ccc1OCc1ccccc1,organic,4.447696890661646
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CC(C(=O)NCc3ccccc3)C2)ccc1OCc1ccccc1,3130.0,nM,=,CHEMBL4850421,active,COc1cc(/C=C/C(=O)N2CC(C(=O)NCc3ccccc3)C2)ccc1OCc1ccccc1,organic,5.504455662453552
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)NCCC(=O)N2CCCCC2)ccc1OCc1ccccc1,8170.0,nM,=,CHEMBL4872439,active,COc1cc(/C=C/C(=O)NCCC(=O)N2CCCCC2)ccc1OCc1ccccc1,organic,5.087777943467585
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)NCCC(=O)NCc2ccccc2)ccc1OCc1ccccc1,81560.0,nM,=,CHEMBL4869616,inactive,COc1cc(/C=C/C(=O)NCCC(=O)NCc2ccccc2)ccc1OCc1ccccc1,organic,4.0885227828938975
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CC(C(=O)NCc3ccc(F)cc3)C2)ccc1OCc1ccccc1,3350.0,nM,=,CHEMBL4849121,active,COc1cc(/C=C/C(=O)N2CC(C(=O)NCc3ccc(F)cc3)C2)ccc1OCc1ccccc1,organic,5.474955192963154
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1ccc(CNC(=O)C2CN(C(=O)/C=C/c3ccc(OCc4ccccc4)c(OC)c3)C2)cc1,4780.0,nM,=,CHEMBL4863966,active,COc1ccc(CNC(=O)C2CN(C(=O)/C=C/c3ccc(OCc4ccccc4)c(OC)c3)C2)cc1,organic,5.320572103387881
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CC(C(=O)NCc3ccco3)C2)ccc1OCc1ccccc1,3610.0,nM,=,CHEMBL4859895,active,COc1cc(/C=C/C(=O)N2CC(C(=O)NCc3ccco3)C2)ccc1OCc1ccccc1,organic,5.442492798094342
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)N2CC(C(=O)NCCOc3ccccc3)C2)ccc1OCc1ccccc1,1800.0,nM,=,CHEMBL4863296,active,COc1cc(/C=C/C(=O)N2CC(C(=O)NCCOc3ccccc3)C2)ccc1OCc1ccccc1,organic,5.7447274948966935
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1ccc(CNC(=O)CCNC(=O)/C=C/c2ccc(OCc3ccccc3)c(OC)c2)cc1,54210.0,nM,=,CHEMBL4876813,inactive,COc1ccc(CNC(=O)CCNC(=O)/C=C/c2ccc(OCc3ccccc3)c(OC)c2)cc1,organic,4.2659205927194055
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)NCCC(=O)NCCOc2ccccc2)ccc1OCc1ccccc1,17910.0,nM,=,CHEMBL4863014,inactive,COc1cc(/C=C/C(=O)NCCC(=O)NCCOc2ccccc2)ccc1OCc1ccccc1,organic,4.746904414150968
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(/C=C/C(=O)Nc2nnn[nH]2)ccc1OCc1ccccc1,98460.0,nM,=,CHEMBL4846539,inactive,COc1cc(/C=C/C(=O)Nc2nnn[nH]2)ccc1OCc1ccccc1,organic,4.0067401685632635
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(-c2cncn2CCC(=O)NCCOc2ccccc2)ccc1OCc1ccccc1,7760.0,nM,=,CHEMBL4872213,active,COc1cc(-c2cncn2CCC(=O)NCCOc2ccccc2)ccc1OCc1ccccc1,organic,5.110138278741812
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,COc1cc(-c2cncn2CCC(=O)NCCc2ccccc2)ccc1OCc1ccccc1,9910.0,nM,=,CHEMBL4845958,active,COc1cc(-c2cncn2CCC(=O)NCCc2ccccc2)ccc1OCc1ccccc1,organic,5.003926345514724
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,CCN(CC)C(=O)/C=C/c1ccc(O)c(OC)c1,205460.0,nM,=,CHEMBL4458591,inactive,CCN(CC)C(=O)/C=C/c1ccc(O)c(OC)c1,organic,3.687272716221876
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,CCN(CC)C(=O)/C=C/c1ccc(OS(=O)(=O)c2ccc(C)cc2)c(OC)c1,10640.0,nM,=,CHEMBL4865997,inactive,CCN(CC)C(=O)/C=C/c1ccc(OS(=O)(=O)c2ccc(C)cc2)c(OC)c1,organic,4.9730583720409705
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,CCCN(CCC)C(=O)/C=C/c1ccc(O)c(OC)c1,98790.0,nM,=,CHEMBL4850411,inactive,CCCN(CCC)C(=O)/C=C/c1ccc(O)c(OC)c1,organic,4.00528701456843
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization assessed as decrease in oligomer abundance measured after 1 hr by ELISA,IC50,CCCN(CCC)C(=O)/C=C/c1ccc(OC)c(OC)c1,45310.0,nM,=,CHEMBL4873939,inactive,CCCN(CCC)C(=O)/C=C/c1ccc(OC)c(OC)c1,organic,4.3438059378208145
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,O=c1cc(/C=C/c2ccc(OCCCN3CCCC3)cc2)occ1O,2240.0,nM,=,CHEMBL4868743,active,O=c1cc(/C=C/c2ccc(OCCCN3CCCC3)cc2)occ1O,organic,5.649751981665837
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,O=c1cc(/C=C/c2ccc(OCCCN3CCCCC3)cc2)occ1O,3260.0,nM,=,CHEMBL4852639,active,O=c1cc(/C=C/c2ccc(OCCCN3CCCCC3)cc2)occ1O,organic,5.486782399932061
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,O=c1cc(/C=C/c2ccc(OCCCN3CCOCC3)cc2)occ1O,4120.0,nM,=,CHEMBL4862604,active,O=c1cc(/C=C/c2ccc(OCCCN3CCOCC3)cc2)occ1O,organic,5.3851027839668655
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,CN1CCN(CCCOc2ccc(/C=C/c3cc(=O)c(O)co3)cc2)CC1,5540.0,nM,=,CHEMBL4876778,active,CN1CCN(CCCOc2ccc(/C=C/c3cc(=O)c(O)co3)cc2)CC1,organic,5.2564902352715706
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,CCN(CC)CCCOc1ccc(/C=C/c2cc(=O)c(O)co2)cc1,3950.0,nM,=,CHEMBL4857779,active,CCN(CC)CCCOc1ccc(/C=C/c2cc(=O)c(O)co2)cc1,organic,5.403402904373539
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,CN(C)CCCOc1ccc(/C=C/c2cc(=O)c(O)co2)cc1,4510.0,nM,=,CHEMBL4848375,active,CN(C)CCCOc1ccc(/C=C/c2cc(=O)c(O)co2)cc1,organic,5.345823458122039
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,Cc1oc(/C=C/c2ccc(OCCCN3CCCC3)cc2)cc(=O)c1O,7010.0,nM,=,CHEMBL4870117,active,Cc1oc(/C=C/c2ccc(OCCCN3CCCC3)cc2)cc(=O)c1O,organic,5.154281982033341
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,Cc1oc(/C=C/c2ccc(OCCCN3CCCCC3)cc2)cc(=O)c1O,6260.0,nM,=,CHEMBL4859825,active,Cc1oc(/C=C/c2ccc(OCCCN3CCCCC3)cc2)cc(=O)c1O,organic,5.20342566678957
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,Cn1cc(O)c(=O)cc1/C=C/c1ccc(OCCCN2CCCC2)cc1,3290.0,nM,=,CHEMBL4856094,active,Cn1cc(O)c(=O)cc1/C=C/c1ccc(OCCCN2CCCC2)cc1,organic,5.482804102050026
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,Cn1cc(O)c(=O)cc1/C=C/c1ccc(OCCCN2CCCCC2)cc1,2570.0,nM,=,CHEMBL4846443,active,Cn1cc(O)c(=O)cc1/C=C/c1ccc(OCCCN2CCCCC2)cc1,organic,5.590066876668706
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,Cn1cc(O)c(=O)cc1/C=C/c1ccc(OCCCN2CCOCC2)cc1,5320.0,nM,=,CHEMBL4872910,active,Cn1cc(O)c(=O)cc1/C=C/c1ccc(OCCCN2CCOCC2)cc1,organic,5.274088367704952
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,CN1CCN(CCCOc2ccc(/C=C/c3cc(=O)c(O)cn3C)cc2)CC1,6020.0,nM,=,CHEMBL4848524,active,CN1CCN(CCCOc2ccc(/C=C/c3cc(=O)c(O)cn3C)cc2)CC1,organic,5.220403508742176
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,CCN(CC)CCCOc1ccc(/C=C/c2cc(=O)c(O)cn2C)cc1,5380.0,nM,=,CHEMBL4853496,active,CCN(CC)CCCOc1ccc(/C=C/c2cc(=O)c(O)cn2C)cc1,organic,5.269217724333611
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,CN(C)CCCOc1ccc(/C=C/c2cc(=O)c(O)cn2C)cc1,6180.0,nM,=,CHEMBL4852674,active,CN(C)CCCOc1ccc(/C=C/c2cc(=O)c(O)cn2C)cc1,organic,5.209011524911184
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,CCn1cc(O)c(=O)cc1/C=C/c1ccc(OCCCN2CCCC2)cc1,2070.0,nM,=,CHEMBL4876429,active,CCn1cc(O)c(=O)cc1/C=C/c1ccc(OCCCN2CCCC2)cc1,organic,5.684029654543083
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,CCn1cc(O)c(=O)cc1/C=C/c1ccc(OCCCN2CCCCC2)cc1,3050.0,nM,=,CHEMBL4878762,active,CCn1cc(O)c(=O)cc1/C=C/c1ccc(OCCCN2CCCCC2)cc1,organic,5.515700160653214
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,O=c1cc(/C=C/c2ccc(O)cc2)occ1O,7120.0,nM,=,CHEMBL4287929,active,O=c1cc(/C=C/c2ccc(O)cc2)occ1O,organic,5.147520006363144
Inhibition of amyloid beta (1 to 42) (unknown origin) self-induced aggregation incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,8270.0,nM,=,CHEMBL140,active,COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O,organic,5.082494490447453
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,IC50,CCN(CCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1OC,3560.0,nM,=,CHEMBL4863690,active,CCN(CCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1OC,organic,5.448550002027125
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,IC50,CCN(CCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1OC,1480.0,nM,=,CHEMBL4873761,active,CCN(CCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1OC,organic,5.8297382846050425
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,IC50,CCN(CCCCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1OC,1490.0,nM,=,CHEMBL4854597,active,CCN(CCCCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1OC,organic,5.826813731587726
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,IC50,CCN(CCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1N(C)C,1270.0,nM,=,CHEMBL4861145,active,CCN(CCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1N(C)C,organic,5.896196279044043
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,IC50,CCN(CCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1N(C)C,880.0,nM,=,CHEMBL4865817,active,CCN(CCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1N(C)C,organic,6.055517327849832
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,IC50,CCN(CCCCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1N(C)C,1030.0,nM,=,CHEMBL4876641,active,CCN(CCCCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1N(C)C,organic,5.987162775294828
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,IC50,CCN(CCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccc(N(C)C)cc1,1320.0,nM,=,CHEMBL4857021,active,CCN(CCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccc(N(C)C)cc1,organic,5.87942606879415
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,IC50,CCN(CCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccc(N(C)C)cc1,2100.0,nM,=,CHEMBL4858987,active,CCN(CCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccc(N(C)C)cc1,organic,5.6777807052660805
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,IC50,CCN(CCCCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccc(N(C)C)cc1,1380.0,nM,=,CHEMBL4874405,active,CCN(CCCCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccc(N(C)C)cc1,organic,5.860120913598763
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,IC50,CCN(CCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1,1680.0,nM,=,CHEMBL4854252,active,CCN(CCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1,organic,5.774690718274137
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,IC50,CCN(CCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1,3780.0,nM,=,CHEMBL4850978,active,CCN(CCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1,organic,5.422508200162775
Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation by T-fluorescence assay relative to control,IC50,CCN(CCCCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1,3170.0,nM,=,CHEMBL4872327,active,CCN(CCCCCCOc1ccc(C(=O)/C=C/c2ccc(N(C)C)cc2)c(O)c1)Cc1ccccc1,organic,5.498940737782249
Inhibition of amyloid beta (1 to 42 ) (unknown origin) self aggregation measured after 24 hrs by thioflavin-T fluorescence method,IC50,Cc1ccc(-n2cc(C(=O)Nc3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)nn2)cc1C,4600.0,nM,=,CHEMBL4878996,active,Cc1ccc(-n2cc(C(=O)Nc3ccc(C(O)(C(F)(F)F)C(F)(F)F)cc3)nn2)cc1C,organic,5.337242168318426
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CNS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,53010.0,nM,=,CHEMBL4850080,inactive,CNS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,organic,4.275642195773574
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CC(O)c1ccc(CNS(=O)(=O)c2cc(C(=O)O)c(NCc3ccco3)cc2Cl)cc1,68500.0,nM,=,CHEMBL4860892,inactive,CC(O)c1ccc(CNS(=O)(=O)c2cc(C(=O)O)c(NCc3ccco3)cc2Cl)cc1,organic,4.164309428507575
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,O=C(O)c1cc(S(=O)(=O)N2CCOCC2)c(Cl)cc1NCc1ccco1,41160.0,nM,=,CHEMBL4879194,inactive,O=C(O)c1cc(S(=O)(=O)N2CCOCC2)c(Cl)cc1NCc1ccco1,organic,4.385524633909605
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CN(Cc1ccccc1)S(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,21920.0,nM,=,CHEMBL4861569,inactive,CN(Cc1ccccc1)S(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,organic,4.659159450187668
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CC(NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl)c1ccccc1,41150.0,nM,=,CHEMBL4871443,inactive,CC(NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl)c1ccccc1,organic,4.385630160451711
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CCNS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,137390.0,nM,=,CHEMBL4877793,inactive,CCNS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,organic,3.8620448764676394
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CN(C)S(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,113130.0,nM,=,CHEMBL4846727,inactive,CN(C)S(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,organic,3.9464222128747175
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CCCCCCNS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,47810.0,nM,=,CHEMBL4848103,inactive,CCCCCCNS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl,organic,4.320481256304211
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,O=C(O)c1cc(S(=O)(=O)Nc2ccccc2)c(Cl)cc1NCc1ccco1,167530.0,nM,=,CHEMBL4852897,inactive,O=C(O)c1cc(S(=O)(=O)Nc2ccccc2)c(Cl)cc1NCc1ccco1,organic,3.7759074115057323
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,O=C(O)c1cc(S(=O)(=O)NC2CCCCC2)c(Cl)cc1NCc1ccco1,115520.0,nM,=,CHEMBL4848555,inactive,O=C(O)c1cc(S(=O)(=O)NC2CCCCC2)c(Cl)cc1NCc1ccco1,organic,3.937342819774436
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CNS(=O)(=O)c1cc(C(=O)O)c(NCC2CCCO2)cc1Cl,136390.0,nM,=,CHEMBL4867846,inactive,CNS(=O)(=O)c1cc(C(=O)O)c(NCC2CCCO2)cc1Cl,organic,3.8652174706181444
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CNS(=O)(=O)c1cc(CO)c(NCc2ccco2)cc1Cl,117490.0,nM,=,CHEMBL4850077,inactive,CNS(=O)(=O)c1cc(CO)c(NCc2ccco2)cc1Cl,organic,3.9299990961976548
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CNS(=O)(=O)c1cc(C(=O)OC)c(NCc2ccco2)cc1Cl,55950.0,nM,=,CHEMBL4851224,inactive,CNS(=O)(=O)c1cc(C(=O)OC)c(NCc2ccco2)cc1Cl,organic,4.252199909135631
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CNS(=O)(=O)c1cc(C(N)=O)c(NCc2ccco2)cc1Cl,82410.0,nM,=,CHEMBL4863425,inactive,CNS(=O)(=O)c1cc(C(N)=O)c(NCc2ccco2)cc1Cl,organic,4.084020085859776
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CNC(=O)c1cc(S(=O)(=O)NC)c(Cl)cc1NCc1ccco1,102590.0,nM,=,CHEMBL4850840,inactive,CNC(=O)c1cc(S(=O)(=O)NC)c(Cl)cc1NCc1ccco1,organic,3.98889497018402
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CNS(=O)(=O)c1cc(C(=O)N(C)C)c(NCc2ccco2)cc1Cl,6560.0,nM,=,CHEMBL4870723,active,CNS(=O)(=O)c1cc(C(=O)N(C)C)c(NCc2ccco2)cc1Cl,organic,5.1830961606243395
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,CNS(=O)(=O)c1cc(-c2nnn[nH]2)c(NCc2ccco2)cc1Cl,70480.0,nM,=,CHEMBL4874275,inactive,CNS(=O)(=O)c1cc(-c2nnn[nH]2)c(NCc2ccco2)cc1Cl,organic,4.151934104596008
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,O=C(O)c1ccc(F)cc1NCc1ccco1,129540.0,nM,=,CHEMBL4864237,inactive,O=C(O)c1ccc(F)cc1NCc1ccco1,organic,3.8875961072821257
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,O=C(O)c1ccc(Br)cc1NCc1ccco1,154420.0,nM,=,CHEMBL4858866,inactive,O=C(O)c1ccc(Br)cc1NCc1ccco1,organic,3.8112964518815713
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,OC(c1ccc(F)cc1NCc1ccco1)C(F)(F)F,153050.0,nM,=,CHEMBL4858198,inactive,OC(c1ccc(F)cc1NCc1ccco1)C(F)(F)F,organic,3.8151666660666463
Inhibition of human biotinylated amyloid beta (1 to 42) oligomerization measured after 1 hr by ELISA,IC50,COc1ccc(C(O)C(F)(F)F)c(NCc2cscn2)c1,129690.0,nM,=,CHEMBL4848389,inactive,COc1ccc(C(O)C(F)(F)F)c(NCc2cscn2)c1,organic,3.887093509746686
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,O=c1c2cc(NCc3ccccc3O)ccc2nc2n1CCC2,4690.0,nM,=,CHEMBL4846102,active,O=c1c2cc(NCc3ccccc3O)ccc2nc2n1CCC2,organic,5.328827157284917
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,O=c1c2cc(NCc3cccc(Br)c3O)ccc2nc2n1CCC2,8340.0,nM,=,CHEMBL4871074,active,O=c1c2cc(NCc3cccc(Br)c3O)ccc2nc2n1CCC2,organic,5.078833949362261
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,O=c1c2cc(NCc3ccc(Cl)cc3O)ccc2nc2n1CCC2,7020.0,nM,=,CHEMBL4876164,active,O=c1c2cc(NCc3ccc(Cl)cc3O)ccc2nc2n1CCC2,organic,5.153662887870195
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,COc1cccc(CNc2ccc3nc4n(c(=O)c3c2)CCC4)c1O,4200.0,nM,=,CHEMBL4874834,active,COc1cccc(CNc2ccc3nc4n(c(=O)c3c2)CCC4)c1O,organic,5.376750709602099
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,O=c1c2cc(NCc3cc(Br)ccc3O)ccc2nc2n1CCC2,7630.0,nM,=,CHEMBL4871454,active,O=c1c2cc(NCc3cc(Br)ccc3O)ccc2nc2n1CCC2,organic,5.117475462045119
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,O=c1c2cc(NCc3cc(F)ccc3O)ccc2nc2n1CCC2,6300.0,nM,=,CHEMBL4861468,active,O=c1c2cc(NCc3cc(F)ccc3O)ccc2nc2n1CCC2,organic,5.200659450546418
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,COc1ccc(CNc2ccc3nc4n(c(=O)c3c2)CCC4)c(O)c1,3910.0,nM,=,CHEMBL4852660,active,COc1ccc(CNc2ccc3nc4n(c(=O)c3c2)CCC4)c(O)c1,organic,5.407823242604133
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,Cc1cc2nc3n(c(=O)c2cc1NCc1ccccc1O)CCC3,5090.0,nM,=,CHEMBL4849288,active,Cc1cc2nc3n(c(=O)c2cc1NCc1ccccc1O)CCC3,organic,5.293282217663241
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,Cc1cc2nc3n(c(=O)c2cc1NCc1cccc(Br)c1O)CCC3,9270.0,nM,=,CHEMBL4879281,active,Cc1cc2nc3n(c(=O)c2cc1NCc1cccc(Br)c1O)CCC3,organic,5.032920265855503
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,Cc1cc2nc3n(c(=O)c2cc1NCc1ccc(Cl)cc1O)CCC3,6100.0,nM,=,CHEMBL4875354,active,Cc1cc2nc3n(c(=O)c2cc1NCc1ccc(Cl)cc1O)CCC3,organic,5.214670164989233
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,COc1cccc(CNc2cc3c(=O)n4c(nc3cc2C)CCC4)c1O,4260.0,nM,=,CHEMBL4870217,active,COc1cccc(CNc2cc3c(=O)n4c(nc3cc2C)CCC4)c1O,organic,5.370590400897281
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,Cc1cc2nc3n(c(=O)c2cc1NCc1cc(Br)ccc1O)CCC3,7370.0,nM,=,CHEMBL4853059,active,Cc1cc2nc3n(c(=O)c2cc1NCc1cc(Br)ccc1O)CCC3,organic,5.132532512140949
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,Cc1cc2nc3n(c(=O)c2cc1NCc1cc(F)ccc1O)CCC3,6330.0,nM,=,CHEMBL4856085,active,Cc1cc2nc3n(c(=O)c2cc1NCc1cc(F)ccc1O)CCC3,organic,5.198596289982645
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,COc1ccc(CNc2cc3c(=O)n4c(nc3cc2C)CCC4)c(O)c1,3220.0,nM,=,CHEMBL4860689,active,COc1ccc(CNc2cc3c(=O)n4c(nc3cc2C)CCC4)c(O)c1,organic,5.492144128304169
Inhibition of human amyloid beta (1 to 42) self-induced aggregation measured after 48 hrs by ThT flourescence assay,IC50,Oc1c(I)cc(Cl)c2cccnc12,9800.0,nM,=,CHEMBL497,active,Oc1c(I)cc(Cl)c2cccnc12,organic,5.008773924307505
Inhibition of self-induced aggregation amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,COc1c(O)c(O)c(C(=O)O)c(C)c1C/C=C(\C)CC/C=C(\C)CCC=C(C)C,6600.0,nM,=,CHEMBL4845912,active,COc1c(O)c(O)c(C(=O)O)c(C)c1C/C=C(\C)CC/C=C(\C)CCC=C(C)C,organic,5.180456064458132
Inhibition of self-induced aggregation amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,COC(=O)c1c(C)cc(O)c(C/C=C(\C)CCCC2=C/C(=C\C(C)(C)O)OC2=O)c1O,40700.0,nM,=,CHEMBL4847749,inactive,COC(=O)c1c(C)cc(O)c(C/C=C(\C)CCCC2=C/C(=C\C(C)(C)O)OC2=O)c1O,organic,4.39040559077478
Inhibition of self-induced aggregation amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,C/C(=C\Cc1c(O)cc(C)c(C(=O)O)c1O)CCCC1=C/C(=C\C(C)(C)O)OC1=O,51400.0,nM,=,CHEMBL4846858,inactive,C/C(=C\Cc1c(O)cc(C)c(C(=O)O)c1O)CCCC1=C/C(=C\C(C)(C)O)OC1=O,organic,4.289036881004725
Inhibition of self-induced aggregation amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,C/C(=C\Cc1c(O)cc(C)c(C(=O)O)c1O)CC/C=C(\C)CC[C@H](O)C(C)(C)O,53300.0,nM,=,CHEMBL4871044,inactive,C/C(=C\Cc1c(O)cc(C)c(C(=O)O)c1O)CC/C=C(\C)CC[C@H](O)C(C)(C)O,organic,4.273272790973428
Inhibition of self-induced aggregation amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,CC(C)=CCC/C(C)=C/CC/C(C)=C/Cc1c(O)cc(C)cc1O,148800.0,nM,=,CHEMBL487804,inactive,CC(C)=CCC/C(C)=C/CC/C(C)=C/Cc1c(O)cc(C)cc1O,organic,3.82739706879014
Inhibition of self-induced aggregation amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,CC(C)=CCC/C(C)=C/CC/C(C)=C/Cc1c(O)cc(C)c(C(=O)O)c1O,20300.0,nM,=,CHEMBL513978,inactive,CC(C)=CCC/C(C)=C/CC/C(C)=C/Cc1c(O)cc(C)c(C(=O)O)c1O,organic,4.692503962086787
Inhibition of self-induced aggregation amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,COC(=O)c1c(C)c(C/C=C(\C)CC/C=C(\C)CCC=C(C)C)c(OC)c(O)c1O,50300.0,nM,=,CHEMBL4877566,inactive,COC(=O)c1c(C)c(C/C=C(\C)CC/C=C(\C)CCC=C(C)C)c(OC)c(O)c1O,organic,4.298432014944073
Inhibition of self-induced aggregation amyloid beta (1 to 40) (unknown origin) incubated for 24 hrs by Thioflavin T based fluorometric assay,IC50,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,9900.0,nM,=,CHEMBL164,active,O=c1c(O)c(-c2cc(O)c(O)c(O)c2)oc2cc(O)cc(O)c12,organic,5.00436480540245
Inhibition of HFIP-pretreated human recombinant amyloid beta (1 to 42) self aggregation incubated up to 48 hrs under shaking condition and measured every 3 min by Thioflavin T based fluorescence assay,IC50,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCCNc3c4c(nc5ccccc35)CCCC4)cccc21,1100.0,nM,=,CHEMBL4850546,active,O=S(=O)(c1ccccc1)n1ccc2c(OCCNCCNc3c4c(nc5ccccc35)CCCC4)cccc21,organic,5.958607314841775
Inhibition of HFIP-pretreated human recombinant amyloid beta (1 to 42) self aggregation incubated up to 48 hrs under shaking condition and measured every 3 min by Thioflavin T based fluorescence assay,IC50,CCN(C)C(=O)Oc1cccc(CNCCNCCOc2cccc3c2ccn3S(=O)(=O)c2ccccc2)c1,1380.0,nM,=,CHEMBL4845823,active,CCN(C)C(=O)Oc1cccc(CNCCNCCOc2cccc3c2ccn3S(=O)(=O)c2ccccc2)c1,organic,5.860120913598763
Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,IC50,C[C@@]1(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)Cn2c(C#N)cnc2C(N)=N1,3.3,nM,=,CHEMBL2152899,active,C[C@@]1(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)Cn2c(C#N)cnc2C(N)=N1,organic,8.481486060122112
Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,IC50,C[C@@]1(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)Cn2cc(C#N)nc2C(N)=N1,8.5,nM,=,CHEMBL5085521,active,C[C@@]1(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)Cn2cc(C#N)nc2C(N)=N1,organic,8.070581074285707
Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,IC50,C[C@@]1(c2cc(NC(=O)c3ccc(F)cn3)ccc2F)Cn2c(C#N)cnc2C(N)=N1,12.6,nM,=,CHEMBL5088449,active,C[C@@]1(c2cc(NC(=O)c3ccc(F)cn3)ccc2F)Cn2c(C#N)cnc2C(N)=N1,organic,7.8996294548824375
Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,IC50,C[C@@]1(c2cc(NC(=O)c3ccc(Cl)cn3)ccc2F)Cn2c(C#N)cnc2C(N)=N1,3.6,nM,=,CHEMBL5075933,active,C[C@@]1(c2cc(NC(=O)c3ccc(Cl)cn3)ccc2F)Cn2c(C#N)cnc2C(N)=N1,organic,8.443697499232712
Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,IC50,COc1cnc(C(=O)Nc2ccc(F)c([C@]3(C)Cn4c(C#N)cnc4C(N)=N3)c2)cn1,6.3,nM,=,CHEMBL5073381,active,COc1cnc(C(=O)Nc2ccc(F)c([C@]3(C)Cn4c(C#N)cnc4C(N)=N3)c2)cn1,organic,8.200659450546418
Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,IC50,C[C@@]1(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)Cn2nc(C#N)cc2C(N)=N1,1.0,nM,=,CHEMBL5084378,active,C[C@@]1(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)Cn2nc(C#N)cc2C(N)=N1,organic,9.0
Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,IC50,C[C@@]1(c2cc(NC(=O)c3ccc(F)cn3)ccc2F)Cn2nc(C#N)cc2C(N)=N1,2.6,nM,=,CHEMBL5085412,active,C[C@@]1(c2cc(NC(=O)c3ccc(F)cn3)ccc2F)Cn2nc(C#N)cc2C(N)=N1,organic,8.585026652029182
Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,IC50,C[C@@]1(c2cc(NC(=O)c3ccc(OC(F)F)cn3)ccc2F)Cn2nc(C#N)cc2C(N)=N1,1.0,nM,=,CHEMBL5093303,active,C[C@@]1(c2cc(NC(=O)c3ccc(OC(F)F)cn3)ccc2F)Cn2nc(C#N)cc2C(N)=N1,organic,9.0
Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,IC50,Cc1nc(C(=O)Nc2ccc(F)c([C@]3(C)Cn4nc(C#N)cc4C(N)=N3)c2)co1,4.8,nM,=,CHEMBL5093195,active,Cc1nc(C(=O)Nc2ccc(F)c([C@]3(C)Cn4nc(C#N)cc4C(N)=N3)c2)co1,organic,8.318758762624412
Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,IC50,C[C@@]1(c2cc(NC(=O)c3cnc(C(F)F)cn3)ccc2F)Cn2nc(C#N)cc2C(N)=N1,2.5,nM,=,CHEMBL5077699,active,C[C@@]1(c2cc(NC(=O)c3cnc(C(F)F)cn3)ccc2F)Cn2nc(C#N)cc2C(N)=N1,organic,8.602059991327963
Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,IC50,C[C@@]1(c2cc(NC(=O)c3cnc(OCF)cn3)ccc2F)Cn2nc(C#N)cc2C(N)=N1,1.2,nM,=,CHEMBL5082406,active,C[C@@]1(c2cc(NC(=O)c3cnc(OCF)cn3)ccc2F)Cn2nc(C#N)cc2C(N)=N1,organic,8.920818753952375
Inhibition of human amyloid beta (1 to 42) in human SKNBE2 cells expressing wild-type amyloid precursor protein hAPP695 incubated for 18 hrs by sandwich ELISA,IC50,COc1cnc(C(=O)Nc2ccc(F)c([C@]3(C)Cn4nc(C#N)cc4C(N)=N3)c2)cn1,1.3,nM,=,CHEMBL5074068,active,COc1cnc(C(=O)Nc2ccc(F)c([C@]3(C)Cn4nc(C#N)cc4C(N)=N3)c2)cn1,organic,8.886056647693163
Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,IC50,Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1,98.0,nM,=,CHEMBL3261067,active,Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1,organic,7.008773924307505
Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,IC50,Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)n1,3.0,nM,=,CHEMBL3261069,active,Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)n1,organic,8.522878745280337
Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,IC50,Cc1cc(C#N)cnc1C(=O)Nc1cc([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c(F)cn1,98.0,nM,=,CHEMBL3261068,active,Cc1cc(C#N)cnc1C(=O)Nc1cc([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c(F)cn1,organic,7.008773924307505
Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,IC50,C[C@@]1(c2nc(NC(=O)c3ncc(C#N)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,3.0,nM,=,CHEMBL3670365,active,C[C@@]1(c2nc(NC(=O)c3ncc(C#N)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,organic,8.522878745280337
Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,IC50,C[C@@]1(c2nc(NC(=O)c3ncc(C#N)cc3N)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,5.0,nM,=,CHEMBL3670368,active,C[C@@]1(c2nc(NC(=O)c3ncc(C#N)cc3N)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,organic,8.301029995663981
Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,IC50,C[C@@]1(c2nc(NC(=O)c3ncc(OC(F)F)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,24.0,nM,=,CHEMBL3670371,active,C[C@@]1(c2nc(NC(=O)c3ncc(OC(F)F)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,organic,7.619788758288394
Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,IC50,C[C@@]1(c2nc(NC(=O)c3ncc(Cl)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,10.0,nM,=,CHEMBL3670372,active,C[C@@]1(c2nc(NC(=O)c3ncc(Cl)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,organic,8.0
Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,IC50,C[C@@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,3.0,nM,=,CHEMBL3670375,active,C[C@@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,organic,8.522878745280337
Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,IC50,C[C@@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3N)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,30.0,nM,=,CHEMBL5070669,active,C[C@@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3N)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,organic,7.522878745280337
Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,IC50,C[C@@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)nc3N)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,26.0,nM,=,CHEMBL3670385,active,C[C@@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)nc3N)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,organic,7.585026652029182
Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,IC50,C[C@@]1(c2nc(NC(=O)c3ncc(OCC(F)(F)F)nc3N)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,284.0,nM,=,CHEMBL3670367,active,C[C@@]1(c2nc(NC(=O)c3ncc(OCC(F)(F)F)nc3N)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,organic,6.546681659952962
Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,IC50,C[C@@]1(c2nc(NC(=O)c3ncc(OCCF)nc3N)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,263.0,nM,=,CHEMBL5089745,active,C[C@@]1(c2nc(NC(=O)c3ncc(OCCF)nc3N)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,organic,6.580044251510242
Inhibition of wild type APP751 (unknown origin) expressed in CHO cells,IC50,COCCOc1cnc(C(=O)Nc2ccc(F)c([C@]3(C)CO[C@@](C)(C(F)(F)F)C(N)=N3)n2)c(N)n1,23.0,nM,=,CHEMBL5080033,active,COCCOc1cnc(C(=O)Nc2ccc(F)c([C@]3(C)CO[C@@](C)(C(F)(F)F)C(N)=N3)n2)c(N)n1,organic,7.638272163982407
Inhibition of wild type human APP751 expressed in CHO cells assessed as reduction in amyloid beta42 level,IC50,C[C@@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,3.0,nM,=,CHEMBL3670375,active,C[C@@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,organic,8.522878745280337
Inhibition of wild type human APP751 expressed in CHO cells assessed as reduction in amyloid beta40 level,IC50,C[C@@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,4.0,nM,=,CHEMBL3670375,active,C[C@@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,organic,8.397940008672037
Inhibition of wild type human APP751 expressed in CHO cells assessed as reduction in amyloid beta(1 to 40 residues) level,IC50,C[C@@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,3.0,nM,=,CHEMBL3670375,active,C[C@@]1(c2nc(NC(=O)c3ncc(C(F)(F)F)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,organic,8.522878745280337
Inhibition of APP751 (unknown origin) expressed in CHO cells,IC50,C[C@@]1(c2cccc(NC(=O)c3ccc(Br)cn3)c2)CCSC(N)=N1,4.0,nM,=,CHEMBL5093426,active,C[C@@]1(c2cccc(NC(=O)c3ccc(Br)cn3)c2)CCSC(N)=N1,organic,8.397940008672037
Inhibition of wild type human APP expressed in CHO cells assessed as reduction in soluble APP beta level incubated for 24 hrs by immunoassay,IC50,Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1,4.0,nM,=,CHEMBL3261067,active,Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1,organic,8.397940008672037
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,C[C@@]1(c2cccc(NC(=O)c3ccc(Br)cn3)c2)COCC(N)=N1,17.0,nM,=,CHEMBL3653341,active,C[C@@]1(c2cccc(NC(=O)c3ccc(Br)cn3)c2)COCC(N)=N1,organic,7.769551078621726
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,CC1(c2cc(NC(=O)c3ccc(Br)cn3)ccc2F)COCC(N)=N1,3.0,nM,=,CHEMBL3653393,active,CC1(c2cc(NC(=O)c3ccc(Br)cn3)ccc2F)COCC(N)=N1,organic,8.522878745280337
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,C[C@]1(C(F)(F)F)OC[C@@](C)(c2cccc(NC(=O)c3ccc(Br)cn3)c2)N=C1N,1160.0,nM,=,CHEMBL4128145,active,C[C@]1(C(F)(F)F)OC[C@@](C)(c2cccc(NC(=O)c3ccc(Br)cn3)c2)N=C1N,organic,5.935542010773082
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,C[C@@]1(c2cccc(NC(=O)c3ccc(Br)cn3)c2)CO[C@@](C)(C(F)(F)F)C(N)=N1,32.0,nM,=,CHEMBL3653399,active,C[C@@]1(c2cccc(NC(=O)c3ccc(Br)cn3)c2)CO[C@@](C)(C(F)(F)F)C(N)=N1,organic,7.494850021680094
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,C[C@@]1(c2cc(NC(=O)c3ncc(Br)cn3)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,5.0,nM,=,CHEMBL3653404,active,C[C@@]1(c2cc(NC(=O)c3ncc(Br)cn3)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,organic,8.301029995663981
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,C[C@@]1(c2cc(NC(=O)c3ncc(C#N)cn3)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,24.0,nM,=,CHEMBL3653403,active,C[C@@]1(c2cc(NC(=O)c3ncc(C#N)cn3)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,organic,7.619788758288394
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,C[C@@]1(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,9.0,nM,=,CHEMBL3653405,active,C[C@@]1(c2cc(NC(=O)c3ccc(C#N)cn3)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,organic,8.045757490560675
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1,3.0,nM,=,CHEMBL3261067,active,Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1,organic,8.522878745280337
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,Cc1nc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1,105.0,nM,=,CHEMBL5077684,active,Cc1nc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1,organic,6.978810700930062
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,C[C@@]1(c2cc(NC(=O)c3ncc(C#N)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,4.0,nM,=,CHEMBL5073160,active,C[C@@]1(c2cc(NC(=O)c3ncc(C#N)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,organic,8.397940008672037
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,C[C@@]1(c2cc(NC(=O)c3ncc(C#N)cc3N)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,4.0,nM,=,CHEMBL5090563,active,C[C@@]1(c2cc(NC(=O)c3ncc(C#N)cc3N)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,organic,8.397940008672037
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,COc1cnc(C(=O)Nc2ccc(F)c([C@]3(C)CO[C@@](C)(C(F)(F)F)C(N)=N3)c2)c(C)c1,17.0,nM,=,CHEMBL5075177,active,COc1cnc(C(=O)Nc2ccc(F)c([C@]3(C)CO[C@@](C)(C(F)(F)F)C(N)=N3)c2)c(C)c1,organic,7.769551078621726
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,Cc1cc(OC(F)F)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1,6.0,nM,=,CHEMBL5086270,active,Cc1cc(OC(F)F)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1,organic,8.221848749616356
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,C[C@@]1(c2cc(NC(=O)c3ncc(OC(F)F)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,9.0,nM,=,CHEMBL5074449,active,C[C@@]1(c2cc(NC(=O)c3ncc(OC(F)F)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,organic,8.045757490560675
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,C[C@@]1(c2cc(NC(=O)c3ncc(Cl)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,22.0,nM,=,CHEMBL5085959,active,C[C@@]1(c2cc(NC(=O)c3ncc(Cl)cc3Cl)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,organic,7.657577319177793
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,C[C@@]1(c2cc(NC(=O)c3ccc(Br)cn3)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,22.0,nM,=,CHEMBL3653401,active,C[C@@]1(c2cc(NC(=O)c3ccc(Br)cn3)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,organic,7.657577319177793
Inhibition of wild type human APP751 expressed in CHO cells incubated for 24 hrs by immunoassay,IC50,C[C@@]1(c2cc(NC(=O)c3ccc(Br)cn3)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,22.0,nM,=,CHEMBL3653401,active,C[C@@]1(c2cc(NC(=O)c3ccc(Br)cn3)ccc2F)CO[C@@](C)(C(F)(F)F)C(N)=N1,organic,7.657577319177793
Inhibition of wild type human APP expressed in CHO cells assessed as reduction in amyloid beta 40 secretion incubated for 24 hrs by immunoassay,IC50,Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1,3.0,nM,=,CHEMBL3261067,active,Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1,organic,8.522878745280337
Inhibition of wild type human APP expressed in CHO cells assessed as reduction in amyloid beta 42 secretion incubated for 24 hrs by immunoassay,IC50,Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1,3.0,nM,=,CHEMBL3261067,active,Cc1cc(C#N)cnc1C(=O)Nc1ccc(F)c([C@]2(C)CO[C@@](C)(C(F)(F)F)C(N)=N2)c1,organic,8.522878745280337
